| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | COL6A5 COL24A1 COL21A1 COL2A1 COL4A1 COL4A2 COL4A3 COL4A6 COL5A1 COL5A2 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 COL6A6 COL28A1 COL27A1 COL5A3 MARCOL | 4.11e-27 | 46 | 233 | 20 | GO:0030020 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | COL6A5 COL24A1 COL21A1 ACAN COL2A1 COL4A1 COL4A2 COL4A3 COL4A6 COL5A1 COL5A2 HSPG2 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 ABI3BP COL6A6 COL28A1 COL27A1 COL5A3 ELN MARCOL | 3.03e-18 | 188 | 233 | 24 | GO:0005201 |
| GeneOntologyMolecularFunction | structural molecule activity | DLGAP1 RPS14 COL6A5 ADD1 COL24A1 COL21A1 ACAN AHNAK COL2A1 COL4A1 COL4A2 COL4A3 COL4A6 COL5A1 COL5A2 HSPG2 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 ABI3BP COL6A6 COL28A1 COL27A1 NUP98 COL5A3 SHANK3 LORICRIN ELN CTNND2 MARCOL | 1.56e-08 | 891 | 233 | 32 | GO:0005198 |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 2.59e-08 | 28 | 233 | 7 | GO:0051959 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 3.91e-08 | 18 | 233 | 6 | GO:0008569 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 4.07e-06 | 37 | 233 | 6 | GO:0045505 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.02e-05 | 118 | 233 | 9 | GO:0003774 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.73e-05 | 70 | 233 | 7 | GO:0003777 | |
| GeneOntologyMolecularFunction | mitogen-activated protein kinase binding | 5.06e-05 | 35 | 233 | 5 | GO:0051019 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | MYO1E RTEL1 RECQL4 HSPA1A DNAH5 HSPA1B DNAH8 DNAH9 DHX58 DYNC2H1 FIGNL2 RNF213 MMAA DNAH12 ABCB11 ACIN1 | 6.55e-05 | 441 | 233 | 16 | GO:0016887 |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYO1E RTEL1 RECQL4 HSPA1A DNAH5 HSPA1B DNAH8 DNAH9 DHX58 DYNC2H1 KIF26B FIGNL2 RNF213 DNAH1 MMAA DNAH12 ABCB11 ACIN1 MYO15A | 1.14e-04 | 614 | 233 | 19 | GO:0140657 |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | HDAC4 TRIP6 RXRB ADD1 TTC8 FOXL2 TAF4 HSPA1A HSPA1B MED13 DNMT1 WWP2 TACC2 ARNT EP300 | 1.22e-04 | 417 | 233 | 15 | GO:0061629 |
| GeneOntologyMolecularFunction | transcription factor binding | HDAC4 TRIP6 RXRB ADD1 TTC8 FOXL2 PER3 PTPRN TAF4 HSPA1A HSPA1B MED13 DNMT1 ZNF703 FLNA ZNF618 WWP2 SALL4 TACC2 ARNT EP300 | 2.11e-04 | 753 | 233 | 21 | GO:0008134 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | ABL1 ABI3 STUB1 MYO1E MARK3 ADGRV1 ADD1 HAUS8 PTPRN PXN MTCL1 CDK5R2 VASP FLNA ABI3BP KIF26B SYNE1 RAB3D PKD2L1 LASP1 SHANK3 CCDC88C NISCH ENAH RAB11FIP5 MYO15A EP300 | 2.12e-04 | 1099 | 233 | 27 | GO:0008092 |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic density | 2.41e-04 | 11 | 233 | 3 | GO:0098919 | |
| GeneOntologyMolecularFunction | platelet-derived growth factor binding | 3.19e-04 | 12 | 233 | 3 | GO:0048407 | |
| GeneOntologyMolecularFunction | denatured protein binding | 4.04e-04 | 3 | 233 | 2 | GO:0031249 | |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic specialization | 4.11e-04 | 13 | 233 | 3 | GO:0098879 | |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 4.22e-04 | 83 | 233 | 6 | GO:1990841 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | HDAC4 TRIP6 RXRB ADD1 TTC8 FOXL2 TAF4 HSPA1A HSPA1B MED13 DNMT1 ZNF703 FLNA WWP2 TACC2 ARNT EP300 | 5.08e-04 | 582 | 233 | 17 | GO:0140297 |
| GeneOntologyMolecularFunction | SMAD binding | 5.11e-04 | 86 | 233 | 6 | GO:0046332 | |
| GeneOntologyMolecularFunction | protein-containing complex destabilizing activity | 6.43e-04 | 15 | 233 | 3 | GO:0140776 | |
| GeneOntologyMolecularFunction | misfolded protein binding | 1.12e-03 | 18 | 233 | 3 | GO:0051787 | |
| GeneOntologyMolecularFunction | neuropilin binding | 1.32e-03 | 5 | 233 | 2 | GO:0038191 | |
| GeneOntologyMolecularFunction | death receptor agonist activity | 1.32e-03 | 5 | 233 | 2 | GO:0038177 | |
| GeneOntologyMolecularFunction | alpha-2A adrenergic receptor binding | 1.32e-03 | 5 | 233 | 2 | GO:0031694 | |
| GeneOntologyMolecularFunction | actin filament binding | 1.44e-03 | 227 | 233 | 9 | GO:0051015 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | MYO1E RTEL1 RAB22A RECQL4 HSPA1A DNAH5 HSPA1B DNAH8 DNAH9 DHX58 DYNC2H1 FIGNL2 RAB3D RNF213 MMAA DNAH12 GPN2 ABCB11 ACIN1 | 1.93e-03 | 775 | 233 | 19 | GO:0017111 |
| GeneOntologyMolecularFunction | ATP-dependent protein disaggregase activity | 1.97e-03 | 6 | 233 | 2 | GO:0140545 | |
| GeneOntologyMolecularFunction | C3HC4-type RING finger domain binding | 1.97e-03 | 6 | 233 | 2 | GO:0055131 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | MYO1E RTEL1 RAB22A RECQL4 HSPA1A DNAH5 HSPA1B DNAH8 DNAH9 PRUNE2 DHX58 DYNC2H1 FIGNL2 RAB3D RNF213 MMAA DNAH12 GPN2 ABCB11 ACIN1 | 2.04e-03 | 839 | 233 | 20 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | MYO1E RTEL1 RAB22A RECQL4 HSPA1A DNAH5 HSPA1B DNAH8 DNAH9 PRUNE2 DHX58 DYNC2H1 FIGNL2 RAB3D RNF213 MMAA DNAH12 GPN2 ABCB11 ACIN1 | 2.07e-03 | 840 | 233 | 20 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | MYO1E RTEL1 RAB22A RECQL4 HSPA1A DNAH5 HSPA1B DNAH8 DNAH9 PRUNE2 DHX58 DYNC2H1 FIGNL2 RAB3D RNF213 MMAA DNAH12 GPN2 ABCB11 ACIN1 | 2.07e-03 | 840 | 233 | 20 | GO:0016818 |
| GeneOntologyMolecularFunction | double-stranded RNA binding | 2.19e-03 | 78 | 233 | 5 | GO:0003725 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | SUPT20HL1 ZSWIM8 DLGAP1 ABL1 ABI3 HDAC4 STUB1 GON4L SUPT20HL2 IRS1 HCN2 RXRB MEN1 PXN MBD2 HSPA1A HSPA1B MED13 COL4A2 COL11A1 TCF20 LIMD1 SYNE1 NUP98 SHANK3 KMT2D PUS1 EP300 | 2.37e-03 | 1356 | 233 | 28 | GO:0060090 |
| GeneOntologyMolecularFunction | transcription coregulator activity | SUPT20HL1 ABL1 HDAC4 GON4L SUPT20HL2 RXRB HSPA1A HSPA1B MED13 TCF20 LIMD1 NUP98 KMT2D PUS1 EP300 | 2.59e-03 | 562 | 233 | 15 | GO:0003712 |
| GeneOntologyBiologicalProcess | extracellular matrix organization | ABL1 RAMP2 MYO1E COL24A1 ZNF469 ACAN COL2A1 COL4A1 COL4A2 COL4A3 COL4A6 COL5A1 COL5A2 HSPG2 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 ABI3BP COL28A1 COL27A1 COL5A3 APLP1 ELN MARCOL | 1.82e-13 | 377 | 233 | 26 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | ABL1 RAMP2 MYO1E COL24A1 ZNF469 ACAN COL2A1 COL4A1 COL4A2 COL4A3 COL4A6 COL5A1 COL5A2 HSPG2 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 ABI3BP COL28A1 COL27A1 COL5A3 APLP1 ELN MARCOL | 1.93e-13 | 378 | 233 | 26 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | ABL1 RAMP2 MYO1E COL24A1 ZNF469 ACAN COL2A1 COL4A1 COL4A2 COL4A3 COL4A6 COL5A1 COL5A2 HSPG2 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 ABI3BP COL28A1 COL27A1 COL5A3 APLP1 ELN MARCOL | 2.06e-13 | 379 | 233 | 26 | GO:0045229 |
| GeneOntologyBiologicalProcess | collagen fibril organization | 2.29e-06 | 76 | 233 | 8 | GO:0030199 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | ABL1 MYO1E ADD1 TTC8 HAUS8 ACAN PXN HSPA1A HSPA1B VASP COL2A1 COL5A1 COL5A2 HSPG2 FLNA COL11A1 COL28A1 COL27A1 ARHGAP17 COL5A3 TACC2 SPECC1L SHANK3 CCDC88C ENAH ELN MYO15A EP300 | 4.07e-06 | 957 | 233 | 28 | GO:0097435 |
| GeneOntologyBiologicalProcess | collagen-activated tyrosine kinase receptor signaling pathway | 7.32e-06 | 12 | 233 | 4 | GO:0038063 | |
| GeneOntologyBiologicalProcess | response to transforming growth factor beta | ABL1 STUB1 ING1 RYR1 MEN1 SKOR2 PXN HSPA1A DNMT1 COL4A2 ZNF703 LATS2 ZFHX3 MAPK7 EP300 | 9.01e-06 | 343 | 233 | 15 | GO:0071559 |
| GeneOntologyBiologicalProcess | cellular response to transforming growth factor beta stimulus | ABL1 STUB1 ING1 RYR1 MEN1 SKOR2 PXN HSPA1A DNMT1 COL4A2 ZNF703 LATS2 MAPK7 EP300 | 3.07e-05 | 336 | 233 | 14 | GO:0071560 |
| GeneOntologyBiologicalProcess | embryo development | SUPT20HL1 ABL1 MYO1E TRIP6 HLX SUPT20HL2 FOXI3 RXRB ADD1 MEN1 HOXB2 FOXL2 LRRC7 MBD2 VASP COL2A1 COL5A1 COL5A2 HSPG2 COL11A1 DYNC2H1 COL27A1 SALL4 SPECC1L SHANK3 SYDE1 ARNT KMT2D LATS2 ENAH PAX1 MAPK7 MYO15A EP300 | 3.35e-05 | 1437 | 233 | 34 | GO:0009790 |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | HLX FOXI3 ADARB1 RYR1 MEN1 TTC8 HOXB2 FOXL2 ACAN RECQL4 NKX6-1 COL2A1 COL5A1 COL5A2 HSPG2 FLNA ATG9B COL10A1 COL11A1 KIF26B COL27A1 MUC19 APLP1 SHANK3 SLC12A2 SP6 PAX1 ELN MYO15A EP300 SP7 | 4.27e-05 | 1269 | 233 | 31 | GO:0009887 |
| GeneOntologyBiologicalProcess | collagen-activated signaling pathway | 4.29e-05 | 18 | 233 | 4 | GO:0038065 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | SUPT20HL1 ABL1 HLX SUPT20HL2 MEN1 HOXB2 FOXL2 VASP COL2A1 COL5A1 COL5A2 HSPG2 COL11A1 DYNC2H1 SALL4 SPECC1L SHANK3 LATS2 ENAH MAPK7 MYO15A | 6.35e-05 | 713 | 233 | 21 | GO:0048598 |
| GeneOntologyBiologicalProcess | extracellular transport | 7.06e-05 | 62 | 233 | 6 | GO:0006858 | |
| GeneOntologyBiologicalProcess | skeletal system development | HDAC4 SPNS2 SLC10A7 RYR1 MEN1 HOXB2 ACAN RECQL4 COL2A1 COL5A2 HSPG2 ATG9B COL10A1 COL11A1 COL27A1 LRRK1 GPR68 PAX1 EP300 | 7.68e-05 | 615 | 233 | 19 | GO:0001501 |
| GeneOntologyBiologicalProcess | cell morphogenesis | ABL1 ABI3 NUMBL GBX1 ADARB1 ADD1 TTC8 SKOR2 PXN NKX6-1 DMRT1 CDK5R2 VASP CACNA1F HSPG2 FLNA ABI3BP LIMD1 SYNE1 COL27A1 APLP1 ZNF385A SHANK3 CCDC88C LATS2 ENAH CTNND2 ARHGEF26 EP300 | 8.52e-05 | 1194 | 233 | 29 | GO:0000902 |
| GeneOntologyBiologicalProcess | axonemal dynein complex assembly | 9.48e-05 | 41 | 233 | 5 | GO:0070286 | |
| GeneOntologyBiologicalProcess | epithelium development | FOXJ2 ABL1 MYO1E FOXI3 ADD1 MEN1 TTC8 HOXB2 FOXL2 PXN NKX6-1 DMRT1 VASP COL2A1 COL4A1 COL5A1 ZNF703 FLNA KIF26B COL27A1 FIGNL2 SALL4 SPECC1L SHANK3 CCDC88C LATS2 SLC12A2 LORICRIN ENAH PAX1 DUSP10 ARHGEF26 EP300 | 1.20e-04 | 1469 | 233 | 33 | GO:0060429 |
| GeneOntologyBiologicalProcess | regulation of supramolecular fiber organization | ABL1 ADD1 TTC8 HAUS8 PXN HSPA1A HSPA1B VASP HSPG2 FLNA SPECC1L SHANK3 CCDC88C ELN EP300 | 1.47e-04 | 438 | 233 | 15 | GO:1902903 |
| GeneOntologyBiologicalProcess | circulatory system development | FOXJ2 ABL1 RAMP2 MYO1E RXRB RYR1 ADD1 ACAN PXN MBD2 DNAH5 DNMT1 FOXL1 COL2A1 COL4A1 COL4A2 COL4A3 COL5A1 HSPG2 FLNA COL11A1 ABI3BP DYNC2H1 SYNE1 COL27A1 RNF213 SALL4 SYDE1 SLC12A2 ELN MAPK7 EP300 | 1.91e-04 | 1442 | 233 | 32 | GO:0072359 |
| GeneOntologyBiologicalProcess | bone development | SPNS2 SLC10A7 RYR1 COL2A1 HSPG2 ATG9B COL10A1 COL27A1 LRRK1 GPR68 PAX1 | 2.18e-04 | 264 | 233 | 11 | GO:0060348 |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | FOXJ2 SUPT20HL1 ABL1 HDAC4 MAFA SUPT20HL2 RXRB MEN1 HOXB2 FOXL2 PTPRN NKX6-1 TAF4 TAF5 DMRT1 MED13 TCF20 WWP2 SALL4 MLLT10 RFXAP ARNT KMT2D PUS1 ZFHX3 PAX1 SSBP4 MAPK7 PRDM15 EP300 SP7 | 2.23e-04 | 1390 | 233 | 31 | GO:0045944 |
| GeneOntologyBiologicalProcess | microtubule bundle formation | 2.48e-04 | 145 | 233 | 8 | GO:0001578 | |
| GeneOntologyBiologicalProcess | skeletal system morphogenesis | MEN1 HOXB2 ACAN RECQL4 COL2A1 HSPG2 ATG9B COL10A1 COL11A1 COL27A1 PAX1 | 3.29e-04 | 277 | 233 | 11 | GO:0048705 |
| GeneOntologyCellularComponent | complex of collagen trimers | COL2A1 COL4A1 COL4A2 COL4A3 COL4A6 COL5A1 COL5A2 COL7A1 COL10A1 COL11A1 COL28A1 COL27A1 COL5A3 | 4.91e-21 | 21 | 231 | 13 | GO:0098644 |
| GeneOntologyCellularComponent | collagen trimer | COL6A5 COL24A1 COL21A1 COL2A1 COL4A1 COL4A2 COL4A3 COL4A6 COL5A1 COL5A2 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 COL6A6 COL28A1 COL27A1 COL5A3 MARCO | 5.08e-21 | 88 | 231 | 20 | GO:0005581 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | IL16 COL6A5 COL24A1 COL21A1 ACAN COL2A1 COL4A1 COL4A2 COL4A3 COL4A6 COL5A1 COL5A2 HSPG2 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 ABI3BP COL6A6 COL28A1 COL27A1 COL5A3 APLP1 SDC3 ELN MARCOL MARCO | 7.73e-12 | 530 | 231 | 28 | GO:0062023 |
| GeneOntologyCellularComponent | fibrillar collagen trimer | 1.39e-11 | 12 | 231 | 7 | GO:0005583 | |
| GeneOntologyCellularComponent | banded collagen fibril | 1.39e-11 | 12 | 231 | 7 | GO:0098643 | |
| GeneOntologyCellularComponent | extracellular matrix | IL16 COL6A5 COL24A1 COL21A1 ACAN COL2A1 COL4A1 COL4A2 COL4A3 COL4A6 COL5A1 COL5A2 HSPG2 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 ABI3BP COL6A6 COL28A1 COL27A1 COL5A3 APLP1 SDC3 ELN MARCOL MARCO | 1.04e-09 | 656 | 231 | 28 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | IL16 COL6A5 COL24A1 COL21A1 ACAN COL2A1 COL4A1 COL4A2 COL4A3 COL4A6 COL5A1 COL5A2 HSPG2 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 ABI3BP COL6A6 COL28A1 COL27A1 COL5A3 APLP1 SDC3 ELN MARCOL MARCO | 1.11e-09 | 658 | 231 | 28 | GO:0030312 |
| GeneOntologyCellularComponent | network-forming collagen trimer | 8.60e-09 | 8 | 231 | 5 | GO:0098642 | |
| GeneOntologyCellularComponent | collagen network | 8.60e-09 | 8 | 231 | 5 | GO:0098645 | |
| GeneOntologyCellularComponent | collagen type V trimer | 1.45e-08 | 4 | 231 | 4 | GO:0005588 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | MEN1 COL24A1 COL21A1 COL2A1 COL4A1 COL4A2 COL4A3 COL4A6 COL5A1 COL5A2 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 COL28A1 COL27A1 COL5A3 | 3.41e-08 | 332 | 231 | 18 | GO:0005788 |
| GeneOntologyCellularComponent | collagen type XI trimer | 7.20e-08 | 5 | 231 | 4 | GO:0005592 | |
| GeneOntologyCellularComponent | basement membrane | ACAN COL2A1 COL4A1 COL4A2 COL4A3 COL4A6 COL5A1 HSPG2 COL7A1 COL28A1 APLP1 | 1.13e-07 | 122 | 231 | 11 | GO:0005604 |
| GeneOntologyCellularComponent | collagen type IV trimer | 2.14e-07 | 6 | 231 | 4 | GO:0005587 | |
| GeneOntologyCellularComponent | actin cytoskeleton | ABL1 HDAC4 MYO1E TRIP6 RAB22A ADD1 AHNAK PXN LRRC7 TAF5 VASP FLNA PKD2L1 LASP1 SPECC1L MST1R LPP ENAH PEAK1 MYO15A FYB1 PPP1R12C | 4.82e-07 | 576 | 231 | 22 | GO:0015629 |
| GeneOntologyCellularComponent | basement membrane collagen trimer | 9.82e-07 | 8 | 231 | 4 | GO:0098651 | |
| GeneOntologyCellularComponent | focal adhesion | IL16 TRIP6 RPS14 ADD1 AHNAK PXN HSPA1A HSPA1B VASP HSPG2 FLNA LIMD1 TNS2 LASP1 LPP ENAH PEAK1 | 6.65e-06 | 431 | 231 | 17 | GO:0005925 |
| GeneOntologyCellularComponent | axonemal dynein complex | 7.00e-06 | 25 | 231 | 5 | GO:0005858 | |
| GeneOntologyCellularComponent | supramolecular polymer | HDAC4 STUB1 RYR1 HAUS8 AHNAK MTCL1 DNAH5 DNAH8 DNAH9 COL2A1 COL4A1 COL4A2 COL4A3 COL4A6 COL5A1 COL5A2 FLNA COL10A1 COL11A1 DYNC2H1 KIF26B COL28A1 SYNE1 COL27A1 RAB3D COL5A3 SPECC1L DNAH1 DNAH12 ELN CEP170B | 7.64e-06 | 1187 | 231 | 31 | GO:0099081 |
| GeneOntologyCellularComponent | cell-substrate junction | IL16 TRIP6 RPS14 ADD1 AHNAK PXN HSPA1A HSPA1B VASP HSPG2 FLNA LIMD1 TNS2 LASP1 LPP ENAH PEAK1 | 9.51e-06 | 443 | 231 | 17 | GO:0030055 |
| GeneOntologyCellularComponent | dynein complex | 2.83e-05 | 54 | 231 | 6 | GO:0030286 | |
| GeneOntologyCellularComponent | anchoring junction | IL16 MYO1E TRIP6 RPS14 ADD1 AHNAK PXN LRRC7 HSPA1A HSPA1B VASP HSPG2 FLNA LIMD1 ARHGAP17 TNS2 GJC2 LASP1 SPECC1L CCDC88C LPP ENAH ABCB11 PEAK1 CTNND2 FYB1 | 3.16e-05 | 976 | 231 | 26 | GO:0070161 |
| GeneOntologyCellularComponent | chromatin | FOXJ2 SUPT20HL1 HDAC4 ING1 MAFA HLX GON4L GBX1 SUPT20HL2 RXRB MEN1 HOXB2 FOXL2 NKX6-1 TAF4 TAF5 DMRT1 MBD2 DNMT1 FOXL1 ZNF618 BICRA ISX SALL4 ZNF385A ZNF446 ARNT MORF4L2 SP6 ZFHX3 PAX1 EP300 SP7 | 9.06e-05 | 1480 | 231 | 33 | GO:0000785 |
| GeneOntologyCellularComponent | outer dynein arm | 2.72e-04 | 12 | 231 | 3 | GO:0036157 | |
| GeneOntologyCellularComponent | actomyosin | 3.25e-04 | 117 | 231 | 7 | GO:0042641 | |
| GeneOntologyCellularComponent | actin filament bundle | 3.43e-04 | 118 | 231 | 7 | GO:0032432 | |
| GeneOntologyCellularComponent | microtubule associated complex | 4.34e-04 | 161 | 231 | 8 | GO:0005875 | |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 6.18e-04 | 94 | 231 | 6 | GO:0000123 | |
| GeneOntologyCellularComponent | supramolecular fiber | HDAC4 STUB1 RYR1 HAUS8 AHNAK MTCL1 DNAH5 DNAH8 DNAH9 COL2A1 COL5A1 COL5A2 FLNA COL11A1 DYNC2H1 KIF26B COL28A1 SYNE1 COL27A1 RAB3D COL5A3 SPECC1L DNAH1 DNAH12 ELN CEP170B | 6.28e-04 | 1179 | 231 | 26 | GO:0099512 |
| GeneOntologyCellularComponent | collagen type IX trimer | 7.19e-04 | 4 | 231 | 2 | GO:0005594 | |
| GeneOntologyCellularComponent | SAGA-type complex | 8.82e-04 | 39 | 231 | 4 | GO:0070461 | |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 1.05e-03 | 104 | 231 | 6 | GO:0031248 | |
| GeneOntologyCellularComponent | nuclear body | ATXN2L IL16 ABL1 HDAC4 RTEL1 GON4L ADD1 HSPA1A HSPA1B TCF20 NUP98 RFXAP THOC6 ARNT SUGP2 YLPM1 CHFR ACIN1 ZFHX3 MAPK7 PRDM15 | 1.10e-03 | 903 | 231 | 21 | GO:0016604 |
| GeneOntologyCellularComponent | contractile actin filament bundle | 1.22e-03 | 107 | 231 | 6 | GO:0097517 | |
| GeneOntologyCellularComponent | stress fiber | 1.22e-03 | 107 | 231 | 6 | GO:0001725 | |
| GeneOntologyCellularComponent | acetyltransferase complex | 1.34e-03 | 109 | 231 | 6 | GO:1902493 | |
| GeneOntologyCellularComponent | dendritic shaft | 1.37e-03 | 74 | 231 | 5 | GO:0043198 | |
| GeneOntologyCellularComponent | FACIT collagen trimer | 1.77e-03 | 6 | 231 | 2 | GO:0005593 | |
| GeneOntologyCellularComponent | axoneme | 2.19e-03 | 207 | 231 | 8 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 2.26e-03 | 208 | 231 | 8 | GO:0097014 | |
| GeneOntologyCellularComponent | transcription regulator complex | HDAC4 RXRB MEN1 SKOR2 TAF4 TAF5 MBD2 LIMD1 SALL4 RFXAP ARNT PUS1 ZFHX3 PAX1 EP300 | 2.70e-03 | 596 | 231 | 15 | GO:0005667 |
| HumanPheno | Abnormality of dental structure | ABL1 RTEL1 ADGRV1 SLC10A7 ZNF469 RECQL4 HERC2 COL2A1 COL5A1 COL5A2 FLNA COL7A1 THOC6 VAC14 KMT2D SLC12A2 GPR68 SP6 PAX1 ELN EP300 SP7 | 5.26e-07 | 368 | 94 | 22 | HP:0011061 |
| HumanPheno | Carious teeth | ABL1 RTEL1 ADGRV1 SLC10A7 RECQL4 HERC2 COL2A1 COL7A1 THOC6 KMT2D PAX1 ELN EP300 | 1.48e-05 | 174 | 94 | 13 | HP:0000670 |
| HumanPheno | Abnormality of refraction | KMT2B HDAC4 MARK3 TBC1D2B ADGRV1 TTC8 ZNF469 FOXL2 RECQL4 TAF4 HERC2 COL2A1 COL4A1 COL4A3 COL4A6 COL5A1 CACNA1F HSPG2 FLNA COL9A3 COL11A1 TCF20 PPM1D BICRA SYNE1 GJC2 THOC6 ELN EP300 | 1.58e-05 | 709 | 94 | 29 | HP:0000539 |
| HumanPheno | Anisospondyly | 2.40e-05 | 4 | 94 | 3 | HP:0002879 | |
| HumanPheno | Abnormal forearm morphology | RECQL4 COL2A1 COL5A1 COL5A2 FLNA COL7A1 COL9A3 COL10A1 COL11A1 DYNC2H1 BICRA COL27A1 SALL4 ELN EP300 | 2.54e-05 | 239 | 94 | 15 | HP:0002973 |
| HumanPheno | Abnormal knee physiology | 2.64e-05 | 87 | 94 | 9 | HP:0034670 | |
| HumanPheno | Conductive hearing impairment | HDAC4 DNAJB13 TTC8 ZNF469 RECQL4 SLC25A11 TAF4 DNAH5 DNAH9 FOXL1 COL2A1 HSPG2 FLNA SALL4 DNAH1 KMT2D PAX1 EP300 SP7 | 3.68e-05 | 373 | 94 | 19 | HP:0000405 |
| HumanPheno | Lower extremity joint dislocation | HDAC4 SLC10A7 RYR1 ZNF469 RECQL4 COL2A1 COL5A1 COL5A2 HSPG2 FLNA SYNE1 COL27A1 VAC14 KMT2D SLC12A2 ELN EP300 | 5.53e-05 | 318 | 94 | 17 | HP:0030311 |
| HumanPheno | Abnormality of the knee | STUB1 ADGRV1 SLC10A7 RYR1 ACAN RECQL4 TAF4 HERC2 COL2A1 COL5A1 COL5A2 HSPG2 FLNA COL7A1 COL9A3 COL10A1 COL11A1 SYNE1 CCDC88C VAC14 ELN EP300 | 5.86e-05 | 491 | 94 | 22 | HP:0002815 |
| HumanPheno | Functional abnormality of the middle ear | HDAC4 DNAJB13 TTC8 ZNF469 RECQL4 SLC25A11 TAF4 DNAH5 DNAH9 FOXL1 COL2A1 HSPG2 FLNA SALL4 DNAH1 KMT2D PAX1 EP300 SP7 | 5.91e-05 | 386 | 94 | 19 | HP:0011452 |
| HumanPheno | Abnormal forearm bone morphology | RECQL4 COL2A1 COL5A1 COL5A2 FLNA COL9A3 COL10A1 COL11A1 DYNC2H1 BICRA COL27A1 SALL4 ELN EP300 | 9.03e-05 | 236 | 94 | 14 | HP:0040072 |
| HumanPheno | Abnormality of the joints of the lower limbs | STUB1 ADGRV1 SLC10A7 RYR1 ACAN RECQL4 TAF4 HERC2 COL2A1 COL5A1 COL5A2 HSPG2 FLNA COL7A1 COL9A3 COL10A1 COL11A1 SYNE1 GJC2 CCDC88C VAC14 ELN EP300 | 1.03e-04 | 547 | 94 | 23 | HP:0100239 |
| HumanPheno | Intestinal malrotation | ABL1 DNAJB13 DNAH5 DNAH9 FLNA DYNC2H1 SALL4 DNAH1 KMT2D SLC12A2 EP300 | 1.27e-04 | 157 | 94 | 11 | HP:0002566 |
| HumanPheno | Abnormality of the chin | ABL1 TBC1D2B SLC10A7 MEN1 ACAN RECQL4 TAF4 HERC2 COL2A1 HSPG2 FLNA BICRA SPECC1L SHANK3 THOC6 VAC14 KMT2D SLC12A2 ELN | 1.29e-04 | 409 | 94 | 19 | HP:0000306 |
| HumanPheno | Joint hypermobility | CEP104 ABL1 HDAC4 SLC10A7 RYR1 TTC8 ZNF469 ACAN TAF4 COL2A1 COL5A1 COL5A2 FLNA COL9A3 COL11A1 BICRA SHANK3 KMT2D PUS1 ELN CTNND2 EP300 SP7 | 1.36e-04 | 557 | 94 | 23 | HP:0001382 |
| HumanPheno | Congenital hip dislocation | 1.37e-04 | 84 | 94 | 8 | HP:0001374 | |
| HumanPheno | Myopia | ADGRV1 TTC8 ZNF469 RECQL4 HERC2 COL2A1 COL4A1 COL4A3 COL4A6 COL5A1 CACNA1F HSPG2 FLNA COL9A3 COL11A1 TCF20 BICRA GJC2 THOC6 ELN | 1.40e-04 | 447 | 94 | 20 | HP:0000545 |
| HumanPheno | Abnormal morphology of the radius | RECQL4 COL2A1 COL5A1 COL5A2 FLNA COL9A3 COL10A1 COL11A1 BICRA COL27A1 SALL4 ELN EP300 | 1.49e-04 | 217 | 94 | 13 | HP:0002818 |
| HumanPheno | Abnormal patella morphology | 1.57e-04 | 109 | 94 | 9 | HP:0003045 | |
| HumanPheno | Osteoarthritis | 1.69e-04 | 65 | 94 | 7 | HP:0002758 | |
| HumanPheno | Abnormal hip joint morphology | HDAC4 SLC10A7 RYR1 ZNF469 RECQL4 HERC2 COL2A1 COL5A1 COL5A2 HSPG2 FLNA COL9A3 COL10A1 DYNC2H1 BICRA COL27A1 VAC14 KMT2D SLC12A2 ELN EP300 | 1.70e-04 | 490 | 94 | 21 | HP:0001384 |
| HumanPheno | Hyperlordosis | SLC10A7 RYR1 ACAN TAF4 COL2A1 HSPG2 COL10A1 PPM1D SYNE1 COL27A1 VAC14 PUS1 ELN | 1.88e-04 | 222 | 94 | 13 | HP:0003307 |
| HumanPheno | Lordosis | SLC10A7 RYR1 ACAN TAF4 COL2A1 HSPG2 COL10A1 PPM1D SYNE1 COL27A1 VAC14 PUS1 ELN | 1.88e-04 | 222 | 94 | 13 | HP:0002939 |
| HumanPheno | Amblyopia | 1.94e-04 | 112 | 94 | 9 | HP:0000646 | |
| HumanPheno | Molluscoid pseudotumors | 2.02e-04 | 7 | 94 | 3 | HP:0000993 | |
| HumanPheno | Uterine prolapse | 2.02e-04 | 7 | 94 | 3 | HP:0000139 | |
| HumanPheno | Joint dislocation | HDAC4 SLC10A7 RYR1 ZNF469 RECQL4 COL2A1 COL5A1 COL5A2 HSPG2 FLNA SYNE1 COL27A1 SALL4 VAC14 KMT2D SLC12A2 ELN EP300 | 2.18e-04 | 390 | 94 | 18 | HP:0001373 |
| HumanPheno | Abnormal synovial membrane morphology | HDAC4 SLC10A7 RYR1 ZNF469 RECQL4 HERC2 COL2A1 COL5A1 COL5A2 HSPG2 FLNA COL9A3 COL10A1 DYNC2H1 BICRA COL27A1 VAC14 KMT2D SLC12A2 ELN EP300 | 2.46e-04 | 503 | 94 | 21 | HP:0005262 |
| HumanPheno | Hip dislocation | HDAC4 RYR1 ZNF469 RECQL4 COL2A1 COL5A1 COL5A2 HSPG2 FLNA COL27A1 VAC14 KMT2D SLC12A2 ELN | 2.85e-04 | 263 | 94 | 14 | HP:0002827 |
| HumanPheno | Narrow palpebral fissure | 2.96e-04 | 71 | 94 | 7 | HP:0045025 | |
| HumanPheno | Abnormal lower limb epiphysis morphology | 3.02e-04 | 94 | 94 | 8 | HP:0006500 | |
| HumanPheno | Genital hernia | 3.19e-04 | 8 | 94 | 3 | HP:0100823 | |
| HumanPheno | Chronic constipation | 3.27e-04 | 120 | 94 | 9 | HP:0012450 | |
| HumanPheno | Internal tibial torsion | 3.37e-04 | 2 | 94 | 2 | HP:0034372 | |
| HumanPheno | Narrow maxilla | 3.37e-04 | 2 | 94 | 2 | HP:0002010 | |
| HumanPheno | Reduced respiratory ciliary beating frequency | 3.37e-04 | 2 | 94 | 2 | HP:0033158 | |
| HumanPheno | Shoulder dislocation | 4.20e-04 | 20 | 94 | 4 | HP:0003834 | |
| HumanPheno | Lumbar hyperlordosis | 4.30e-04 | 99 | 94 | 8 | HP:0002938 | |
| MousePheno | abnormal head morphology | KMT2B RTEL1 GON4L FOXI3 SLC10A7 RYR1 TTC8 HOXB2 MAST4 ACAN SKOR2 RECQL4 DNAH5 CRAMP1 COL2A1 COL4A2 HSPG2 FLNA COL7A1 COL10A1 COL11A1 ABI3BP DYNC2H1 WWP2 COL27A1 SALL4 LASP1 SPECC1L LRRK1 MLLT10 ARNT KMT2D NISCH SP6 PEAK1 MAPK7 PRDM15 EP300 | 1.70e-07 | 1120 | 193 | 38 | MP:0000432 |
| MousePheno | abnormal facial morphology | GON4L FOXI3 SLC10A7 RYR1 TTC8 HOXB2 MAST4 ACAN SKOR2 RECQL4 DNAH5 CRAMP1 COL2A1 HSPG2 FLNA COL7A1 COL10A1 COL11A1 ABI3BP DYNC2H1 WWP2 COL27A1 SALL4 LASP1 SPECC1L LRRK1 MLLT10 KMT2D NISCH SP6 PEAK1 EP300 | 8.78e-07 | 910 | 193 | 32 | MP:0003743 |
| MousePheno | abnormal craniofacial morphology | ABL1 HDAC4 TRIP6 GON4L FOXI3 SLC10A7 RYR1 MEN1 TTC8 HOXB2 MAST4 ACAN SKOR2 RECQL4 DNAH5 CRAMP1 COL2A1 COL4A2 HSPG2 FLNA COL7A1 COL10A1 COL11A1 ABI3BP DYNC2H1 WWP2 COL27A1 SALL4 LASP1 SPECC1L LRRK1 MLLT10 ARNT KMT2D LATS2 NISCH SP6 PAX1 PEAK1 MAPK7 EP300 | 1.47e-06 | 1372 | 193 | 41 | MP:0000428 |
| MousePheno | craniofacial phenotype | ABL1 HDAC4 TRIP6 GON4L FOXI3 SLC10A7 RYR1 MEN1 TTC8 HOXB2 MAST4 ACAN SKOR2 RECQL4 DNAH5 CRAMP1 COL2A1 COL4A2 HSPG2 FLNA COL7A1 COL10A1 COL11A1 ABI3BP DYNC2H1 WWP2 COL27A1 SALL4 LASP1 SPECC1L LRRK1 MLLT10 ARNT KMT2D LATS2 NISCH SP6 PAX1 PEAK1 MAPK7 EP300 | 1.47e-06 | 1372 | 193 | 41 | MP:0005382 |
| MousePheno | postnatal lethality | ABL1 HDAC4 STUB1 MARK3 IRS1 FOXI3 HCN2 ADARB1 TTC8 HOXB2 FOXL2 RECQL4 LRRC7 HERC2 DNAH5 FOXL1 COL2A1 COL4A1 COL4A2 COL5A2 FLNA COL7A1 COL10A1 TCF20 SYNE1 SALL4 ZNF385A VAC14 SLC12A2 NISCH ELAVL2 ZFHX3 ELN EP300 | 4.93e-06 | 1084 | 193 | 34 | MP:0002082 |
| MousePheno | abnormal mouth morphology | GON4L FOXI3 SLC10A7 RYR1 HOXB2 MAST4 ACAN SKOR2 RECQL4 CRAMP1 COL2A1 HSPG2 FLNA COL7A1 COL10A1 COL11A1 ABI3BP DYNC2H1 WWP2 COL27A1 LASP1 SPECC1L LRRK1 SP6 PEAK1 | 5.72e-06 | 670 | 193 | 25 | MP:0000452 |
| MousePheno | abnormal cartilage development | HDAC4 IRS1 SLC10A7 ACAN CACNA1H COL2A1 HSPG2 COL10A1 COL11A1 COL27A1 PAX1 | 2.67e-05 | 172 | 193 | 11 | MP:0000164 |
| MousePheno | abnormal long bone epiphyseal plate proliferative zone | 4.08e-05 | 68 | 193 | 7 | MP:0003662 | |
| MousePheno | postnatal lethality, incomplete penetrance | ABL1 STUB1 HCN2 TTC8 HOXB2 FOXL2 RECQL4 HERC2 FOXL1 COL2A1 COL4A1 COL5A2 FLNA COL10A1 TCF20 SYNE1 SALL4 ZNF385A SLC12A2 NISCH ELAVL2 ZFHX3 EP300 | 5.04e-05 | 669 | 193 | 23 | MP:0011086 |
| MousePheno | hemorrhage | RAMP2 MYO1E RTEL1 MEN1 TMEM145 COL2A1 COL4A1 COL4A2 COL4A3 HSPG2 FLNA BICRA COL27A1 ZNF385A MLLT10 ARNT LATS2 SLC12A2 EIF4B MAPK7 NEURL4 EP300 | 1.27e-04 | 664 | 193 | 22 | MP:0001914 |
| MousePheno | abnormal jaw morphology | FOXI3 SLC10A7 MAST4 RECQL4 DNAH5 COL2A1 HSPG2 COL10A1 COL11A1 ABI3BP DYNC2H1 WWP2 COL27A1 LRRK1 KMT2D NISCH SP6 PAX1 PEAK1 | 1.38e-04 | 530 | 193 | 19 | MP:0000454 |
| MousePheno | abnormal cranium morphology | ABL1 HDAC4 TRIP6 FOXI3 SLC10A7 RYR1 MAST4 ACAN RECQL4 DNAH5 COL2A1 HSPG2 COL10A1 COL11A1 ABI3BP DYNC2H1 WWP2 COL27A1 SALL4 LRRK1 KMT2D NISCH SP6 PAX1 PEAK1 | 1.40e-04 | 813 | 193 | 25 | MP:0000438 |
| MousePheno | abnormal chondrocyte morphology | 1.47e-04 | 83 | 193 | 7 | MP:0000166 | |
| MousePheno | abnormal digestive system morphology | ABL1 HLX GON4L FOXI3 RYR1 MEN1 CAMKV ACAN SKOR2 RECQL4 PXN DNAH5 CRAMP1 FOXL1 COL2A1 COL4A2 HSPG2 FLNA COL7A1 COL11A1 DYNC2H1 COL27A1 PHRF1 MUC19 ARHGAP17 TNS2 SALL4 LASP1 SPECC1L MLLT10 SLC12A2 MAPK7 EP300 | 1.63e-04 | 1233 | 193 | 33 | MP:0000462 |
| MousePheno | domed cranium | 1.71e-04 | 85 | 193 | 7 | MP:0000440 | |
| MousePheno | abnormal craniofacial bone morphology | ABL1 HDAC4 TRIP6 FOXI3 SLC10A7 RYR1 MAST4 ACAN RECQL4 DNAH5 COL2A1 HSPG2 COL10A1 COL11A1 ABI3BP DYNC2H1 WWP2 COL27A1 SALL4 LRRK1 KMT2D NISCH SP6 PAX1 PEAK1 | 1.83e-04 | 827 | 193 | 25 | MP:0002116 |
| MousePheno | abnormal long bone metaphysis morphology | 1.87e-04 | 39 | 193 | 5 | MP:0000133 | |
| MousePheno | cleft palate | FOXI3 RYR1 ACAN SKOR2 RECQL4 CRAMP1 COL2A1 HSPG2 FLNA COL11A1 COL27A1 LASP1 SPECC1L | 1.91e-04 | 289 | 193 | 13 | MP:0000111 |
| MousePheno | oral cleft | FOXI3 RYR1 ACAN SKOR2 RECQL4 CRAMP1 COL2A1 HSPG2 FLNA COL11A1 COL27A1 LASP1 SPECC1L | 2.04e-04 | 291 | 193 | 13 | MP:0021164 |
| MousePheno | abnormal viscerocranium morphology | FOXI3 SLC10A7 MAST4 RECQL4 DNAH5 COL2A1 HSPG2 COL10A1 COL11A1 ABI3BP DYNC2H1 WWP2 COL27A1 SALL4 LRRK1 KMT2D NISCH SP6 PAX1 PEAK1 | 2.07e-04 | 593 | 193 | 20 | MP:0005274 |
| Domain | Collagen | COL6A5 COL24A1 COL21A1 COL2A1 COL4A1 COL4A2 COL4A3 COL4A6 COL5A1 COL5A2 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 COL6A6 COL28A1 COL27A1 COL5A3 MARCO | 1.48e-20 | 85 | 227 | 20 | IPR008160 |
| Domain | Collagen | COL6A5 COL24A1 COL21A1 COL2A1 COL4A1 COL4A2 COL4A3 COL4A6 COL5A1 COL5A2 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 COL6A6 COL28A1 COL27A1 COL5A3 MARCO | 1.48e-20 | 85 | 227 | 20 | PF01391 |
| Domain | NC1_FIB | 1.13e-11 | 11 | 227 | 7 | PS51461 | |
| Domain | Fib_collagen_C | 1.13e-11 | 11 | 227 | 7 | PD002078 | |
| Domain | Fib_collagen_C | 1.13e-11 | 11 | 227 | 7 | IPR000885 | |
| Domain | COLFI | 1.13e-11 | 11 | 227 | 7 | PF01410 | |
| Domain | COLFI | 1.13e-11 | 11 | 227 | 7 | SM00038 | |
| Domain | TSPN | 7.42e-09 | 23 | 227 | 7 | SM00210 | |
| Domain | Dynein_heavy_chain_D4_dom | 8.35e-09 | 14 | 227 | 6 | IPR024317 | |
| Domain | Dynein_heavy_dom-2 | 8.35e-09 | 14 | 227 | 6 | IPR013602 | |
| Domain | DHC_N2 | 8.35e-09 | 14 | 227 | 6 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 8.35e-09 | 14 | 227 | 6 | IPR011704 | |
| Domain | AAA_8 | 8.35e-09 | 14 | 227 | 6 | PF12780 | |
| Domain | AAA_5 | 8.35e-09 | 14 | 227 | 6 | PF07728 | |
| Domain | DHC_fam | 1.38e-08 | 15 | 227 | 6 | IPR026983 | |
| Domain | Dynein_heavy | 1.38e-08 | 15 | 227 | 6 | PF03028 | |
| Domain | Dynein_heavy_dom | 1.38e-08 | 15 | 227 | 6 | IPR004273 | |
| Domain | C4 | 3.13e-07 | 6 | 227 | 4 | SM00111 | |
| Domain | Collagen_VI_NC | 3.13e-07 | 6 | 227 | 4 | IPR001442 | |
| Domain | NC1_IV | 3.13e-07 | 6 | 227 | 4 | PS51403 | |
| Domain | - | 3.13e-07 | 6 | 227 | 4 | 2.170.240.10 | |
| Domain | C4 | 3.13e-07 | 6 | 227 | 4 | PF01413 | |
| Domain | Dynein_HC_stalk | 4.65e-07 | 14 | 227 | 5 | IPR024743 | |
| Domain | MT | 4.65e-07 | 14 | 227 | 5 | PF12777 | |
| Domain | Laminin_G | 4.78e-07 | 58 | 227 | 8 | IPR001791 | |
| Domain | DHC_N1 | 1.43e-06 | 8 | 227 | 4 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 1.43e-06 | 8 | 227 | 4 | IPR013594 | |
| Domain | FYrich_C | 1.74e-05 | 5 | 227 | 3 | IPR003889 | |
| Domain | FYrich_N | 1.74e-05 | 5 | 227 | 3 | IPR003888 | |
| Domain | FYRC | 1.74e-05 | 5 | 227 | 3 | SM00542 | |
| Domain | FYRN | 1.74e-05 | 5 | 227 | 3 | SM00541 | |
| Domain | FYRN | 1.74e-05 | 5 | 227 | 3 | PF05964 | |
| Domain | FYRC | 1.74e-05 | 5 | 227 | 3 | PF05965 | |
| Domain | FYRC | 1.74e-05 | 5 | 227 | 3 | PS51543 | |
| Domain | FYRN | 1.74e-05 | 5 | 227 | 3 | PS51542 | |
| Domain | - | 2.06e-05 | 95 | 227 | 8 | 2.60.120.200 | |
| Domain | AAA | 6.79e-05 | 144 | 227 | 9 | SM00382 | |
| Domain | AAA+_ATPase | 6.79e-05 | 144 | 227 | 9 | IPR003593 | |
| Domain | ConA-like_dom | ADGRV1 RYR1 COL24A1 COL21A1 COL5A1 HSPG2 COL11A1 COL16A1 COL27A1 COL5A3 NEURL4 | 7.93e-05 | 219 | 227 | 11 | IPR013320 |
| Domain | Laminin_G_2 | 1.18e-04 | 40 | 227 | 5 | PF02210 | |
| Domain | EPHD | 1.31e-04 | 22 | 227 | 4 | PS51805 | |
| Domain | VASP_tetra | 4.38e-04 | 3 | 227 | 2 | PF08776 | |
| Domain | hSH3 | 4.38e-04 | 3 | 227 | 2 | PF14603 | |
| Domain | VASP_tetra | 4.38e-04 | 3 | 227 | 2 | IPR014885 | |
| Domain | hSH3 | 4.38e-04 | 3 | 227 | 2 | IPR029294 | |
| Domain | VWA | 5.85e-04 | 56 | 227 | 5 | PF00092 | |
| Domain | PHD | 7.57e-04 | 89 | 227 | 6 | SM00249 | |
| Domain | - | MYO1E RTEL1 RAB22A RECQL4 DNAH5 DNAH8 DNAH9 DHX58 DYNC2H1 FIGNL2 RAB3D RNF213 LRRK1 DNAH1 MMAA DNAH12 GPN2 YLPM1 ABCB11 MYO15A | 8.11e-04 | 746 | 227 | 20 | 3.40.50.300 |
| Domain | Znf_PHD | 8.51e-04 | 91 | 227 | 6 | IPR001965 | |
| Domain | ZF_PHD_2 | 1.07e-03 | 95 | 227 | 6 | PS50016 | |
| Domain | ZF_PHD_1 | 1.13e-03 | 96 | 227 | 6 | PS01359 | |
| Domain | LAM_G_DOMAIN | 1.13e-03 | 38 | 227 | 4 | PS50025 | |
| Domain | SH3 | 1.34e-03 | 216 | 227 | 9 | SM00326 | |
| Domain | NUT | 1.44e-03 | 5 | 227 | 2 | IPR024310 | |
| Domain | NUT_N | 1.44e-03 | 5 | 227 | 2 | IPR024309 | |
| Domain | NUT | 1.44e-03 | 5 | 227 | 2 | PF12881 | |
| Domain | LIM | 1.52e-03 | 69 | 227 | 5 | PF00412 | |
| Domain | SH3_domain | 1.52e-03 | 220 | 227 | 9 | IPR001452 | |
| Domain | - | 1.62e-03 | 70 | 227 | 5 | 2.10.110.10 | |
| Domain | P-loop_NTPase | MYO1E RTEL1 RAB22A RECQL4 DNAH5 DNAH8 DNAH9 DHX58 DYNC2H1 KIF26B FIGNL2 RAB3D RNF213 LRRK1 DNAH1 MMAA DNAH12 GPN2 YLPM1 ABCB11 MYO15A | 1.62e-03 | 848 | 227 | 21 | IPR027417 |
| Domain | LIM | 1.72e-03 | 71 | 227 | 5 | SM00132 | |
| Domain | Znf_LIM | 1.72e-03 | 71 | 227 | 5 | IPR001781 | |
| Domain | LIM_DOMAIN_1 | 1.72e-03 | 71 | 227 | 5 | PS00478 | |
| Domain | LIM_DOMAIN_2 | 1.72e-03 | 71 | 227 | 5 | PS50023 | |
| Domain | LamG | 1.97e-03 | 44 | 227 | 4 | SM00282 | |
| Domain | - | 2.07e-03 | 74 | 227 | 5 | 3.40.50.410 | |
| Domain | PHD | 2.20e-03 | 75 | 227 | 5 | PF00628 | |
| Domain | TF_fork_head_CS_2 | 2.32e-03 | 46 | 227 | 4 | IPR030456 | |
| Domain | TF_fork_head_CS_1 | 2.52e-03 | 47 | 227 | 4 | IPR018122 | |
| Domain | PAS_fold_3 | 2.62e-03 | 23 | 227 | 3 | IPR013655 | |
| Domain | PAS_3 | 2.62e-03 | 23 | 227 | 3 | PF08447 | |
| Domain | Znf_PHD-finger | 2.76e-03 | 79 | 227 | 5 | IPR019787 | |
| Domain | FH | 2.93e-03 | 49 | 227 | 4 | SM00339 | |
| Domain | FORK_HEAD_1 | 2.93e-03 | 49 | 227 | 4 | PS00657 | |
| Domain | FORK_HEAD_2 | 2.93e-03 | 49 | 227 | 4 | PS00658 | |
| Domain | Fork_head_dom | 2.93e-03 | 49 | 227 | 4 | IPR001766 | |
| Domain | FORK_HEAD_3 | 2.93e-03 | 49 | 227 | 4 | PS50039 | |
| Domain | Forkhead | 2.93e-03 | 49 | 227 | 4 | PF00250 | |
| Domain | PAS-assoc_C | 2.97e-03 | 24 | 227 | 3 | IPR000700 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL6A5 COL24A1 COL21A1 COL2A1 COL4A1 COL4A2 COL4A3 COL4A6 COL5A1 COL5A2 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 COL6A6 COL28A1 COL27A1 COL5A3 | 5.92e-26 | 44 | 163 | 19 | M27812 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL6A5 COL24A1 COL21A1 COL2A1 COL4A1 COL4A2 COL4A3 COL4A6 COL5A1 COL5A2 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 COL6A6 COL28A1 COL27A1 COL5A3 | 8.10e-22 | 67 | 163 | 19 | M26999 |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL6A5 COL2A1 COL4A1 COL4A2 COL4A3 COL4A6 COL5A1 COL5A2 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 COL6A6 COL28A1 COL5A3 | 3.87e-21 | 41 | 163 | 16 | MM15538 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL6A5 COL24A1 COL21A1 COL2A1 COL4A1 COL4A2 COL4A3 COL4A6 COL5A1 COL5A2 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 COL6A6 COL28A1 COL27A1 COL5A3 | 3.85e-19 | 90 | 163 | 19 | M631 |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | COL6A5 COL24A1 COL2A1 COL4A1 COL4A2 COL4A3 COL4A6 COL5A1 COL5A2 COL7A1 COL9A3 COL10A1 COL11A1 COL6A6 COL27A1 COL5A3 | 6.26e-18 | 61 | 163 | 16 | M27103 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL6A5 COL2A1 COL4A1 COL4A2 COL4A3 COL4A6 COL5A1 COL5A2 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 COL6A6 COL28A1 COL5A3 | 6.26e-18 | 61 | 163 | 16 | MM14637 |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | COL6A5 COL2A1 COL4A1 COL4A2 COL4A3 COL4A6 COL5A1 COL5A2 COL7A1 COL9A3 COL10A1 COL11A1 COL6A6 COL5A3 | 2.84e-16 | 50 | 163 | 14 | MM14796 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL6A5 COL2A1 COL4A1 COL4A2 COL4A3 COL4A6 COL5A1 COL5A2 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 COL6A6 COL28A1 COL5A3 | 2.88e-16 | 76 | 163 | 16 | MM14573 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | COL6A5 COL2A1 COL4A1 COL4A2 COL4A3 COL4A6 COL5A1 COL5A2 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 COL6A6 COL5A3 | 4.49e-16 | 64 | 163 | 15 | M26953 |
| Pathway | REACTOME_NCAM1_INTERACTIONS | COL6A5 COL2A1 COL4A1 COL4A2 COL4A3 COL5A1 COL5A2 COL9A3 COL6A6 COL5A3 | 5.41e-15 | 20 | 163 | 10 | MM15061 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | COL6A5 COL2A1 COL4A1 COL4A2 COL4A3 COL4A6 COL5A1 COL5A2 COL7A1 COL10A1 COL11A1 COL6A6 COL5A3 | 2.30e-14 | 53 | 163 | 13 | MM14566 |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | COL6A5 ACAN COL2A1 COL4A1 COL4A2 COL4A3 COL4A6 COL5A1 COL5A2 HSPG2 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 COL6A6 COL5A3 ELN | 3.34e-14 | 140 | 163 | 18 | M587 |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | COL2A1 COL4A1 COL4A2 COL4A3 COL4A6 COL5A1 COL5A2 COL10A1 COL11A1 COL5A3 SDC3 | 3.68e-14 | 32 | 163 | 11 | MM14924 |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | COL6A5 COL2A1 COL4A1 COL4A2 COL4A3 COL4A6 COL5A1 COL5A2 HSPG2 COL7A1 COL9A3 COL10A1 COL16A1 COL6A6 COL5A3 | 4.11e-14 | 85 | 163 | 15 | M16441 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL6A5 COL24A1 COL21A1 ACAN COL2A1 COL4A1 COL4A2 COL4A3 COL4A6 COL5A1 COL5A2 HSPG2 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 COL6A6 COL28A1 COL27A1 COL5A3 SDC3 ELN | 5.97e-13 | 300 | 163 | 23 | M610 |
| Pathway | REACTOME_NCAM1_INTERACTIONS | COL6A5 CACNA1H COL2A1 COL4A1 COL4A2 COL4A3 COL5A1 COL5A2 COL9A3 COL6A6 COL5A3 | 1.10e-12 | 42 | 163 | 11 | M7169 |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | IRS1 PXN COL2A1 COL4A1 COL4A3 COL4A6 COL5A1 COL5A2 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 | 2.32e-12 | 74 | 163 | 13 | M160 |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | COL2A1 COL4A1 COL4A2 COL4A3 COL4A6 COL5A1 COL5A2 HSPG2 COL10A1 COL11A1 COL5A3 SDC3 | 2.66e-12 | 59 | 163 | 12 | M27218 |
| Pathway | PID_SYNDECAN_1_PATHWAY | COL2A1 COL4A1 COL4A3 COL4A6 COL5A1 COL5A2 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 | 3.31e-12 | 46 | 163 | 11 | M198 |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | COL6A5 COL2A1 COL4A1 COL4A2 COL4A3 COL4A6 COL5A1 COL5A2 COL7A1 COL9A3 COL16A1 COL6A6 COL5A3 | 3.32e-12 | 76 | 163 | 13 | MM14867 |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | COL6A5 ACAN COL2A1 COL4A1 COL4A2 COL4A3 COL4A6 COL5A1 COL5A2 HSPG2 COL9A3 COL6A6 COL5A3 | 3.32e-12 | 76 | 163 | 13 | M27219 |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | COL6A5 ACAN COL2A1 COL4A1 COL4A2 COL4A3 COL4A6 COL5A1 COL5A2 COL7A1 COL10A1 COL11A1 COL6A6 COL5A3 ELN | 3.58e-12 | 114 | 163 | 15 | MM14571 |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | COL6A5 COL2A1 COL4A1 COL4A2 COL4A3 COL5A1 COL5A2 COL9A3 COL6A6 COL5A3 | 1.16e-11 | 38 | 163 | 10 | MM14969 |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | COL6A5 CACNA1H COL2A1 COL4A1 COL4A2 COL4A3 COL5A1 COL5A2 COL9A3 COL6A6 COL5A3 | 1.29e-10 | 63 | 163 | 11 | M11187 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL6A5 ACAN COL2A1 COL4A1 COL4A2 COL4A3 COL4A6 COL5A1 COL5A2 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 COL6A6 COL28A1 COL5A3 SDC3 ELN | 1.42e-10 | 258 | 163 | 19 | MM14572 |
| Pathway | REACTOME_SIGNALING_BY_PDGF | COL6A5 COL2A1 COL4A1 COL4A2 COL4A3 COL5A1 COL5A2 COL9A3 COL6A6 COL5A3 | 8.76e-10 | 57 | 163 | 10 | MM14713 |
| Pathway | REACTOME_SIGNALING_BY_PDGF | COL6A5 COL2A1 COL4A1 COL4A2 COL4A3 COL5A1 COL5A2 COL9A3 COL6A6 COL5A3 | 1.05e-09 | 58 | 163 | 10 | M2049 |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | COL2A1 COL4A1 COL4A2 COL4A6 COL5A1 COL5A2 HSPG2 COL11A1 COL6A6 COL5A3 SDC3 | 3.16e-09 | 84 | 163 | 11 | M7098 |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 3.95e-08 | 30 | 163 | 7 | M27772 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 5.77e-08 | 47 | 163 | 8 | MM14925 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | ABL1 COL6A5 ARHGEF11 VASP COL2A1 COL4A1 COL4A2 COL4A3 COL5A1 COL5A2 COL9A3 COL6A6 COL5A3 SHANK3 ENAH MAPK7 | 5.89e-08 | 261 | 163 | 16 | MM15676 |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 3.92e-07 | 41 | 163 | 7 | M27778 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 5.32e-07 | 15 | 163 | 5 | M27161 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | STUB1 COL6A5 IRS1 COL24A1 PXN CDK5R2 DNMT1 COL2A1 COL4A1 COL4A2 COL4A3 COL5A1 COL5A2 COL9A3 COL11A1 COL6A6 COL27A1 COL5A3 MST1R MAPK7 EP300 | 8.64e-07 | 532 | 163 | 21 | M27870 |
| Pathway | PID_INTEGRIN1_PATHWAY | 8.74e-07 | 66 | 163 | 8 | M18 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 1.03e-06 | 30 | 163 | 6 | M27216 | |
| Pathway | WP_FOCAL_ADHESION | PXN VASP COL2A1 COL4A1 COL4A2 COL4A6 COL5A1 COL5A2 FLNA COL11A1 COL5A3 MAPK7 | 1.77e-06 | 187 | 163 | 12 | MM15913 |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.98e-06 | 19 | 163 | 5 | MM15512 | |
| Pathway | KEGG_FOCAL_ADHESION | PXN VASP COL2A1 COL4A1 COL4A2 COL4A6 COL5A1 COL5A2 FLNA COL11A1 COL6A6 COL5A3 | 3.39e-06 | 199 | 163 | 12 | M7253 |
| Pathway | BIOCARTA_NPP1_PATHWAY | 3.43e-06 | 10 | 163 | 4 | M22040 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 3.43e-06 | 10 | 163 | 4 | MM1560 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 5.34e-06 | 11 | 163 | 4 | M15422 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 7.93e-06 | 12 | 163 | 4 | MM1526 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 1.14e-05 | 13 | 163 | 4 | MM1347 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 1.14e-05 | 13 | 163 | 4 | M12950 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 1.28e-05 | 27 | 163 | 5 | M47755 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 1.58e-05 | 14 | 163 | 4 | MM1458 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 1.58e-05 | 14 | 163 | 4 | M6487 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 2.13e-05 | 15 | 163 | 4 | MM14922 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 2.19e-05 | 30 | 163 | 5 | MM15517 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | STUB1 COL6A5 PXN COL2A1 COL4A1 COL4A2 COL4A3 COL5A1 COL5A2 COL9A3 COL11A1 COL6A6 COL5A3 MST1R MAPK7 EP300 | 2.76e-05 | 418 | 163 | 16 | MM15587 |
| Pathway | REACTOME_SIGNALING_BY_MET | 3.50e-05 | 79 | 163 | 7 | M27643 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | ZSWIM8 ABL1 RPS14 COL6A5 ADGRV1 ARHGEF11 CACNA1H VASP COL2A1 COL4A1 COL4A2 COL4A3 COL5A1 COL5A2 COL9A3 COL6A6 COL5A3 ENAH MAPK7 | 3.67e-05 | 575 | 163 | 19 | M29853 |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 4.65e-05 | 18 | 163 | 4 | M27164 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 4.65e-05 | 18 | 163 | 4 | MM14882 | |
| Pathway | BIOCARTA_AMI_PATHWAY | 7.22e-05 | 20 | 163 | 4 | M15394 | |
| Pathway | WP_FOCAL_ADHESION | PXN VASP COL2A1 COL4A1 COL4A2 COL4A6 COL5A2 FLNA COL5A3 PPP1R12C | 1.06e-04 | 199 | 163 | 10 | M39402 |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 1.29e-04 | 23 | 163 | 4 | M15997 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 1.29e-04 | 23 | 163 | 4 | MM1427 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 1.31e-04 | 43 | 163 | 5 | M39565 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 1.31e-04 | 43 | 163 | 5 | M47669 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 1.63e-04 | 45 | 163 | 5 | M47670 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | ABL1 COL6A5 ARHGEF11 VASP COL2A1 COL4A1 COL4A2 COL4A3 COL5A1 COL5A2 COL9A3 COL6A6 COL5A3 SHANK3 ENAH MAPK7 | 2.35e-04 | 502 | 163 | 16 | MM14537 |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 2.46e-04 | 27 | 163 | 4 | M27217 | |
| Pathway | REACTOME_ATTENUATION_PHASE | 2.84e-04 | 28 | 163 | 4 | M27254 | |
| Pathway | REACTOME_ATTENUATION_PHASE | 3.99e-04 | 13 | 163 | 3 | MM14952 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | ZSWIM8 ABL1 MAFA RPS14 COL6A5 ADGRV1 ARHGEF11 HOXB2 FOXL2 CACNA1H NKX6-1 DMRT1 VASP MED13 COL2A1 COL4A1 COL4A2 COL4A3 COL5A1 COL5A2 COL9A3 COL6A6 COL5A3 SALL4 KMT2D LORICRIN EIF4B ENAH MAPK7 EP300 | 9.29e-04 | 1432 | 163 | 30 | M509 |
| Pathway | REACTOME_HSF1_DEPENDENT_TRANSACTIVATION | 9.36e-04 | 38 | 163 | 4 | M27255 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 1.05e-03 | 67 | 163 | 5 | MM15345 | |
| Pathway | REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS | 1.09e-03 | 18 | 163 | 3 | M840 | |
| Pathway | REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS | 1.09e-03 | 18 | 163 | 3 | MM15123 | |
| Pathway | BIOCARTA_LIS1_PATHWAY | 1.28e-03 | 19 | 163 | 3 | M22005 | |
| Pathway | REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS | 1.28e-03 | 19 | 163 | 3 | M27221 | |
| Pathway | REACTOME_SIGNALING_BY_ROBO_RECEPTORS | 1.50e-03 | 20 | 163 | 3 | MM14974 | |
| Pathway | REACTOME_RUNX3_REGULATES_P14_ARF | 1.93e-03 | 6 | 163 | 2 | MM15545 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR | 1.93e-03 | 6 | 163 | 2 | MM14521 | |
| Pathway | REACTOME_HSF1_DEPENDENT_TRANSACTIVATION | 2.27e-03 | 23 | 163 | 3 | MM14953 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | COL6A5 COL24A1 COL21A1 COL2A1 COL4A1 COL4A2 COL4A3 COL4A6 COL5A1 COL5A2 HSPG2 COL7A1 COL11A1 COL16A1 ABI3BP COL6A6 COL28A1 COL5A3 ELN | 1.07e-19 | 135 | 237 | 19 | 28675934 |
| Pubmed | COL6A5 COL24A1 COL2A1 COL4A1 COL4A2 COL4A3 COL4A6 COL5A1 COL5A2 HSPG2 COL7A1 COL10A1 COL11A1 COL16A1 COL6A6 COL28A1 COL27A1 COL5A3 ELN | 1.59e-17 | 175 | 237 | 19 | 28071719 | |
| Pubmed | IL16 COL6A5 COL24A1 COL4A1 COL4A2 COL4A6 COL5A1 COL5A2 HSPG2 COL7A1 COL9A3 COL10A1 COL16A1 ABI3BP COL28A1 COL27A1 COL5A3 ELN | 1.31e-16 | 167 | 237 | 18 | 22159717 | |
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | COL6A5 COL2A1 COL4A1 COL4A2 COL4A3 COL4A6 COL5A1 COL5A2 COL7A1 COL10A1 COL16A1 COL27A1 COL5A3 | 3.03e-16 | 62 | 237 | 13 | 28344315 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MON2 ABL1 KMT2B MYO1E PCNX3 IRS1 ARHGEF11 RYR1 TBC1D9 AHNAK PXN CACNA1H HERC2 ZC3H7B CRAMP1 MED13 ZNF687 HSPG2 FLNA BICRA ZNF316 ARHGAP17 LRRK1 MLLT10 ZNF865 MST1R CCDC88C VAC14 KMT2D LATS2 SUGP2 NISCH SLC45A1 SSBP4 EP300 CEP170B | 7.60e-15 | 1105 | 237 | 36 | 35748872 |
| Pubmed | COL24A1 COL21A1 COL4A1 COL4A2 COL4A3 COL4A6 COL5A1 COL5A2 HSPG2 COL7A1 COL9A3 COL10A1 COL16A1 COL6A6 COL28A1 ELN | 1.09e-14 | 153 | 237 | 16 | 25037231 | |
| Pubmed | DLGAP1 UBAP2 HDAC4 NUMBL LMTK3 HCN2 ARHGEF11 ADD1 CAMKV PPP1R3F LRRC7 MTCL1 TAF4 HERC2 TAF5 DNMT1 TCF20 ZNF618 SYNE1 SPECC1L SHANK3 CCDC88C NISCH YLPM1 ENAH ELAVL2 PRKAR2B CTNND2 ARHGEF26 NEURL4 CEP170B | 9.15e-13 | 963 | 237 | 31 | 28671696 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | ATXN2L ABL1 UBAP2 HDAC4 TRIP6 NUMBL MARK3 CBARP IRS1 ARHGEF17 HAUS8 MAST4 AHNAK MTCL1 DNMT1 TCF20 LIMD1 KIF26B WWP2 ARHGAP17 SYDE1 CCDC88C SLC12A2 EIF4B LPP RAB11FIP5 PEAK1 CEP170B PPP1R12C | 1.76e-12 | 861 | 237 | 29 | 36931259 |
| Pubmed | ATXN2L UBAP2 KMT2B TRIP6 GPRIN1 ADD1 AHNAK SLC25A11 TAF4 TAF5 DNMT1 FLNA TCF20 LIMD1 SPECC1L KMT2D SUGP2 LPP YLPM1 ENAH ACIN1 PEAK1 EP300 | 5.37e-12 | 549 | 237 | 23 | 38280479 | |
| Pubmed | UBAP2 KMT2B STUB1 TRIP6 ING1 GON4L SLC25A11 TAF4 HERC2 TAF5 MBD2 ZNF687 FOXL1 ZNF703 HSPG2 TCF20 LIMD1 BICRA NUP98 ZBTB9 ISX PROSER1 LASP1 MLLT10 RFXAP ARNT KMT2D SUGP2 MORF4L2 YLPM1 ELAVL2 ZFHX3 SSBP4 EP300 SP7 | 5.92e-11 | 1429 | 237 | 35 | 35140242 | |
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | COL2A1 COL4A1 COL4A2 COL5A1 COL5A2 HSPG2 ABI3BP COL6A6 COL28A1 COL5A3 ELN | 6.93e-11 | 97 | 237 | 11 | 27559042 |
| Pubmed | 8.41e-11 | 6 | 237 | 5 | 17876790 | ||
| Pubmed | 2.70e-10 | 25 | 237 | 7 | 19180518 | ||
| Pubmed | CEP104 ATXN2L DLGAP1 NUMBL CBARP LMTK3 GPRIN1 HCN2 XKR4 ADD1 C2CD5 TMEM145 LRRC7 RAB11FIP5 PRKAR2B CTNND2 CEP170B | 3.28e-10 | 347 | 237 | 17 | 17114649 | |
| Pubmed | Perlecan maintains the integrity of cartilage and some basement membranes. | 4.47e-10 | 15 | 237 | 6 | 10579729 | |
| Pubmed | 7.76e-10 | 8 | 237 | 5 | 10382266 | ||
| Pubmed | The pro-alpha2(XI) collagen gene is expressed in odontoblasts. | 7.76e-10 | 8 | 237 | 5 | 20059976 | |
| Pubmed | 7.76e-10 | 8 | 237 | 5 | 3997552 | ||
| Pubmed | 3.45e-09 | 10 | 237 | 5 | 9136074 | ||
| Pubmed | MON2 TRIP6 NUMBL CBARP GPRIN1 PTPRN AHNAK PXN HERC2 DNMT1 ZNF703 PPM1D GRAMD1A NUP98 RNF213 TNS2 KMT2D SLC12A2 LPP YLPM1 ENAH PUS1 RAB11FIP5 DUSP10 PEAK1 NEURL4 PPP1R12C | 3.95e-09 | 1049 | 237 | 27 | 27880917 | |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | STUB1 TRIP6 ING1 RPS14 ADD1 SLC25A11 TAF4 TAF5 HSPA1A HSPA1B ZNF687 FLNA ZBTB9 ZNF865 ZNF446 CCDC88C ARNT EIF4B ACIN1 ZFHX3 | 4.30e-09 | 583 | 237 | 20 | 29844126 |
| Pubmed | Binding of mouse and human fibulin-2 to extracellular matrix ligands. | 6.29e-09 | 11 | 237 | 5 | 7500359 | |
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | COL2A1 COL4A1 COL4A2 COL5A1 COL5A2 HSPG2 COL11A1 COL16A1 ELN | 7.93e-09 | 86 | 237 | 9 | 28327460 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | KMT2B RPS14 IRS1 CSMD2 GPRIN1 ARHGEF17 RYR1 ZFR2 AHNAK RECQL4 LRRC7 MTCL1 CDK5R2 CACNA1F ZNF703 KIF26B ZNF618 COL28A1 ZNF316 MUC19 RNF213 SP7 | 8.60e-09 | 736 | 237 | 22 | 29676528 |
| Pubmed | 1.05e-08 | 5 | 237 | 4 | 9409248 | ||
| Pubmed | 1.07e-08 | 12 | 237 | 5 | 16024816 | ||
| Pubmed | TRIP6 RPS14 ADD1 AHNAK PXN HSPA1A HSPA1B VASP HSPG2 FLNA TNS2 LASP1 LPP ENAH | 1.20e-08 | 285 | 237 | 14 | 21423176 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | ATXN2L UBAP2 TRIP6 NUMBL MARK3 GPRIN1 ADD1 AHNAK PXN LRRC7 HSPA1A JPT2 VASP FLNA LASP1 SLC12A2 EIF4B LPP PEAK1 | 1.46e-08 | 565 | 237 | 19 | 25468996 |
| Pubmed | FOXD1 is required for 3D patterning of the kidney interstitial matrix. | 1.73e-08 | 13 | 237 | 5 | 36335435 | |
| Pubmed | Novel gene function revealed by mouse mutagenesis screens for models of age-related disease. | 1.93e-08 | 44 | 237 | 7 | 27534441 | |
| Pubmed | Chondromodulin I is dispensable during enchondral ossification and eye development. | 2.47e-08 | 27 | 237 | 6 | 12192060 | |
| Pubmed | 2.68e-08 | 14 | 237 | 5 | 9373155 | ||
| Pubmed | 2.68e-08 | 14 | 237 | 5 | 28011632 | ||
| Pubmed | 3.12e-08 | 6 | 237 | 4 | 2426947 | ||
| Pubmed | 3.12e-08 | 6 | 237 | 4 | 21467034 | ||
| Pubmed | Developmental distribution of collagen IV isoforms and relevance to ocular diseases. | 3.12e-08 | 6 | 237 | 4 | 19275937 | |
| Pubmed | Retarded skeletal development in transgenic mice with a type II collagen mutation. | 3.12e-08 | 6 | 237 | 4 | 8952549 | |
| Pubmed | Angiogenesis and collagen type IV expression in different endothelial cell culture systems. | 3.12e-08 | 6 | 237 | 4 | 23551189 | |
| Pubmed | 3.12e-08 | 6 | 237 | 4 | 12225806 | ||
| Pubmed | 3.12e-08 | 6 | 237 | 4 | 10722718 | ||
| Pubmed | Developmental pattern of expression of the mouse alpha 1 (XI) collagen gene (Col11a1). | 3.12e-08 | 6 | 237 | 4 | 8563024 | |
| Pubmed | Insertional mutation of the collagen genes Col4a3 and Col4a4 in a mouse model of Alport syndrome. | 3.12e-08 | 6 | 237 | 4 | 10534397 | |
| Pubmed | 3.12e-08 | 6 | 237 | 4 | 6988303 | ||
| Pubmed | Stimulation of extracellular matrix components in the normal brain by invading glioma cells. | 3.12e-08 | 6 | 237 | 4 | 9506531 | |
| Pubmed | Monoclonal antibody to human basement membrane collagen type IV. | 3.12e-08 | 6 | 237 | 4 | 6811420 | |
| Pubmed | Immunolocalization of collagen types, laminin and fibronectin in the normal human pancreas. | 3.12e-08 | 6 | 237 | 4 | 6389236 | |
| Pubmed | A tumor derived motility factor that stimulates cell migration on extracellular matrix. | 3.12e-08 | 6 | 237 | 4 | 9673377 | |
| Pubmed | 3.12e-08 | 6 | 237 | 4 | 11732842 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | HDAC4 NUMBL RTEL1 MARK3 ADGRV1 SLC10A7 ADARB1 TTC8 C1orf159 CACNA1H LRRC7 TAF4 CRAMP1 PRUNE2 COL5A1 LIMD1 BICRA WWP2 RNF213 ZNF385A DNAH1 LATS2 SUGP2 LPP ENAH SDC3 ZFHX3 ARHGEF26 PRDM15 EP300 CEP170B | 3.59e-08 | 1489 | 237 | 31 | 28611215 |
| Pubmed | Collagen II is essential for the removal of the notochord and the formation of intervertebral discs. | 4.00e-08 | 15 | 237 | 5 | 9832566 | |
| Pubmed | KMT2B ARHGEF11 ARHGEF17 MAST4 HERC2 DNAH9 PRUNE2 SPECC1L SUGP2 | 4.26e-08 | 104 | 237 | 9 | 9205841 | |
| Pubmed | DLGAP1 HDAC4 ARHGEF11 HERC2 HSPA1A FLNA TCF20 ABI3BP KIF26B BICRA SYNE1 NUP98 ARHGAP17 SPECC1L DUSP10 MAPK7 EP300 | 4.91e-08 | 486 | 237 | 17 | 20936779 | |
| Pubmed | ATXN2L DLGAP1 IL16 MYO1E NUMBL MARK3 RPS14 ARHGEF11 ARHGEF17 ADD1 CAMKV LRRC7 SLC25A11 HSPA1A HSPA1B FLNA SYNE1 RAB3D GJC2 SPECC1L SHANK3 SUGP2 MORF4L2 NISCH EIF4B PRKAR2B PEAK1 CTNND2 CEP170B PPP1R12C | 5.24e-08 | 1431 | 237 | 30 | 37142655 | |
| Pubmed | 5.79e-08 | 16 | 237 | 5 | 15878328 | ||
| Pubmed | ACAN COL2A1 COL4A1 COL4A2 COL5A1 COL5A2 HSPG2 COL16A1 ABI3BP SDC3 | 7.03e-08 | 146 | 237 | 10 | 27068509 | |
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 7.11e-08 | 79 | 237 | 8 | 18757743 | |
| Pubmed | 7.24e-08 | 7 | 237 | 4 | 9426396 | ||
| Pubmed | 7.24e-08 | 7 | 237 | 4 | 11711546 | ||
| Pubmed | 7.24e-08 | 7 | 237 | 4 | 1724753 | ||
| Pubmed | Regulation of protease nexin-1 target protease specificity by collagen type IV. | 7.24e-08 | 7 | 237 | 4 | 8006028 | |
| Pubmed | 7.24e-08 | 7 | 237 | 4 | 10416788 | ||
| Pubmed | 7.24e-08 | 7 | 237 | 4 | 9256245 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | FOXJ2 MIS18BP1 MAFA HLX GON4L GBX1 FOXI3 RXRB HOXB2 FOXL2 SKOR2 NKX6-1 DMRT1 CRAMP1 FOXL1 ISX ZNF385A ARNT KMT2D SP6 ZFHX3 PAX1 SP7 | 8.02e-08 | 908 | 237 | 23 | 19274049 |
| Pubmed | 1.12e-07 | 18 | 237 | 5 | 12571105 | ||
| Pubmed | 1.44e-07 | 8 | 237 | 4 | 1377218 | ||
| Pubmed | Lasp1 misexpression influences chondrocyte differentiation in the vertebral column. | 1.44e-07 | 8 | 237 | 4 | 19378260 | |
| Pubmed | 1.44e-07 | 8 | 237 | 4 | 9164858 | ||
| Pubmed | 1.44e-07 | 8 | 237 | 4 | 29422532 | ||
| Pubmed | 3D Mapping Reveals a Complex and Transient Interstitial Matrix During Murine Kidney Development. | 1.44e-07 | 8 | 237 | 4 | 33875569 | |
| Pubmed | Discoidin domain receptor 1 functions in axon extension of cerebellar granule neurons. | 1.44e-07 | 8 | 237 | 4 | 10970885 | |
| Pubmed | 1.44e-07 | 8 | 237 | 4 | 15872058 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | ATXN2L UBAP2 MYO1E TRIP6 ADD1 HAUS8 AHNAK PXN SLC25A11 JPT2 ZNF703 FLNA LIMD1 LASP1 SPECC1L THOC6 TBRG1 SUGP2 EIF4B YLPM1 | 1.50e-07 | 724 | 237 | 20 | 36232890 |
| Pubmed | 1.52e-07 | 19 | 237 | 5 | 15689378 | ||
| Pubmed | COL2A1 COL4A3 COL4A6 COL5A1 COL5A2 COL7A1 COL10A1 COL11A1 COL16A1 COL5A3 SP7 | 2.39e-07 | 210 | 237 | 11 | 16537572 | |
| Pubmed | 2.54e-07 | 39 | 237 | 6 | 33580754 | ||
| Pubmed | Perlecan is essential for cartilage and cephalic development. | 2.58e-07 | 9 | 237 | 4 | 10545953 | |
| Pubmed | 2.58e-07 | 9 | 237 | 4 | 12101409 | ||
| Pubmed | 2.58e-07 | 9 | 237 | 4 | 9878537 | ||
| Pubmed | 2.62e-07 | 21 | 237 | 5 | 27856617 | ||
| Pubmed | 3.12e-07 | 3 | 237 | 3 | 3025878 | ||
| Pubmed | 3.12e-07 | 3 | 237 | 3 | 37158802 | ||
| Pubmed | Isolation of the alpha 3-chain of human type V collagen and characterization by partial sequencing. | 3.12e-07 | 3 | 237 | 3 | 1571108 | |
| Pubmed | Biosynthetic processing of the Pro-alpha1(V)Pro-alpha2(V)Pro-alpha3(V) procollagen heterotrimer. | 3.12e-07 | 3 | 237 | 3 | 15136578 | |
| Pubmed | 3.12e-07 | 3 | 237 | 3 | 15908193 | ||
| Pubmed | cDNA sequence and expression of the mouse alpha1(V) collagen gene (Col5a1). | 3.12e-07 | 3 | 237 | 3 | 9582436 | |
| Pubmed | Collagen mRNA levels changes during colorectal cancer carcinogenesis. | 3.12e-07 | 3 | 237 | 3 | 19422682 | |
| Pubmed | 3.12e-07 | 3 | 237 | 3 | 3070812 | ||
| Pubmed | 3.12e-07 | 3 | 237 | 3 | 17331945 | ||
| Pubmed | 4.28e-07 | 10 | 237 | 4 | 2446864 | ||
| Pubmed | 4.28e-07 | 10 | 237 | 4 | 24436304 | ||
| Pubmed | NESH (Abi-3) is present in the Abi/WAVE complex but does not promote c-Abl-mediated phosphorylation. | 4.28e-07 | 10 | 237 | 4 | 17101133 | |
| Pubmed | 4.28e-07 | 10 | 237 | 4 | 10886375 | ||
| Pubmed | Lethal skeletal dysplasia in mice and humans lacking the golgin GMAP-210. | 4.28e-07 | 10 | 237 | 4 | 20089971 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ATXN2L KMT2B STUB1 GPRIN1 ADARB1 ADD1 TBC1D9 C2CD5 MED13 ZNF687 DNMT1 FLNA TCF20 PHRF1 NUP98 KMT2D SUGP2 EIF4B YLPM1 ACIN1 | 4.29e-07 | 774 | 237 | 20 | 15302935 |
| Pubmed | KMT2B PCNX3 TRIP6 NUMBL MARK3 RAB22A GON4L ARHGEF11 MEN1 PXN SLC25A11 TAF4 HERC2 TAF5 ZC3H7B MBD2 MED13 ZNF687 SYNE1 PHRF1 SPECC1L ZNF385A SLC12A2 MORF4L2 EIF4B ZFHX3 CTNND2 CEP170B PPP1R12C | 4.58e-07 | 1497 | 237 | 29 | 31527615 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | DLGAP1 NUMBL GPRIN1 AHNAK LRRC7 SYNE1 SPECC1L SHANK3 ENAH PRKAR2B CTNND2 CEP170B | 6.04e-07 | 281 | 237 | 12 | 28706196 |
| Pubmed | 6.68e-07 | 11 | 237 | 4 | 14998921 | ||
| Pubmed | 6.68e-07 | 11 | 237 | 4 | 9664687 | ||
| Pubmed | ARD1-mediated Hsp70 acetylation balances stress-induced protein refolding and degradation. | 6.68e-07 | 11 | 237 | 4 | 27708256 | |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | FOXJ2 MIS18BP1 HDAC4 ING1 RXRB TAF5 DMRT1 DNMT1 TCF20 ZBTB9 SALL4 MLLT10 RFXAP ZNF446 ARNT SUGP2 ELAVL2 PAX1 SSBP4 EP300 SP7 | 7.48e-07 | 877 | 237 | 21 | 20211142 |
| Interaction | YWHAH interactions | ATXN2L DLGAP1 ABL1 UBAP2 HDAC4 MYO1E TRIP6 NUMBL ING1 MARK3 RPS14 CBARP IRS1 ARHGEF17 HAUS8 MAST4 AHNAK RECQL4 MTCL1 HSPA1A DNMT1 TCF20 LIMD1 KIF26B ARHGAP17 TNS2 SPECC1L SYDE1 MST1R CCDC88C LATS2 SLC12A2 EIF4B LPP RAB11FIP5 PEAK1 MAPK7 CEP170B PPP1R12C | 2.62e-10 | 1102 | 230 | 39 | int:YWHAH |
| Interaction | TOP3B interactions | MON2 ABL1 UBAP2 KMT2B HDAC4 MYO1E PCNX3 RTEL1 IRS1 ARHGEF11 RYR1 TBC1D9 AHNAK PXN CACNA1H SLC25A11 HERC2 ZC3H7B CRAMP1 MED13 ZNF687 FOXL1 HSPG2 FLNA BICRA ZNF316 ARHGAP17 LRRK1 MLLT10 ZNF865 MST1R CCDC88C VAC14 KMT2D LATS2 SUGP2 NISCH ACIN1 SLC45A1 SSBP4 EP300 CEP170B | 2.83e-08 | 1470 | 230 | 42 | int:TOP3B |
| Interaction | FBLN2 interactions | 5.91e-08 | 66 | 230 | 9 | int:FBLN2 | |
| Interaction | PLOD1 interactions | ATXN2L PTPRN COL21A1 AHNAK RECQL4 HSPA1A COL2A1 COL4A1 COL4A2 COL4A6 COL5A1 COL9A3 COL16A1 WWP2 LATS2 EP300 | 2.67e-07 | 292 | 230 | 16 | int:PLOD1 |
| Interaction | DCN interactions | 5.23e-07 | 43 | 230 | 7 | int:DCN | |
| Interaction | GRB2 interactions | DLGAP1 ABL1 ABI3 HDAC4 STUB1 IRS1 HCN2 AHNAK RECQL4 PXN ZC3H7B HSPA1A HSPA1B VASP HSPG2 FLNA ABI3BP WWP2 ARHGAP17 TNS2 LRRK1 SHANK3 MST1R NISCH YLPM1 PEAK1 EP300 | 5.77e-07 | 806 | 230 | 27 | int:GRB2 |
| Interaction | YWHAG interactions | ATXN2L DLGAP1 ABL1 UBAP2 HDAC4 NUMBL ING1 MARK3 CBARP IRS1 ARHGEF17 HAUS8 MAST4 RECQL4 MTCL1 HSPA1A DNMT1 FLNA LIMD1 KIF26B ARHGAP17 TNS2 SPECC1L SHANK3 SYDE1 MST1R CCDC88C LATS2 EIF4B RAB11FIP5 ACIN1 PEAK1 MAPK7 CEP170B PPP1R12C | 7.45e-07 | 1248 | 230 | 35 | int:YWHAG |
| Interaction | VASP interactions | ABI3 NUMBL TBC1D2B PXN HSPA1A VASP LIMD1 WWP2 LASP1 LPP ENAH RAB11FIP5 PEAK1 FYB1 CEP170B | 1.56e-06 | 294 | 230 | 15 | int:VASP |
| Interaction | TLE3 interactions | FOXJ2 HLX MEN1 TAF4 FOXL1 ZNF703 FLNA TCF20 ISX PROSER1 MLLT10 ARNT KMT2D ZFHX3 SSBP4 EP300 SP7 | 1.64e-06 | 376 | 230 | 17 | int:TLE3 |
| Interaction | WWTR1 interactions | ATXN2L IL16 UBAP2 TRIP6 GPRIN1 SLC25A11 DNMT1 TCF20 LIMD1 SPECC1L ARNT KMT2D LATS2 SUGP2 LPP ENAH PEAK1 EP300 | 1.84e-06 | 422 | 230 | 18 | int:WWTR1 |
| Interaction | YWHAZ interactions | ATXN2L DLGAP1 ABL1 HDAC4 NUMBL ING1 MARK3 CBARP IRS1 ADRA2C MAST4 CAMKV RECQL4 HERC2 HSPA1A HSPA1B DNMT1 COL6A6 KIF26B WWP2 TACC2 SHANK3 MST1R CCDC88C LATS2 NISCH EIF4B ENAH RAB11FIP5 PRKAR2B PEAK1 MAPK7 EP300 CEP170B PPP1R12C | 2.62e-06 | 1319 | 230 | 35 | int:YWHAZ |
| Interaction | FMR1 interactions | ATXN2L DLGAP1 UBAP2 HDAC4 STUB1 NUMBL LMTK3 AHNAK MTCL1 HERC2 ZC3H7B DNMT1 TCF20 WWP2 TACC2 SHANK3 NISCH ELAVL2 CEP170B PPP1R12C | 3.76e-06 | 536 | 230 | 20 | int:FMR1 |
| Interaction | H2BC9 interactions | MAFA RPS14 ADARB1 CFAP100 ZNF469 AHNAK TAF4 DNAH5 CDK5R2 DNMT1 NUP98 SPECC1L RFXAP DNAH1 CCDC88C EIF4B YLPM1 MAPK7 | 3.99e-06 | 446 | 230 | 18 | int:H2BC9 |
| Interaction | YWHAE interactions | ATXN2L DLGAP1 ABL1 HDAC4 STUB1 NUMBL ING1 MARK3 COL6A5 CBARP IRS1 MAST4 RECQL4 TAF4 HSPA1A VASP DNMT1 FLNA STBD1 KIF26B WWP2 TNS2 TACC2 SHANK3 SYDE1 MST1R CCDC88C NISCH EIF4B RAB11FIP5 PEAK1 MAPK7 CEP170B | 6.47e-06 | 1256 | 230 | 33 | int:YWHAE |
| Interaction | MMP2 interactions | 6.86e-06 | 87 | 230 | 8 | int:MMP2 | |
| Interaction | COL5A1 interactions | 9.13e-06 | 65 | 230 | 7 | int:COL5A1 | |
| Interaction | BAG2 interactions | UBAP2 HDAC4 STUB1 MEN1 AHNAK RECQL4 PXN HSPA1A HSPA1B VASP ZNF703 TCF20 LIMD1 WWP2 ARHGAP17 LRRK1 ARNT LATS2 ENAH MAPK7 EP300 | 9.93e-06 | 622 | 230 | 21 | int:BAG2 |
| Interaction | CIC interactions | STUB1 TRIP6 ING1 RPS14 ADD1 SLC25A11 TAF4 TAF5 HSPA1A HSPA1B ZNF687 FOXL1 FLNA ZBTB9 ZNF865 ZNF446 CCDC88C ARNT EIF4B ACIN1 ZFHX3 SP7 | 1.00e-05 | 673 | 230 | 22 | int:CIC |
| Interaction | COLGALT2 interactions | 1.12e-05 | 67 | 230 | 7 | int:COLGALT2 | |
| Interaction | YWHAB interactions | ATXN2L DLGAP1 ABL1 HDAC4 NUMBL ING1 MARK3 CBARP IRS1 ARHGEF17 MAST4 RECQL4 MTCL1 HSPA1A HSPA1B KIF26B PPM1D TNS2 SHANK3 SYDE1 MST1R CCDC88C EIF4B RAB11FIP5 PEAK1 MAPK7 CEP170B PPP1R12C | 1.42e-05 | 1014 | 230 | 28 | int:YWHAB |
| Interaction | C1QTNF1 interactions | 1.50e-05 | 47 | 230 | 6 | int:C1QTNF1 | |
| Interaction | CTTN interactions | ATXN2L ABL1 MYO1E AHNAK RECQL4 PXN HSPA1A FLNA WWP2 ARHGAP17 SPECC1L SHANK3 ARNT SDC3 PEAK1 CTNND2 EP300 | 1.75e-05 | 450 | 230 | 17 | int:CTTN |
| Interaction | LAIR2 interactions | 1.92e-05 | 49 | 230 | 6 | int:LAIR2 | |
| Interaction | FEV interactions | KMT2B TAF4 TAF5 ZNF703 TCF20 BICRA MLLT10 ARNT KMT2D ZFHX3 EP300 | 2.27e-05 | 203 | 230 | 11 | int:FEV |
| Interaction | DVL2 interactions | MIS18BP1 ABL1 NUMBL RTEL1 MARK3 IRS1 ADGRV1 PXN HSPA1A HSPA1B VASP ZNF687 TCF20 SYNE1 WWP2 COL27A1 MST1R RAB11FIP5 EP300 | 2.32e-05 | 557 | 230 | 19 | int:DVL2 |
| Interaction | COL4A2 interactions | 2.36e-05 | 75 | 230 | 7 | int:COL4A2 | |
| Interaction | CDC16 interactions | RPS14 MEN1 TTC8 HAUS8 RECQL4 PXN TAF4 TAF5 ZNF687 LATS2 TRMT44 EP300 | 2.74e-05 | 246 | 230 | 12 | int:CDC16 |
| Interaction | LASP1 interactions | AHNAK HSPA1A VASP DNMT1 ZBTB9 TNS2 LASP1 VAC14 EIF4B LPP PRKAR2B EP300 | 2.85e-05 | 247 | 230 | 12 | int:LASP1 |
| Interaction | BICD2 interactions | HDAC4 TRIP6 MAST4 PXN HERC2 DNAH5 TSGA10IP JPT2 LIMD1 NUP98 TNS2 LASP1 EIF4B ENAH NEURL4 CEP170B | 3.34e-05 | 426 | 230 | 16 | int:BICD2 |
| Interaction | PNMA2 interactions | MARK3 RECQL4 MTCL1 HERC2 ZNF687 ZNF865 ZNF783 LATS2 MORF4L2 DUSP10 NEURL4 CEP170B | 3.34e-05 | 251 | 230 | 12 | int:PNMA2 |
| Interaction | HEY1 interactions | 3.37e-05 | 140 | 230 | 9 | int:HEY1 | |
| Interaction | RNF43 interactions | MIS18BP1 STUB1 TRIP6 LRRC7 HSPA1A HSPA1B STBD1 TCF20 LIMD1 NUP98 LATS2 SLC12A2 SUGP2 LPP RAB11FIP5 PEAK1 | 3.43e-05 | 427 | 230 | 16 | int:RNF43 |
| Interaction | HABP2 interactions | 4.46e-05 | 18 | 230 | 4 | int:HABP2 | |
| Interaction | TBR1 interactions | 4.66e-05 | 113 | 230 | 8 | int:TBR1 | |
| Interaction | PLOD3 interactions | RPS14 PTPRN COL21A1 AHNAK COL4A1 COL4A2 COL4A6 COL9A3 COL16A1 MARCO | 4.99e-05 | 183 | 230 | 10 | int:PLOD3 |
| Interaction | SP7 interactions | KMT2B STUB1 ING1 SLC25A11 ZNF703 TCF20 BICRA PROSER1 ARNT KMT2D YLPM1 EP300 SP7 | 5.01e-05 | 304 | 230 | 13 | int:SP7 |
| Interaction | YAP1 interactions | ATXN2L ABL1 UBAP2 KMT2B STUB1 TRIP6 RPS14 ADD1 MEN1 AHNAK SLC25A11 TAF4 TAF5 HSPA1A JPT2 VASP DNMT1 FLNA TCF20 WWP2 ARNT KMT2D LATS2 EIF4B YLPM1 ENAH ACIN1 EP300 | 5.58e-05 | 1095 | 230 | 28 | int:YAP1 |
| Interaction | SMAD3 interactions | ATXN2L KMT2B HDAC4 STUB1 IRS1 MEN1 FOXL2 COL5A1 COL5A2 FLNA WWP2 EIF4B RAB11FIP5 ZFHX3 EP300 PPP1R12C | 5.91e-05 | 447 | 230 | 16 | int:SMAD3 |
| Interaction | DYRK1A interactions | MYO1E IRS1 ARHGEF17 HAUS8 AHNAK PPP1R3F JPT2 VASP NUP98 TNS2 KMT2D LATS2 EIF4B LPP ENAH RAB11FIP5 PRKAR2B EP300 | 6.82e-05 | 552 | 230 | 18 | int:DYRK1A |
| Interaction | OSM interactions | 6.94e-05 | 20 | 230 | 4 | int:OSM | |
| Interaction | CDH1 interactions | ATXN2L UBAP2 TRIP6 NUMBL MARK3 IRS1 GPRIN1 ADD1 AHNAK PXN LRRC7 HSPA1A JPT2 VASP FLNA LASP1 SLC12A2 EIF4B LPP PEAK1 CTNND2 EP300 | 7.35e-05 | 768 | 230 | 22 | int:CDH1 |
| Interaction | MTDH interactions | KMT2B HDAC4 TBC1D2B RYR1 MEN1 RECQL4 DNAH5 HSPG2 FLNA SYNE1 WWP2 RNF213 TNS2 MST1R ACIN1 ELN EP300 | 7.40e-05 | 505 | 230 | 17 | int:MTDH |
| Interaction | YWHAQ interactions | ATXN2L DLGAP1 ABL1 UBAP2 HDAC4 STUB1 NUMBL ING1 MARK3 CBARP IRS1 MAST4 RECQL4 HSPA1A VASP DNMT1 FLNA KIF26B WWP2 SPECC1L SHANK3 SYDE1 MST1R CCDC88C EIF4B PEAK1 CEP170B PPP1R12C | 7.98e-05 | 1118 | 230 | 28 | int:YWHAQ |
| Interaction | HNF4A interactions | KMT2B HDAC4 ING1 TAF4 TAF5 BICRA MUC19 ZBTB9 RFXAP ARNT KMT2D EP300 | 8.05e-05 | 275 | 230 | 12 | int:HNF4A |
| Interaction | SMARCB1 interactions | IL16 KMT2B ING1 MEN1 RECQL4 MBD2 BICRA WWP2 SALL4 TACC2 MLLT10 CHFR EP300 SP7 | 8.08e-05 | 364 | 230 | 14 | int:SMARCB1 |
| Interaction | MAPRE1 interactions | CEP104 MYO1E ADD1 MAST4 HERC2 HSPA1A VASP FLNA NUP98 ARHGAP17 TACC2 SPECC1L EIF4B LPP PRKAR2B EP300 CEP170B | 9.17e-05 | 514 | 230 | 17 | int:MAPRE1 |
| Interaction | CTNNB1 interactions | ATXN2L DLGAP1 ABL1 HDAC4 STUB1 PCP2 RPS14 MEN1 PXN SLC25A11 HERC2 HSPA1A HSPA1B VASP DNMT1 LIMD1 WWP2 NUP98 SPECC1L MLLT10 CCDC88C ARNT KMT2D LATS2 CTNND2 EP300 | 9.25e-05 | 1009 | 230 | 26 | int:CTNNB1 |
| Interaction | FXR1 interactions | ATXN2L DLGAP1 UBAP2 HDAC4 STUB1 LMTK3 MEN1 RECQL4 HERC2 ZC3H7B HSPA1A FLNA WWP2 TACC2 SHANK3 ELAVL2 MAPK7 EP300 CEP170B PPP1R12C | 1.09e-04 | 679 | 230 | 20 | int:FXR1 |
| Interaction | MMP9 interactions | 1.16e-04 | 67 | 230 | 6 | int:MMP9 | |
| Interaction | ADAMTS5 interactions | 1.17e-04 | 9 | 230 | 3 | int:ADAMTS5 | |
| Interaction | CAPZA2 interactions | DLGAP1 MYO1E ARHGEF17 ADD1 MEN1 AHNAK RECQL4 MTCL1 FLNA ATG9B WWP2 SPECC1L SHANK3 MST1R EIF4B | 1.34e-04 | 430 | 230 | 15 | int:CAPZA2 |
| Interaction | SFN interactions | ATXN2L ABL1 HDAC4 ING1 MARK3 CBARP IRS1 ARHGEF17 HAUS8 MAST4 RECQL4 KIF26B LASP1 MST1R CCDC88C ARNT EIF4B PEAK1 CEP170B PPP1R12C | 1.40e-04 | 692 | 230 | 20 | int:SFN |
| Interaction | KMT2D interactions | 1.44e-04 | 169 | 230 | 9 | int:KMT2D | |
| Interaction | HDAC2 interactions | FOXJ2 ING1 HLX IRS1 ADARB1 MEN1 AHNAK RECQL4 HERC2 MBD2 ZNF687 DNMT1 FOXL1 HSPG2 FLNA TCF20 WWP2 SALL4 LATS2 MORF4L2 LPP CHFR EP300 | 1.52e-04 | 865 | 230 | 23 | int:HDAC2 |
| Interaction | EGR2 interactions | 1.58e-04 | 171 | 230 | 9 | int:EGR2 | |
| Interaction | KCNA3 interactions | ATXN2L IL16 NUMBL MARK3 RPS14 GPRIN1 RYR1 ADD1 AHNAK LRRC7 SLC25A11 DNAH5 HSPA1B COL4A3 STBD1 COL27A1 RNF213 SPECC1L CCDC88C EIF4B RAB11FIP5 PEAK1 ARHGEF26 | 1.68e-04 | 871 | 230 | 23 | int:KCNA3 |
| Interaction | TGFBI interactions | 1.73e-04 | 25 | 230 | 4 | int:TGFBI | |
| Interaction | RHOQ interactions | MYO1E TRIP6 NUMBL MARK3 CBARP GPRIN1 ADD1 C2CD5 WWP2 SYDE1 VAC14 SLC12A2 NISCH RAB11FIP5 PEAK1 | 1.80e-04 | 442 | 230 | 15 | int:RHOQ |
| Interaction | NTRK2 interactions | MARK3 CBARP GPRIN1 LRRC7 HSPA1B NISCH RAB11FIP5 PEAK1 CTNND2 | 1.96e-04 | 176 | 230 | 9 | int:NTRK2 |
| Interaction | RNF123 interactions | KMT2B RPS14 IRS1 CSMD2 GPRIN1 ARHGEF17 RYR1 ZFR2 AHNAK RECQL4 LRRC7 MTCL1 CDK5R2 CACNA1F ZNF703 KIF26B ZNF618 COL28A1 ZNF316 MUC19 RNF213 SP7 | 2.01e-04 | 824 | 230 | 22 | int:RNF123 |
| Interaction | ZNF576 interactions | 2.03e-04 | 26 | 230 | 4 | int:ZNF576 | |
| Interaction | MPDZ interactions | 2.28e-04 | 107 | 230 | 7 | int:MPDZ | |
| Interaction | SS18L2 interactions | 2.32e-04 | 76 | 230 | 6 | int:SS18L2 | |
| Interaction | PDLIM4 interactions | 2.36e-04 | 27 | 230 | 4 | int:PDLIM4 | |
| Interaction | ACTB interactions | STUB1 MYO1E NUMBL RPS14 GPRIN1 ADARB1 ADD1 RECQL4 SLC25A11 MBD2 HSPA1A DNAH5 CDK5R2 VASP FLNA LIMD1 KIF26B ARHGAP17 LASP1 MORF4L2 LPP ENAH DUSP10 PEAK1 MAPK7 EP300 | 2.83e-04 | 1083 | 230 | 26 | int:ACTB |
| Interaction | ATN1 interactions | 3.07e-04 | 187 | 230 | 9 | int:ATN1 | |
| Interaction | MAG interactions | 3.14e-04 | 29 | 230 | 4 | int:MAG | |
| Interaction | NUP43 interactions | MIS18BP1 KMT2B GON4L RECQL4 TAF4 DNAH9 ZNF687 ZNF703 FLNA TCF20 PHRF1 ZNF316 NUP98 MUC19 ZBTB9 KMT2D ACIN1 ZFHX3 | 3.16e-04 | 625 | 230 | 18 | int:NUP43 |
| Interaction | RFX1 interactions | 3.29e-04 | 81 | 230 | 6 | int:RFX1 | |
| Interaction | CXADR interactions | MON2 STUB1 NUMBL MARK3 GPRIN1 ADD1 STBD1 GRAMD1A LATS2 SLC12A2 NISCH RAB11FIP5 PEAK1 | 3.40e-04 | 369 | 230 | 13 | int:CXADR |
| Interaction | HNF1B interactions | 3.46e-04 | 190 | 230 | 9 | int:HNF1B | |
| Interaction | CRK interactions | ABL1 IRS1 MEN1 PXN HSPA1A HSPA1B FLNA BICRA ZBTB9 ARHGAP17 LASP1 VAC14 PEAK1 | 3.49e-04 | 370 | 230 | 13 | int:CRK |
| Interaction | SOHLH1 interactions | 3.55e-04 | 115 | 230 | 7 | int:SOHLH1 | |
| Interaction | BGN interactions | 3.59e-04 | 30 | 230 | 4 | int:BGN | |
| Interaction | TEX19 interactions | 3.72e-04 | 54 | 230 | 5 | int:TEX19 | |
| Interaction | COL9A1 interactions | 3.86e-04 | 13 | 230 | 3 | int:COL9A1 | |
| Interaction | NUDCD2 interactions | CEP104 STUB1 MYO1E RPS14 HAUS8 PXN HERC2 HSPA1A DNAH9 FLNA SYNE1 SLC12A2 EIF4B ABCB11 | 3.89e-04 | 424 | 230 | 14 | int:NUDCD2 |
| Interaction | HDAC1 interactions | KMT2B ING1 GON4L MEN1 AHNAK RECQL4 PXN MBD2 HSPA1A HSPA1B ZNF687 DNMT1 FLNA TCF20 WWP2 NUP98 ZBTB9 SALL4 ARNT KMT2D LATS2 MORF4L2 CHFR PRKAR2B ZFHX3 EP300 | 4.00e-04 | 1108 | 230 | 26 | int:HDAC1 |
| Interaction | POT1 interactions | 4.12e-04 | 237 | 230 | 10 | int:POT1 | |
| Interaction | APBB1 interactions | 4.18e-04 | 195 | 230 | 9 | int:APBB1 | |
| Interaction | ZYX interactions | PXN ZC3H7B HSPA1A VASP LIMD1 LASP1 LATS2 LPP ENAH PEAK1 EP300 CEP170B | 4.21e-04 | 329 | 230 | 12 | int:ZYX |
| Interaction | DNAJC5 interactions | STUB1 NUMBL MARK3 CBARP GPRIN1 ADD1 HSPA1A WWP2 GRAMD1A SLC12A2 NISCH RAB11FIP5 PEAK1 | 4.27e-04 | 378 | 230 | 13 | int:DNAJC5 |
| Interaction | OLA1 interactions | 4.35e-04 | 156 | 230 | 8 | int:OLA1 | |
| Interaction | ARL14 interactions | 4.37e-04 | 119 | 230 | 7 | int:ARL14 | |
| Interaction | SERPINE2 interactions | 4.41e-04 | 56 | 230 | 5 | int:SERPINE2 | |
| Interaction | SIN3A interactions | HDAC4 ING1 GON4L ADARB1 MEN1 MBD2 HSPA1A TCF20 ARNT MORF4L2 CHFR EP300 SP7 | 4.49e-04 | 380 | 230 | 13 | int:SIN3A |
| Interaction | SOX6 interactions | 4.53e-04 | 157 | 230 | 8 | int:SOX6 | |
| Interaction | PDGFA interactions | 4.62e-04 | 32 | 230 | 4 | int:PDGFA | |
| Interaction | GSC interactions | 4.84e-04 | 87 | 230 | 6 | int:GSC | |
| Interaction | MEF2D interactions | 4.84e-04 | 87 | 230 | 6 | int:MEF2D | |
| Interaction | USP7 interactions | DLGAP1 ABL1 UBAP2 STUB1 ING1 MAFA GON4L IRS1 ARHGEF17 ADARB1 DNAJB13 NYNRIN AHNAK RECQL4 PXN DNAH5 DNMT1 FOXL1 TCF20 SYNE1 WWP2 FIGNL2 NUP98 PKD2L1 KMT2D EIF4B YLPM1 CHFR EP300 | 4.94e-04 | 1313 | 230 | 29 | int:USP7 |
| Interaction | SMAD1 interactions | 5.01e-04 | 243 | 230 | 10 | int:SMAD1 | |
| Interaction | EYA4 interactions | FOXJ2 ATXN2L TRIP6 ZNF703 BICRA PROSER1 ARNT FAM222B EP300 SP7 | 5.01e-04 | 243 | 230 | 10 | int:EYA4 |
| Interaction | KLHL4 interactions | 5.22e-04 | 33 | 230 | 4 | int:KLHL4 | |
| Interaction | SLC6A4 interactions | DLGAP1 STUB1 MARK3 ADGRV1 HCN2 ACAN LRRC7 SLC25A11 HERC2 HSPA1A SHANK3 EIF4B ELAVL2 CEP170B | 5.25e-04 | 437 | 230 | 14 | int:SLC6A4 |
| Cytoband | 12q13.13 | 2.62e-05 | 67 | 237 | 5 | 12q13.13 | |
| GeneFamily | Collagens | COL6A5 COL24A1 COL21A1 COL2A1 COL4A1 COL4A2 COL4A3 COL4A6 COL5A1 COL5A2 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 COL6A6 COL28A1 COL27A1 COL5A3 | 1.81e-27 | 46 | 164 | 19 | 490 |
| GeneFamily | Dyneins, axonemal | 3.27e-07 | 17 | 164 | 5 | 536 | |
| GeneFamily | LIM domain containing | 1.95e-04 | 59 | 164 | 5 | 1218 | |
| GeneFamily | ENAH/VASPs | 2.44e-04 | 3 | 164 | 2 | 946 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.34e-03 | 181 | 164 | 7 | 694 | |
| GeneFamily | PHD finger proteins | 1.36e-03 | 90 | 164 | 5 | 88 | |
| GeneFamily | PDZ domain containing | 2.65e-03 | 152 | 164 | 6 | 1220 | |
| GeneFamily | Zinc fingers C2H2-type|Sp transcription factors | 2.82e-03 | 9 | 164 | 2 | 755 | |
| Coexpression | NABA_COLLAGENS | COL6A5 COL24A1 COL21A1 COL2A1 COL4A1 COL4A2 COL4A3 COL4A6 COL5A1 COL5A2 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 COL6A6 COL28A1 COL27A1 COL5A3 | 5.86e-28 | 44 | 233 | 19 | M3005 |
| Coexpression | NABA_COLLAGENS | COL6A5 COL24A1 COL2A1 COL4A1 COL4A2 COL4A3 COL4A6 COL5A1 COL5A2 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 COL6A6 COL28A1 COL27A1 COL5A3 | 3.08e-26 | 43 | 233 | 18 | MM17060 |
| Coexpression | NABA_CORE_MATRISOME | COL6A5 COL24A1 COL21A1 ACAN COL2A1 COL4A1 COL4A2 COL4A3 COL4A6 COL5A1 COL5A2 HSPG2 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 ABI3BP COL6A6 COL28A1 COL27A1 COL5A3 ELN | 5.96e-16 | 275 | 233 | 23 | M5884 |
| Coexpression | NABA_CORE_MATRISOME | COL6A5 COL24A1 ACAN COL2A1 COL4A1 COL4A2 COL4A3 COL4A6 COL5A1 COL5A2 HSPG2 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 ABI3BP COL6A6 COL28A1 COL27A1 COL5A3 ELN | 4.53e-15 | 270 | 233 | 22 | MM17057 |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 4.12e-08 | 23 | 233 | 6 | M48001 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 5.82e-08 | 40 | 233 | 7 | M5887 | |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 1.85e-07 | 29 | 233 | 6 | MM17055 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | COL4A1 COL4A2 COL5A1 COL5A2 FLNA COL7A1 COL11A1 COL16A1 ABI3BP COL5A3 APLP1 ELN | 2.58e-07 | 200 | 233 | 12 | M5930 |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | RAMP2 ARHGEF17 HOXB2 ZNF687 COL4A1 COL4A2 COL4A6 COL5A1 COL5A2 FLNA ABI3BP DYNC2H1 COL27A1 TNS2 COL5A3 SHANK3 SYDE1 SDC3 | 7.14e-07 | 505 | 233 | 18 | M39167 |
| Coexpression | NABA_MATRISOME | IL16 COL6A5 COL24A1 COL21A1 ACAN COL2A1 COL4A1 COL4A2 COL4A3 COL4A6 COL5A1 COL5A2 HSPG2 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 ABI3BP COL6A6 COL28A1 COL27A1 MUC19 COL5A3 SDC3 ELN | 1.71e-06 | 1026 | 233 | 26 | M5889 |
| Coexpression | GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN | ATXN2L ARHGEF11 HAUS8 ZC3H7B BICRA ZNF316 ARHGAP17 NUTM2E KMT2D SUGP2 PUS1 ACIN1 NEURL4 PPP1R12C | 2.28e-06 | 338 | 233 | 14 | M17094 |
| Coexpression | NABA_MATRISOME | IL16 COL6A5 COL24A1 ACAN COL2A1 COL4A1 COL4A2 COL4A3 COL4A6 COL5A1 COL5A2 HSPG2 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 ABI3BP COL6A6 COL28A1 COL27A1 MUC19 COL5A3 SDC3 ELN | 4.01e-06 | 1008 | 233 | 25 | MM17056 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_RESTING_CHONDROCYTE | 6.95e-06 | 111 | 233 | 8 | M45685 | |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | TBC1D2B ARHGEF17 MEN1 AHNAK COL2A1 COL4A2 COL4A6 FLNA NUP98 LASP1 NISCH EP300 | 7.47e-06 | 276 | 233 | 12 | M3063 |
| Coexpression | HEVNER_TELENCEPHALON_VASCULAR_ENDOTHELIUM_AND_MENINGEAL_CELLS | 7.69e-06 | 15 | 233 | 4 | MM402 | |
| Coexpression | GSE20366_TREG_VS_NAIVE_CD4_TCELL_HOMEOSTATIC_CONVERSION_DN | HDAC4 TBC1D2B RYR1 PXN ZNF703 SYNE1 GRAMD1A RNF213 SPECC1L RAB11FIP5 | 1.25e-05 | 199 | 233 | 10 | M4331 |
| Coexpression | KANG_AR_TARGETS_UP | 1.32e-05 | 17 | 233 | 4 | MM1297 | |
| Coexpression | KANG_AR_TARGETS_UP | 1.32e-05 | 17 | 233 | 4 | M2223 | |
| Coexpression | AIZARANI_LIVER_C33_STELLATE_CELLS_2 | 1.76e-05 | 126 | 233 | 8 | M39132 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | RAMP2 IRS1 ARHGEF17 COL21A1 COL4A1 COL4A2 COL5A1 COL5A2 HSPG2 COL7A1 COL11A1 COL16A1 ABI3BP COL28A1 TNS2 COL5A3 TACC2 SYDE1 ENAH SDC3 | 1.91e-05 | 767 | 233 | 20 | M39209 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_LATE_SCHWANN_CELL | 2.61e-05 | 97 | 233 | 7 | M45794 | |
| Coexpression | LAMB_CCND1_TARGETS | 2.64e-05 | 20 | 233 | 4 | M2935 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_MID_SCHWANN_CELL | XKR4 AHNAK COL4A1 COL5A1 HSPG2 COL16A1 COL28A1 COL27A1 COL5A3 LATS2 ARHGEF26 | 3.05e-05 | 268 | 233 | 11 | M45796 |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN | 3.97e-05 | 141 | 233 | 8 | M10381 | |
| Coexpression | GU_PDEF_TARGETS_UP | 4.09e-05 | 71 | 233 | 6 | M3955 | |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | MYO1E NUMBL WBP1L ARHGEF17 HOXB2 ZNF469 AHNAK COL4A1 COL4A2 COL5A1 COL5A2 FLNA COL16A1 COL5A3 SYDE1 LATS2 ENAH PEAK1 | 4.23e-05 | 681 | 233 | 18 | M39175 |
| Coexpression | LIN_MELANOMA_COPY_NUMBER_UP | 4.43e-05 | 72 | 233 | 6 | M346 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN | 5.08e-05 | 146 | 233 | 8 | MM973 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN | 5.18e-05 | 74 | 233 | 6 | M13547 | |
| Coexpression | BENPORATH_ES_WITH_H3K27ME3 | HLX CSMD2 HOXB2 COL24A1 FOXL2 MAST4 ACAN OSBP2 NKX6-1 DMRT1 HSPA1A HSPA1B CDK5R2 FOXL1 COL2A1 PRUNE2 COL4A6 SYNE1 COL27A1 ELAVL2 ZFHX3 PAX1 SSBP4 CTNND2 | 6.20e-05 | 1115 | 233 | 24 | M10371 |
| Coexpression | GSE24574_BCL6_HIGH_TFH_VS_TCONV_CD4_TCELL_DN | 7.16e-05 | 197 | 233 | 9 | M8338 | |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3 | MAFA GBX1 HCN2 XKR4 ADRA2C ACAN AHNAK NKX6-1 CDK5R2 STBD1 SALL4 PAX1 | 7.66e-05 | 350 | 233 | 12 | M1949 |
| Coexpression | GSE13493_DP_VS_CD8POS_THYMOCYTE_UP | 7.73e-05 | 199 | 233 | 9 | M3314 | |
| Coexpression | GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP | 7.73e-05 | 199 | 233 | 9 | M7254 | |
| Coexpression | GSE22589_HEALTHY_VS_SIV_INFECTED_DC_UP | 7.73e-05 | 199 | 233 | 9 | M7798 | |
| Coexpression | GSE25123_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_DN | 7.73e-05 | 199 | 233 | 9 | M7965 | |
| Coexpression | GSE18281_SUBCAPSULAR_VS_PERIMEDULLARY_CORTICAL_REGION_OF_THYMUS_UP | 8.04e-05 | 200 | 233 | 9 | M7235 | |
| Coexpression | GSE17721_CPG_VS_GARDIQUIMOD_0.5H_BMDC_DN | 8.04e-05 | 200 | 233 | 9 | M3877 | |
| Coexpression | GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_PDC_DN | 8.04e-05 | 200 | 233 | 9 | M5005 | |
| Coexpression | GSE16385_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_UP | 8.04e-05 | 200 | 233 | 9 | M7990 | |
| Coexpression | GSE40274_FOXP3_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP | 8.04e-05 | 200 | 233 | 9 | M9186 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | ABI3 MYO1E HLX IRS1 MAST4 AHNAK MTCL1 HSPA1A HSPA1B MED13 COL4A3 ARHGAP17 TNS2 LASP1 ARNT LATS2 SLC12A2 LPP ARHGEF26 EP300 | 8.49e-05 | 854 | 233 | 20 | M1533 |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3 | MAFA GBX1 HCN2 XKR4 ADRA2C ACAN AHNAK NKX6-1 CDK5R2 STBD1 SALL4 PAX1 | 9.23e-05 | 357 | 233 | 12 | MM828 |
| Coexpression | HEBERT_MATRISOME_TNBC_BONE_METASTASIS | 1.09e-04 | 11 | 233 | 3 | M47997 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | ABI3 MYO1E HLX IRS1 MAST4 AHNAK MTCL1 HSPA1A HSPA1B MED13 COL4A3 ARHGAP17 TNS2 LASP1 ARNT LATS2 SLC12A2 LPP ARHGEF26 EP300 | 1.43e-04 | 888 | 233 | 20 | MM1018 |
| Coexpression | DESCARTES_ORGANOGENESIS_JAW_AND_TOOTH_PROGENITORS | 1.44e-04 | 12 | 233 | 3 | MM3646 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP | 1.52e-04 | 128 | 233 | 7 | MM1000 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | ATXN2L IL16 MIS18BP1 ABI3 MARK3 TBC1D2B RPS14 ADARB1 ADD1 HOXB2 PTPRCAP AHNAK MBD2 MED13 DNMT1 FLNA SYNE1 GRAMD1A NUP98 RNF213 LASP1 CCDC88C KMT2D TBRG1 EIF4B SSBP4 FYB1 EP300 | 1.58e-04 | 1492 | 233 | 28 | M40023 |
| Coexpression | CHICAS_RB1_TARGETS_CONFLUENT | ADD1 ZNF469 AHNAK PXN MTCL1 FOXL1 COL5A1 COL5A2 ZNF703 FLNA ABI3BP LIMD1 LPP SDC3 CNTN3 | 1.84e-04 | 567 | 233 | 15 | M2129 |
| Coexpression | GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD4_TCELL_DN | 1.84e-04 | 132 | 233 | 7 | M6764 | |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | 1.94e-04 | 177 | 233 | 8 | M39245 | |
| Coexpression | TSENG_IRS1_TARGETS_DN | 2.02e-04 | 134 | 233 | 7 | M13907 | |
| Coexpression | LINDGREN_BLADDER_CANCER_CLUSTER_3_DN | 2.02e-04 | 226 | 233 | 9 | M11238 | |
| Coexpression | CUI_TCF21_TARGETS_DN | 2.03e-04 | 33 | 233 | 4 | MM664 | |
| Coexpression | CUI_TCF21_TARGETS_DN | 2.29e-04 | 34 | 233 | 4 | M6937 | |
| Coexpression | LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES | 2.32e-04 | 137 | 233 | 7 | M39241 | |
| Coexpression | HOWARD_PBMC_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_19_39YO_AS03_ADJUVANT_VS_BUFFER_1DY_DN | 2.57e-04 | 35 | 233 | 4 | M40938 | |
| Coexpression | WONG_ADULT_TISSUE_STEM_MODULE | ABL1 HLX ADARB1 PTPRCAP HSPA1A HSPA1B COL4A1 COL4A2 COL9A3 COL11A1 STBD1 SHANK3 LATS2 SLC12A2 LPP ENAH RAB11FIP5 | 2.69e-04 | 721 | 233 | 17 | M1999 |
| Coexpression | TSENG_IRS1_TARGETS_DN | 2.76e-04 | 141 | 233 | 7 | MM681 | |
| Coexpression | AKT_UP.V1_DN | 2.82e-04 | 187 | 233 | 8 | M2666 | |
| Coexpression | CUI_DEVELOPING_HEART_COMPACT_VENTRICULAR_CARDIOMYOCYTE | 2.85e-04 | 65 | 233 | 5 | M39309 | |
| Coexpression | KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP | 2.87e-04 | 36 | 233 | 4 | M2047 | |
| Coexpression | PRC2_EED_DN.V1_DN | 3.48e-04 | 193 | 233 | 8 | M2734 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_INTERM_CHONDROCYTE | 3.51e-04 | 68 | 233 | 5 | M45669 | |
| Coexpression | LIAO_METASTASIS | ATXN2L UBAP2 PCNX3 NUMBL MTCL1 FLNA ZNF618 GRAMD1A LASP1 ZNF783 ENAH CHFR SSBP4 CTNND2 | 3.68e-04 | 540 | 233 | 14 | M13809 |
| Coexpression | GSE16755_CTRL_VS_IFNA_TREATED_MAC_UP | 3.86e-04 | 196 | 233 | 8 | M3668 | |
| Coexpression | GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_MAC_UP | 4.00e-04 | 197 | 233 | 8 | M5250 | |
| Coexpression | GSE32423_IL7_VS_IL7_IL4_MEMORY_CD8_TCELL_DN | 4.27e-04 | 199 | 233 | 8 | M5092 | |
| Coexpression | DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC_TUMOR_CELL_DERIVED | 4.30e-04 | 17 | 233 | 3 | M47995 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN | 4.35e-04 | 152 | 233 | 7 | M16842 | |
| Coexpression | GSE43955_1H_VS_20H_ACT_CD4_TCELL_DN | 4.42e-04 | 200 | 233 | 8 | M9662 | |
| Coexpression | GSE15330_LYMPHOID_MULTIPOTENT_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_DN | 4.42e-04 | 200 | 233 | 8 | M7049 | |
| Coexpression | GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_3H_DN | 4.42e-04 | 200 | 233 | 8 | M6414 | |
| Coexpression | GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_45MIN_UP | 4.42e-04 | 200 | 233 | 8 | M6629 | |
| Coexpression | HALLMARK_KRAS_SIGNALING_DN | 4.42e-04 | 200 | 233 | 8 | M5956 | |
| Coexpression | GSE39152_SPLEEN_CD103_NEG_VS_BRAIN_CD103_POS_MEMORY_CD8_TCELL_UP | 4.42e-04 | 200 | 233 | 8 | M9076 | |
| Coexpression | MATSUDA_NATURAL_KILLER_DIFFERENTIATION | MYO1E RPS14 CBARP AHNAK HSPA1B DNAH8 FLNA COL11A1 TACC2 LRRK1 MMAA LATS2 NISCH | 4.44e-04 | 486 | 233 | 13 | M18517 |
| Coexpression | HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_UP | DLGAP1 MYO1E TRIP6 HLX IRS1 GPRIN1 ARHGEF11 COL24A1 ACAN DNAH8 COL4A2 PRUNE2 STBD1 DHX58 ZNF618 RNF213 MST1R DNAH12 SDC3 CTNND2 | 4.66e-04 | 973 | 233 | 20 | M41080 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP | 4.82e-04 | 111 | 233 | 6 | M1348 | |
| Coexpression | HOSHIDA_LIVER_CANCER_SURVIVAL_UP | 4.89e-04 | 73 | 233 | 5 | M6939 | |
| Coexpression | LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES | 4.89e-04 | 155 | 233 | 7 | M39246 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN | FOXJ2 ABL1 GON4L LMTK3 HOXB2 MBD2 DNMT1 BICRA WWP2 GRAMD1A THOC6 DNAH1 SUGP2 CD33 NISCH CHFR ZFHX3 EP300 PPP1R12C | 5.01e-04 | 905 | 233 | 19 | M40865 |
| Coexpression | NABA_MATRISOME_HIGHLY_METASTATIC_MELANOMA | 5.13e-04 | 18 | 233 | 3 | M47984 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CA_ENTEROENDOCRINE_CELLS | MAFA GPRIN1 PTPRN ZFR2 MTCL1 CDK5R2 COL2A1 COL5A2 APLP1 CTNND2 | 5.13e-04 | 312 | 233 | 10 | M39161 |
| Coexpression | DESCARTES_FETAL_LIVER_MESOTHELIAL_CELLS | COL21A1 HSPA1B COL4A3 COL4A6 COL9A3 COL11A1 ABI3BP CNTN3 ELN ARHGEF26 | 5.26e-04 | 313 | 233 | 10 | M40228 |
| Coexpression | GAUTAM_EYE_IRIS_CILIARY_BODY_MEG3_HIGH_FIBROBLASTS | 5.30e-04 | 113 | 233 | 6 | M43610 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K2 | FOXJ2 STUB1 NUMBL SPNS2 LMTK3 HAUS8 PER3 ZFR2 NYNRIN PPP1R3F CACNA1H COL2A1 COL5A1 COL5A2 HSPG2 FLNA COL9A3 COL11A1 COL6A6 KIF26B ZNF618 WWP2 COL27A1 GRAMD1A APLP1 SHANK3 YBX2 TBRG1 RAB11FIP5 DUSP10 ELN PEAK1 PRDM15 | 1.19e-06 | 1228 | 229 | 33 | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_500 | ZSWIM8 ADGRV1 LMTK3 COL24A1 ZFR2 COL2A1 ZNF703 KIF26B SALL4 CCDC88C TBRG1 PRKAR2B CNTN3 ELN PEAK1 SSBP4 FYB1 | 2.11e-05 | 483 | 229 | 17 | Facebase_RNAseq_e9.5_Maxillary Arch_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000_k-means-cluster#5 | COL24A1 ZFR2 COL2A1 COL16A1 ABI3BP KIF26B RNF213 RAB11FIP5 CNTN3 ELN PEAK1 FYB1 | 4.88e-05 | 276 | 229 | 12 | Facebase_RNAseq_e10.5_Olfactory Pit_1000_K5 |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | IRS1 COL24A1 ZNF469 ACAN COL5A1 DIPK1C COL5A2 COL7A1 COL10A1 COL16A1 KIF26B COL27A1 ENAH ELN | 1.37e-12 | 184 | 237 | 14 | 0b336489c10e8c3c957795dd845454f03404382b |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | COL6A5 COL21A1 COL4A1 COL4A2 COL5A1 COL5A2 COL16A1 ABI3BP COL6A6 DYNC2H1 SYNE1 SPECC1L SDC3 PEAK1 | 3.99e-12 | 199 | 237 | 14 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | ZNF469 PTPRN COL5A1 COL5A2 COL7A1 COL10A1 COL11A1 COL16A1 KIF26B COL27A1 COL5A3 PAX1 ELN | 2.10e-11 | 183 | 237 | 13 | 803376f5260de83c48d4f7301278d078a32b3e6e |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | ZNF469 PTPRN COL5A1 COL5A2 COL7A1 COL10A1 COL11A1 COL16A1 KIF26B COL27A1 COL5A3 PAX1 ELN | 2.10e-11 | 183 | 237 | 13 | 6d98973098c6d20c5305bce6a83a549a7d8dbfba |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | ZNF469 PTPRN COL5A1 COL5A2 COL7A1 COL10A1 COL11A1 COL16A1 KIF26B COL27A1 COL5A3 PAX1 ELN | 2.10e-11 | 183 | 237 | 13 | cc7f5a17b40e8d901885174922e5fa8877643071 |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | IRS1 MTCL1 COL4A1 COL4A2 PRUNE2 COL5A1 FLNA COL16A1 KIF26B TACC2 LPP ENAH ELN | 2.95e-11 | 188 | 237 | 13 | 4d1e5f85342ae550086609d7680e32730b78b5d2 |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | IRS1 ARHGEF17 CACNA1H COL4A1 COL4A2 COL5A1 COL5A2 COL7A1 COL11A1 KIF26B COL5A3 LPP ENAH | 4.37e-11 | 194 | 237 | 13 | 2d66091097e106c7bee22e5281f50724700bdf8d |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | COL6A5 ADARB1 COL21A1 COL4A1 COL5A1 COL5A2 COL16A1 ABI3BP COL6A6 DYNC2H1 SYNE1 SPECC1L SDC3 | 6.01e-11 | 199 | 237 | 13 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | COL6A5 COL21A1 COL4A1 COL5A1 COL5A2 COL16A1 ABI3BP COL6A6 DYNC2H1 KIF26B SYNE1 SPECC1L SDC3 | 6.40e-11 | 200 | 237 | 13 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | COL21A1 ACAN MTCL1 COL2A1 COL4A1 COL4A2 COL4A6 COL5A1 COL7A1 COL27A1 MST1R SP6 | 1.78e-10 | 174 | 237 | 12 | fa0681e91724b9a51ee28b214ea5aa14e62ba1a3 |
| ToppCell | Mesenchymal-airway_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | IRS1 MTCL1 COL4A1 COL4A2 PRUNE2 COL4A6 COL5A1 FLNA COL16A1 KIF26B ENAH ELN | 4.90e-10 | 190 | 237 | 12 | 645e56b02edc3702c7db917b8ecd5eed0decaf71 |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | DLGAP1 COL6A5 ADARB1 LRRC7 COL5A1 COL5A2 COL16A1 ABI3BP COL6A6 KIF26B ENAH ELN | 6.22e-10 | 194 | 237 | 12 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG|World / Primary Cells by Cluster | TRIP6 ADGRV1 MAST4 AHNAK COL4A6 COL5A1 DIPK1C FLNA COL11A1 COL27A1 COL5A3 LPP | 7.42e-10 | 197 | 237 | 12 | 61749ccafeb938c310cff1de5ff924a1c794325a |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG-25|World / Primary Cells by Cluster | TRIP6 ADGRV1 MAST4 AHNAK COL4A6 COL5A1 DIPK1C FLNA COL11A1 COL27A1 COL5A3 LPP | 7.42e-10 | 197 | 237 | 12 | 9d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6 |
| ToppCell | droplet-Trachea-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | CFAP100 ACAN COL2A1 COL5A1 COL5A2 COL9A3 COL11A1 COL16A1 ABI3BP WWP2 COL27A1 ELN | 7.86e-10 | 198 | 237 | 12 | 1beed34f469aad07e8f674f0b668d6e1e916403c |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | IL16 COL6A5 ADARB1 COL21A1 COL5A1 COL5A2 COL16A1 ABI3BP COL6A6 KIF26B ENAH ELN | 7.86e-10 | 198 | 237 | 12 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CFAP100 ACAN COL2A1 COL5A1 COL5A2 COL9A3 COL11A1 COL16A1 ABI3BP WWP2 COL27A1 ELN | 7.86e-10 | 198 | 237 | 12 | d3a475be01657a03fcbb0ee0a246b1e90deacaa4 |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CFAP100 ACAN COL2A1 COL5A1 COL5A2 COL9A3 COL11A1 COL16A1 ABI3BP WWP2 COL27A1 ELN | 7.86e-10 | 198 | 237 | 12 | 985022c1722ab7b67675ebe814022a439e715b5e |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | IRS1 COL24A1 MTCL1 FOXL1 COL4A1 COL4A2 FLNA COL27A1 LORICRIN ENAH ZFHX3 | 8.74e-10 | 157 | 237 | 11 | b9d04ee417c0d8ea0801d10f1c54e138587009fd |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | IRS1 ARHGEF17 COL4A1 COL4A2 PRUNE2 COL5A2 FLNA ABI3BP SYNE1 COL5A3 LPP ZFHX3 | 8.82e-10 | 200 | 237 | 12 | 67dcbd86fbc79fd585d0793f979e4aac100326c9 |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass | COL24A1 ZNF469 PTPRN ACAN COL5A1 COL5A2 COL7A1 COL10A1 COL16A1 KIF26B SALL4 | 1.39e-09 | 164 | 237 | 11 | 9b4a6007abae992db871d9f6f731d5af724de30d |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | DLGAP1 COL6A5 ADARB1 TTC8 COL21A1 LRRC7 COL16A1 ABI3BP COL27A1 ENAH ELN | 3.71e-09 | 180 | 237 | 11 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ADGRV1 COL24A1 DNAH5 DNAH9 COL2A1 CACNA1F COL11A1 KIF26B SALL4 DNAH1 MYO15A | 4.67e-09 | 184 | 237 | 11 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ADGRV1 COL24A1 DNAH5 DNAH9 COL2A1 CACNA1F COL11A1 KIF26B SALL4 DNAH1 MYO15A | 4.67e-09 | 184 | 237 | 11 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ADGRV1 COL24A1 DNAH5 DNAH9 COL2A1 CACNA1F COL11A1 KIF26B SALL4 DNAH1 MYO15A | 4.67e-09 | 184 | 237 | 11 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | PTPRN COL5A1 COL5A2 COL10A1 COL11A1 COL16A1 KIF26B COL27A1 COL5A3 ELN SP7 | 4.94e-09 | 185 | 237 | 11 | 87c416d14ca6255bee39b16e7571553e36ee3069 |
| ToppCell | PCW_13-14|World / Celltypes from embryonic and fetal-stage human lung | COL24A1 MAST4 COL21A1 HSPA1A HSPA1B ABI3BP LIMD1 ENAH CNTN3 ELN ARHGEF26 | 6.53e-09 | 190 | 237 | 11 | 62a3ec1ae0829602b0569cc051210551644f1d46 |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | DLGAP1 COL6A5 ADARB1 COL4A1 COL5A2 COL16A1 ABI3BP COL6A6 KIF26B SDC3 ELN | 7.28e-09 | 192 | 237 | 11 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | IRS1 CSMD2 COL24A1 COL5A1 COL5A2 COL7A1 COL10A1 COL11A1 KIF26B SALL4 ENAH | 7.28e-09 | 192 | 237 | 11 | 67e845e513e76e820f55e2f0d15eb16f2944d05c |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | COL24A1 COL4A1 COL4A2 COL4A3 COL5A1 COL5A2 ABI3BP DYNC2H1 COL5A3 ZFHX3 ELN | 7.28e-09 | 192 | 237 | 11 | 356160b113c3305a61ceeaff33ce3c9da0be2878 |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | DLGAP1 COL6A5 ADARB1 COL4A1 COL4A2 COL5A2 COL16A1 ABI3BP COL6A6 KIF26B ELN | 7.28e-09 | 192 | 237 | 11 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | DLGAP1 COL6A5 ADARB1 COL21A1 COL5A1 COL5A2 COL16A1 ABI3BP COL6A6 KIF26B ELN | 7.28e-09 | 192 | 237 | 11 | deeecd26972241846b4cb998edf0c7a87ff0c4df |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | CSMD2 COL24A1 COL4A1 COL5A1 COL5A2 COL11A1 COL16A1 ABI3BP COL6A6 KIF26B ENAH | 8.11e-09 | 194 | 237 | 11 | 03a269f75a481ea54aea8e6444605db8d6df493d |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | DLGAP1 COL6A5 ADARB1 COL21A1 COL5A1 COL5A2 COL16A1 ABI3BP COL6A6 SYNE1 ELN | 8.11e-09 | 194 | 237 | 11 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | COL21A1 COL4A1 COL4A2 COL5A1 COL5A2 FLNA COL11A1 COL16A1 ENAH ELN ARHGEF26 | 8.55e-09 | 195 | 237 | 11 | dd281a249854800f737dc22e0f375f66dfb5cf5f |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | PER3 ACAN COL2A1 COL4A1 COL4A2 COL5A1 COL5A2 HSPG2 COL11A1 COL16A1 ELN | 8.55e-09 | 195 | 237 | 11 | fee9d13f48149cd5f921cfe4b8b3053cf6a6dbd2 |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | COL21A1 COL4A1 COL4A2 COL5A1 COL5A2 FLNA COL11A1 COL16A1 ENAH ELN ARHGEF26 | 8.55e-09 | 195 | 237 | 11 | 49c99553629cdd83ee56a2e508d5bc8d34b8507b |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | AHNAK COL4A1 COL4A2 COL5A1 COL5A2 HSPG2 COL7A1 COL11A1 ABI3BP TNS2 COL5A3 | 8.55e-09 | 195 | 237 | 11 | 78cfde21dde4b877fc76c8b0d5ddaabe44b912d7 |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | DLGAP1 IL16 ADARB1 COL21A1 COL5A1 COL5A2 COL16A1 ABI3BP COL6A6 COL5A3 ELN | 9.02e-09 | 196 | 237 | 11 | bc94909f9b2dc08a59eef1914148b69720569c8f |
| ToppCell | Mesenchymal_cells-Fibro/Chondro_p.|World / Lineage and Cell class | ACAN NKX6-1 COL2A1 COL5A2 COL9A3 COL10A1 COL11A1 COL16A1 ABI3BP COL27A1 PAX1 | 9.02e-09 | 196 | 237 | 11 | ddc168849e0e97005a111be004463bb72d433853 |
| ToppCell | metastatic_Lymph_Node-Fibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | COL4A1 COL4A2 COL5A1 COL5A2 HSPG2 COL10A1 COL16A1 ABI3BP COL6A6 COL5A3 ELN | 9.02e-09 | 196 | 237 | 11 | 275e153347caf94edc0c50021bbab49c8696fecb |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | COL6A5 ADARB1 COL21A1 LRRC7 COL4A1 COL5A2 COL16A1 ABI3BP COL6A6 DYNC2H1 SYNE1 | 9.51e-09 | 197 | 237 | 11 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | CSMD2 ADARB1 COL4A1 COL4A2 COL5A1 COL5A2 COL16A1 ABI3BP KIF26B ENAH ELN | 9.51e-09 | 197 | 237 | 11 | fb847f2277609c31fffcdf49517243ce0684facf |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ADARB1 COL21A1 CACNA1H NKX6-1 COL4A1 COL4A2 PRUNE2 COL4A6 FLNA SYNE1 ELAVL2 | 9.51e-09 | 197 | 237 | 11 | ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7 |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL2A1 COL4A1 COL4A2 COL5A1 COL5A2 HSPG2 COL11A1 COL16A1 ABI3BP COL5A3 ELN | 1.00e-08 | 198 | 237 | 11 | b086af292a508a156266c2d899ba1caf820bf61c |
| ToppCell | droplet-Trachea|droplet / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CFAP100 ACAN HSPA1A COL2A1 COL5A2 HSPG2 COL9A3 COL11A1 COL16A1 ABI3BP COL27A1 | 1.06e-08 | 199 | 237 | 11 | 1c7d30765ddb2291967da5d15664c6238c680c1d |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | COL6A5 COL21A1 COL4A1 COL5A1 COL5A2 COL16A1 ABI3BP COL6A6 SYNE1 SPECC1L SDC3 | 1.06e-08 | 199 | 237 | 11 | e1849505b92820a219c5a2c35492bdd55579fb48 |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | ADARB1 COL21A1 COL4A1 COL4A2 COL5A1 COL5A2 COL16A1 ABI3BP COL6A6 ENAH ELN | 1.06e-08 | 199 | 237 | 11 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 |
| ToppCell | droplet-Trachea|droplet / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | CFAP100 ACAN HSPA1A COL2A1 COL5A2 HSPG2 COL9A3 COL11A1 COL16A1 ABI3BP COL27A1 | 1.06e-08 | 199 | 237 | 11 | b9038a1ccf3ef3123e2e39afbe6213c363437443 |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | COL6A5 COL21A1 COL4A1 COL5A1 COL5A2 COL16A1 ABI3BP COL6A6 SYNE1 SPECC1L SDC3 | 1.11e-08 | 200 | 237 | 11 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | COL6A5 COL21A1 COL4A1 COL5A1 COL5A2 COL16A1 ABI3BP COL6A6 SYNE1 SPECC1L SDC3 | 1.11e-08 | 200 | 237 | 11 | 50ca6550998e461ef26dd670351060bd940765a8 |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | IL16 ACAN COL2A1 COL4A1 COL4A2 COL5A1 COL5A2 COL11A1 COL16A1 ABI3BP SYNE1 | 1.11e-08 | 200 | 237 | 11 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | COL6A5 COL21A1 COL4A1 COL4A2 COL5A1 COL5A2 COL16A1 ABI3BP COL6A6 DYNC2H1 SDC3 | 1.11e-08 | 200 | 237 | 11 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | RAMP2 COL21A1 COL4A1 COL4A2 COL5A1 COL5A2 ABI3BP COL6A6 TNS2 COL5A3 ELN | 1.11e-08 | 200 | 237 | 11 | 76f3043cb88071256ff661885fe5a82a54f5b733 |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | RAMP2 COL21A1 COL4A1 COL4A2 COL5A1 COL5A2 ABI3BP COL6A6 TNS2 COL5A3 ELN | 1.11e-08 | 200 | 237 | 11 | 64d2941689d7ca8af54f9ba21c5aeabf719084ef |
| ToppCell | Adult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor | TARM1 NYNRIN COL5A1 COL5A2 COL16A1 ABI3BP COL27A1 TNS2 SALL4 ELN | 1.46e-08 | 159 | 237 | 10 | 3f7305ee76447064b5c846c4f576360a2f7e0b7c |
| ToppCell | Nasal_Brush-Epithelial-Basal_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.09e-08 | 172 | 237 | 10 | 58eaadf12366701103a0d1f133462c9495fedc30 | |
| ToppCell | Nasal_Brush-Epithelial-Basal_1|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.09e-08 | 172 | 237 | 10 | 4483073469001770015526303772fd54906c5d68 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | ADARB1 COL24A1 COL5A1 COL5A2 COL10A1 ABI3BP LPP ELN PEAK1 ARHGEF26 | 3.64e-08 | 175 | 237 | 10 | 1799a7be623dc3bf53ba580a7c47d2619969d708 |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | COL21A1 COL4A1 COL4A2 COL5A1 COL5A2 COL16A1 ABI3BP COL6A6 KIF26B ENAH | 4.05e-08 | 177 | 237 | 10 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | COL21A1 COL4A1 COL4A2 COL5A1 COL5A2 COL16A1 ABI3BP COL6A6 KIF26B ENAH | 4.05e-08 | 177 | 237 | 10 | db222faaecbe5600da39277243c4e7e764eb63c9 |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | ZNF469 PTPRN COL5A1 COL5A2 COL7A1 COL10A1 COL11A1 COL16A1 KIF26B COL5A3 | 4.75e-08 | 180 | 237 | 10 | 935c091bbcd6d10b81dc4731779e5bd98205c99f |
| ToppCell | 5'-Airway_Nasal-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | ZNF469 PTPRN COL5A1 COL5A2 COL7A1 COL10A1 COL11A1 COL16A1 KIF26B COL5A3 | 4.75e-08 | 180 | 237 | 10 | 3dd384b7f3d9582b8fec9fe05100e466e6218b76 |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | IRS1 ARHGEF17 COL21A1 CACNA1H COL4A1 COL4A2 COL5A2 TNS2 COL5A3 PRKAR2B | 5.00e-08 | 181 | 237 | 10 | 451b87ac95154bb80018b8dd245b4a6389d81411 |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte-Resting_chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | ADRA2C ACAN COL2A1 COL9A3 COL11A1 COL16A1 ABI3BP WWP2 COL27A1 SP7 | 5.27e-08 | 182 | 237 | 10 | 00a148b1e499bf16325491536d187d4dd6b70c06 |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.55e-08 | 183 | 237 | 10 | e84539978ab4de42e19186aed00f24bb50cbc21f | |
| ToppCell | Mesenchymal_cells-Chondrocytes|World / Lineage and Cell class | ACAN COL2A1 COL9A3 COL11A1 COL16A1 KIF26B WWP2 COL27A1 SDC3 PAX1 | 5.84e-08 | 184 | 237 | 10 | 1e03f9f08de5ad4d45388a95afad9f23ff0d0e28 |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | CACNA1H COL4A1 COL4A2 PRUNE2 COL5A2 COL11A1 KIF26B LPP ENAH ELN | 6.80e-08 | 187 | 237 | 10 | 464a0c3b92b778911b5f9cd73642e09e3472063a |
| ToppCell | Pericytes-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | ACAN CACNA1H COL4A1 COL4A2 COL5A1 COL5A2 ZNF703 COL5A3 SYDE1 ELN | 7.15e-08 | 188 | 237 | 10 | f16ff998393bf1954bbf10caab15173bdb104ac1 |
| ToppCell | Mesenchymal-chondrocyte|World / Lineage, Cell type, age group and donor | IRS1 COL24A1 ACAN COL2A1 COL5A1 COL9A3 COL11A1 COL16A1 COL27A1 ELN | 7.15e-08 | 188 | 237 | 10 | 7b1e3f8a941eaa68e89c562129a92314642eec66 |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | CSMD2 DNAH5 COL4A1 COL4A2 COL4A6 COL5A1 COL5A2 COL27A1 SALL4 PRKAR2B | 7.15e-08 | 188 | 237 | 10 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 |
| ToppCell | Entopeduncular-Endothelial|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 7.15e-08 | 188 | 237 | 10 | 94774652fd42bad5012356672ffac8b6d2c22d37 | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | IRS1 COL24A1 COL4A1 COL4A2 COL5A1 COL5A2 COL16A1 COL27A1 ENAH ELN | 7.51e-08 | 189 | 237 | 10 | 44e37f88137bb249933eb615235b2cf2ae7f3925 |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | IRS1 LRRC7 MTCL1 COL4A1 COL4A2 PRUNE2 FLNA CCDC88C LPP ZFHX3 | 7.51e-08 | 189 | 237 | 10 | b6d5dec55bf352f6ae19d8f488ae70aa10fb9a8f |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | ACAN COL2A1 COL5A1 COL5A2 COL11A1 COL16A1 ABI3BP COL6A6 COL27A1 ELN | 7.51e-08 | 189 | 237 | 10 | 40764f461b8aa1d3a2c5a30590b7fb9307d47d09 |
| ToppCell | (3)_Chondrocytes-(31)_Chondro-hyper|(3)_Chondrocytes / Cell class and subclass of bone marrow stroma cells in homeostatis | RPS14 ACAN COL2A1 HSPG2 COL9A3 COL11A1 COL27A1 ENAH SDC3 SP7 | 7.51e-08 | 189 | 237 | 10 | 864526ed3e338c0353d10699f650f88c065ce72b |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | ACAN COL2A1 COL5A1 COL5A2 COL11A1 COL16A1 ABI3BP COL6A6 COL27A1 ELN | 7.51e-08 | 189 | 237 | 10 | eccf3d49354a67c94f1ed7c15a98a48a5e8e2ed0 |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.51e-08 | 189 | 237 | 10 | f75cebd4c3e54e297557449ba67ccc8d1a2a14f5 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | DLGAP1 COL6A5 ADARB1 COL5A1 COL5A2 COL16A1 ABI3BP COL6A6 KIF26B ELN | 7.51e-08 | 189 | 237 | 10 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 |
| ToppCell | E18.5-samps-Mesenchymal|E18.5-samps / Age Group, Lineage, Cell class and subclass | COL5A1 COL5A2 FLNA COL16A1 ABI3BP COL27A1 SUGP2 ELN PEAK1 MAPK7 | 7.51e-08 | 189 | 237 | 10 | 0c18d3de4720759cf802eefb4d0ddde2a9246a1a |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | COL21A1 ACAN LRRC7 COL5A1 FLNA COL16A1 LPP ENAH ELN ARHGEF26 | 7.90e-08 | 190 | 237 | 10 | 2e88e366d377d74deb53a4ea870973ce5c6532e8 |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | COL21A1 ACAN LRRC7 COL5A1 FLNA COL16A1 LPP ENAH ELN ARHGEF26 | 7.90e-08 | 190 | 237 | 10 | 0028f886c789ba238c031eae5d96acaed4af8c25 |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | IL16 ADARB1 COL21A1 COL4A1 COL5A1 COL5A2 COL16A1 ABI3BP COL6A6 ELN | 7.90e-08 | 190 | 237 | 10 | 3a42a9b98d954685d38a741f44545898d0e3e9ce |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | COL4A1 COL4A2 COL4A3 COL5A1 COL5A2 ABI3BP DYNC2H1 COL5A3 ZFHX3 ELN | 7.90e-08 | 190 | 237 | 10 | 12992ec80a7b4f4f17de693f0719ee061a9918fd |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | ZNF469 COL5A1 COL5A2 COL7A1 COL11A1 COL16A1 ABI3BP COL6A6 COL5A3 ELN | 8.29e-08 | 191 | 237 | 10 | 75d2197076a9dfc868e8baf95bd4c5e44f438e3e |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | COL21A1 ACAN CACNA1H COL4A1 COL4A2 COL5A1 COL5A2 FLNA ZFHX3 ELN | 8.29e-08 | 191 | 237 | 10 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | ACAN DNAH9 COL2A1 COL5A1 COL5A2 COL11A1 COL6A6 COL27A1 ELN SLC45A1 | 8.29e-08 | 191 | 237 | 10 | 44b1f62fdee03b157fe545f2ae6ff84f8929a8ac |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | COL4A1 COL4A2 COL4A3 COL5A1 COL5A2 ABI3BP DYNC2H1 COL5A3 ZFHX3 ELN | 8.29e-08 | 191 | 237 | 10 | 70c067c54084bfb02c29bab085f4defd477194fb |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | DLGAP1 COL6A5 ADARB1 COL21A1 COL5A1 COL5A2 COL16A1 ABI3BP COL6A6 ELN | 8.71e-08 | 192 | 237 | 10 | 3d0cb19f037f604253d7d728689aeaa94251e92b |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | DLGAP1 COL6A5 COL4A1 COL5A2 COL16A1 ABI3BP COL6A6 KIF26B SDC3 ELN | 8.71e-08 | 192 | 237 | 10 | df1545670370fb1010c567cd059c2783eab315f7 |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | COL21A1 MTCL1 HSPA1A COL4A1 COL4A2 PRUNE2 FLNA ABI3BP LPP ENAH | 9.14e-08 | 193 | 237 | 10 | a402e736440684ebe123673b6b0c6fcd8fa057b2 |
| ToppCell | Parenchymal-NucSeq-Stromal-Chondrocytic-Chondrocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ACAN SLC25A11 COL2A1 COL9A3 COL11A1 COL16A1 ZNF316 COL5A3 SYDE1 SP7 | 9.14e-08 | 193 | 237 | 10 | ab36d684bde8fe77d11a5188425135328052c58b |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | IRS1 FOXL1 COL4A1 COL4A2 COL5A1 COL5A2 FLNA LPP PRKAR2B CTNND2 | 9.14e-08 | 193 | 237 | 10 | 146e8c148478ab61b1c1dbaf1ee98a8cd4a0ff8a |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | COL6A5 ADARB1 COL21A1 COL5A1 COL5A2 COL16A1 ABI3BP COL6A6 KIF26B ELN | 9.14e-08 | 193 | 237 | 10 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | DLGAP1 COL6A5 ADARB1 COL21A1 COL5A1 COL5A2 COL16A1 ABI3BP COL6A6 ELN | 9.14e-08 | 193 | 237 | 10 | fb28717fadd06c3840636d25409ce80c9254bd34 |
| ToppCell | Parenchymal-NucSeq-Stromal-Chondrocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ACAN SLC25A11 COL2A1 COL9A3 COL11A1 COL16A1 ZNF316 COL5A3 SYDE1 SP7 | 9.14e-08 | 193 | 237 | 10 | df4afb4848eb9d7d8d39e5c612919663cbbb2514 |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | COL4A1 COL4A2 COL4A3 COL5A1 COL5A2 ABI3BP DYNC2H1 COL5A3 ZFHX3 ELN | 9.14e-08 | 193 | 237 | 10 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | IRS1 COL24A1 COL5A1 COL5A2 COL7A1 COL10A1 COL11A1 KIF26B SALL4 ENAH | 9.14e-08 | 193 | 237 | 10 | 5de87fc94a6e58899ef4124cf4887ed3ff96163a |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | DLGAP1 ADARB1 COL21A1 COL5A1 COL5A2 ABI3BP COL6A6 ENAH CNTN3 ELN | 9.14e-08 | 193 | 237 | 10 | acad568621ed677031797b8c2e34dafea798d681 |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | IL16 CBARP DNMT1 COL4A1 COL4A2 COL5A2 COL16A1 ABI3BP COL5A3 ELN | 9.14e-08 | 193 | 237 | 10 | 261cafc167c86ab277be4ea7f08b0173e2dde26e |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.74e-05 | 50 | 129 | 6 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4 | |
| Computational | Adhesion molecules. | 2.88e-04 | 141 | 129 | 8 | MODULE_122 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.17e-04 | 50 | 129 | 5 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.17e-04 | 50 | 129 | 5 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_2 | |
| Drug | NSC49633 | COL24A1 COL21A1 ACAN COL2A1 COL4A1 COL4A3 COL4A6 COL5A1 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 COL27A1 APLP1 ABCB11 | 8.52e-20 | 53 | 232 | 16 | CID000023340 |
| Drug | GK-101 | COL24A1 COL21A1 COL2A1 COL4A1 COL4A3 COL4A6 COL5A1 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 COL27A1 | 1.71e-17 | 36 | 232 | 13 | CID000161853 |
| Drug | Madecassol | COL24A1 COL21A1 COL2A1 COL4A1 COL4A3 COL4A6 COL5A1 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 COL27A1 | 6.88e-16 | 46 | 232 | 13 | CID000108062 |
| Drug | d-indobufen | COL24A1 COL21A1 COL2A1 COL4A1 COL4A3 COL4A6 COL5A1 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 COL27A1 | 2.32e-15 | 50 | 232 | 13 | CID000044562 |
| Drug | ridogrel | COL24A1 COL21A1 COL2A1 COL4A1 COL4A3 COL4A6 COL5A1 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 COL27A1 | 4.07e-15 | 52 | 232 | 13 | CID005362391 |
| Drug | malotilate | COL24A1 COL21A1 MBD2 COL2A1 COL4A1 COL4A3 COL4A6 COL5A1 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 COL27A1 | 1.26e-14 | 71 | 232 | 14 | CID000004006 |
| Drug | BAPN | COL24A1 COL21A1 COL2A1 COL4A1 COL4A3 COL4A6 COL5A1 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 COL27A1 ELN | 1.26e-14 | 71 | 232 | 14 | CID000001647 |
| Drug | DMSe | HOXB2 COL24A1 COL21A1 COL2A1 COL4A1 COL4A3 COL4A6 COL5A1 FLNA COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 COL27A1 COL5A3 ELN | 2.91e-14 | 132 | 232 | 17 | CID000020796 |
| Drug | strontium ranelate | COL24A1 COL21A1 COL2A1 COL4A1 COL4A3 COL4A6 COL5A1 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 COL27A1 SLC12A2 | 4.18e-14 | 77 | 232 | 14 | CID006918182 |
| Drug | AC1LAKND | COL24A1 COL21A1 COL2A1 COL4A1 COL4A3 COL4A6 COL5A1 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 COL27A1 | 4.87e-14 | 62 | 232 | 13 | CID000470146 |
| Drug | Selara | HCN2 COL24A1 COL21A1 VASP COL2A1 COL4A1 COL4A3 COL4A6 COL5A1 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 COL27A1 MAPK7 | 1.87e-13 | 125 | 232 | 16 | CID000150310 |
| Drug | AC1L1C2F | COL24A1 COL21A1 COL2A1 COL4A1 COL4A3 COL4A6 COL5A1 HSPG2 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 COL27A1 KCNH4 | 4.20e-13 | 110 | 232 | 15 | CID000001711 |
| Drug | 4-hydroxyproline | COL24A1 COL21A1 COL2A1 COL4A1 COL4A3 COL4A6 COL5A1 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 COL27A1 ELN | 4.68e-13 | 91 | 232 | 14 | CID000000825 |
| Drug | AC1NMZ1B | COL24A1 COL21A1 COL2A1 COL4A1 COL4A3 COL4A6 COL5A1 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 COL27A1 | 6.60e-13 | 75 | 232 | 13 | CID005034185 |
| Drug | DL-penicillamine | COL24A1 PTPRN COL21A1 MBD2 COL2A1 COL4A1 COL4A3 COL4A6 COL5A1 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 COL27A1 ELN | 1.00e-12 | 139 | 232 | 16 | CID000004727 |
| Drug | halofuginone lactate | COL24A1 COL21A1 COL2A1 COL4A1 COL4A3 COL4A6 COL5A1 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 COL27A1 | 3.52e-12 | 85 | 232 | 13 | CID000062891 |
| Drug | hydroxylysine | COL24A1 COL21A1 COL2A1 COL4A1 COL4A3 COL4A6 COL5A1 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 COL27A1 ELN | 5.98e-12 | 109 | 232 | 14 | CID000001029 |
| Drug | AC1L9732 | COL24A1 COL21A1 ACAN COL2A1 COL4A1 COL4A3 COL4A6 COL5A1 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 COL27A1 | 1.11e-11 | 114 | 232 | 14 | CID000439300 |
| Drug | ticlopidine | COL24A1 COL21A1 COL2A1 COL4A1 COL4A3 COL4A6 COL5A1 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 COL27A1 | 4.34e-11 | 103 | 232 | 13 | CID000005472 |
| Drug | AC1L1DD6 | COL24A1 COL21A1 ACAN COL2A1 COL4A1 COL4A3 COL4A6 COL5A1 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 COL27A1 ELN MAPK7 | 4.92e-11 | 179 | 232 | 16 | CID000002299 |
| Drug | PPACK | COL24A1 COL21A1 COL2A1 COL4A1 COL4A3 COL4A6 COL5A1 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 COL27A1 | 1.42e-10 | 113 | 232 | 13 | CID003036757 |
| Drug | PCR 4099 | COL24A1 COL21A1 VASP COL2A1 COL4A1 COL4A3 COL4A6 COL5A1 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 COL27A1 | 1.67e-10 | 139 | 232 | 14 | CID000002806 |
| Drug | Tranilast sodium | COL24A1 COL21A1 COL2A1 COL4A1 COL4A3 COL4A6 COL5A1 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 COL27A1 | 1.78e-10 | 115 | 232 | 13 | CID000005527 |
| Drug | khellin | COL24A1 COL21A1 COL2A1 COL4A1 COL4A3 COL4A6 COL5A1 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 COL27A1 KCNH4 CNTN3 | 2.62e-10 | 171 | 232 | 15 | CID000003828 |
| Drug | candesartan cilexetil | COL24A1 COL21A1 COL2A1 COL4A1 COL4A3 COL4A6 COL5A1 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 COL27A1 MAPK7 | 2.94e-10 | 145 | 232 | 14 | CID000002540 |
| Drug | L-lysyl-L-lysyl-L-lysine | COL24A1 COL21A1 COL2A1 COL4A1 COL4A3 COL4A6 COL5A1 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 COL27A1 APLP1 | 1.28e-09 | 162 | 232 | 14 | CID000072363 |
| Drug | pirfenidone | COL24A1 COL21A1 COL2A1 COL4A1 COL4A3 COL4A6 COL5A1 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 COL27A1 | 1.75e-09 | 138 | 232 | 13 | CID000040632 |
| Drug | hyaluronan | COL24A1 COL21A1 ACAN COL2A1 COL4A1 COL4A3 COL4A6 COL5A1 HSPG2 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 COL27A1 SDC3 ELN | 1.91e-09 | 263 | 232 | 17 | CID000024759 |
| Drug | prostacyclin sodium salt | COL24A1 COL21A1 VASP COL2A1 COL4A1 COL4A3 COL4A6 COL5A1 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 COL27A1 GPR68 SP7 | 6.66e-09 | 250 | 232 | 16 | CID000000159 |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | COL24A1 COL21A1 COL2A1 COL4A1 COL4A3 COL4A6 COL5A1 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 COL27A1 MAPK7 | 9.45e-09 | 189 | 232 | 14 | CID000001413 |
| Drug | NC-4 | 1.33e-08 | 44 | 232 | 8 | CID006420119 | |
| Drug | AC1Q6PCP | COL24A1 COL21A1 CACNA1H COL2A1 COL4A1 COL4A3 COL4A6 COL5A1 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 COL27A1 SLC12A2 | 1.55e-08 | 230 | 232 | 15 | CID000005267 |
| Drug | colchine | TBC1D9 COL24A1 PTPRN COL21A1 ACAN COL2A1 COL4A1 COL4A3 COL4A6 COL5A1 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 COL27A1 ABCB11 SDC3 CNTN3 | 1.63e-08 | 383 | 232 | 19 | CID000002833 |
| Drug | silibinin | IRS1 COL24A1 COL21A1 COL2A1 COL4A1 COL4A3 COL4A6 COL5A1 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 COL27A1 ABCB11 MAPK7 | 4.21e-08 | 285 | 232 | 16 | CID000005213 |
| Drug | L-3,4-dehydroproline | COL21A1 COL2A1 COL5A1 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 ELN | 5.59e-08 | 73 | 232 | 9 | CID000094284 |
| Drug | losartan | IRS1 ADD1 COL24A1 COL21A1 COL2A1 COL4A1 COL4A3 COL4A6 COL5A1 HSPG2 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 COL27A1 SDC3 MAPK7 | 7.29e-08 | 378 | 232 | 18 | CID000003961 |
| Drug | foscarnet | COL24A1 COL21A1 COL2A1 COL4A1 COL4A3 COL4A6 COL5A1 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 COL27A1 | 8.25e-08 | 190 | 232 | 13 | CID000003414 |
| Drug | AC1L1KMJ | ADD1 COL24A1 COL21A1 COL2A1 COL4A1 COL4A3 COL4A6 COL5A1 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 COL27A1 SLC12A2 ENAH PRKAR2B MAPK7 MYO15A MARCO | 1.04e-07 | 476 | 232 | 20 | CID000030956 |
| Drug | BPAT-143 | 1.55e-07 | 6 | 232 | 4 | CID000146249 | |
| Drug | (2s,5s)-5-Carboxymethylproline | COL24A1 COL21A1 SLC25A11 COL2A1 COL4A1 COL4A3 COL4A6 COL5A1 HSPG2 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 COL27A1 CD33 | 1.59e-07 | 314 | 232 | 16 | CID000447989 |
| Drug | Y-27632 | IRS1 ARHGEF11 MEN1 COL24A1 COL21A1 VASP COL2A1 COL4A1 COL4A3 COL4A6 COL5A1 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 COL27A1 APLP1 MAPK7 | 1.66e-07 | 444 | 232 | 19 | CID000005711 |
| Drug | AC1L18QD | COL24A1 COL21A1 VASP COL2A1 COL4A1 COL4A3 COL4A6 COL5A1 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 COL27A1 MAPK7 SP7 | 2.53e-07 | 325 | 232 | 16 | CID000000213 |
| Drug | chondroitin sulfate | COL24A1 COL21A1 ACAN COL2A1 COL4A1 COL4A3 COL4A6 COL5A1 HSPG2 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 COL27A1 APLP1 SDC3 ELN | 2.72e-07 | 413 | 232 | 18 | CID000024766 |
| Drug | pyridinoline | PCP2 COL21A1 COL2A1 COL5A1 COL9A3 COL10A1 COL11A1 COL27A1 ELN | 7.92e-07 | 99 | 232 | 9 | CID000105068 |
| Drug | isodesmosine | 9.23e-07 | 33 | 232 | 6 | CID000013811 | |
| Drug | Pseudopelletierine hydrochloride [6164-62-1]; Down 200; 21uM; PC3; HT_HG-U133A | RTEL1 C1orf159 COL4A2 COL4A6 COL7A1 TNS2 LRRK1 ARNT SUGP2 LPP PUS1 SDC3 | 1.07e-06 | 200 | 232 | 12 | 5828_DN |
| Drug | 351A | 1.44e-06 | 20 | 232 | 5 | CID000122144 | |
| Drug | trapidil | 1.79e-06 | 57 | 232 | 7 | CID000005531 | |
| Drug | Flunisolide [3385-03-3]; Up 200; 9.2uM; PC3; HT_HG-U133A | ARHGEF11 ACAN PXN MBD2 PRUNE2 COL4A6 HSPG2 COL16A1 SYDE1 ARNT MAPK7 | 4.72e-06 | 192 | 232 | 11 | 4303_UP |
| Drug | LMWH | RYR1 COL24A1 COL21A1 ACAN COL2A1 COL4A1 COL4A3 COL4A6 COL5A1 HSPG2 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 COL27A1 APLP1 SDC3 ELAVL2 PRKAR2B ELN | 4.78e-06 | 663 | 232 | 21 | CID000000772 |
| Drug | Cyanocobalamin [68-19-9]; Up 200; 3uM; PC3; HT_HG-U133A | RPS14 AHNAK NKX6-1 MBD2 PRUNE2 COL10A1 RAB3D SYDE1 ELN CTNND2 ARHGEF26 | 6.03e-06 | 197 | 232 | 11 | 4572_UP |
| Drug | Sulfasalazine [599-79-1]; Down 200; 10uM; PC3; HT_HG-U133A | MYO1E ING1 RTEL1 C1orf159 NUP98 TNS2 APLP1 MLLT10 YLPM1 SDC3 ZFHX3 | 6.33e-06 | 198 | 232 | 11 | 6346_DN |
| Drug | Isoquinoline, 6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro, hydrochloride; Up 200; 16.4uM; MCF7; HT_HG-U133A | GNMT OSBP2 MBD2 COL4A1 COL4A3 COL9A3 GPR68 ELAVL2 DUSP10 ELN FYB1 | 6.64e-06 | 199 | 232 | 11 | 4810_UP |
| Drug | diphenylamine-2-carboxylate | FOXL2 DNAH5 COL2A1 COL4A3 COL5A1 COL9A3 COL10A1 DNAH1 SLC12A2 PRKAR2B | 7.42e-06 | 164 | 232 | 10 | CID000004386 |
| Drug | 2-phenylacetylenesulfonamide | 1.03e-05 | 5 | 232 | 3 | ctd:C545747 | |
| Drug | desmosine | 1.61e-05 | 53 | 232 | 6 | CID000025435 | |
| Drug | dermatan sulfate | COL21A1 ACAN COL2A1 COL4A3 COL5A1 HSPG2 COL9A3 COL11A1 COL27A1 SDC3 ELN | 1.71e-05 | 220 | 232 | 11 | CID000032756 |
| Drug | hematoxilina | 1.93e-05 | 183 | 232 | 10 | CID000010603 | |
| Drug | Sirius red | 2.66e-05 | 35 | 232 | 5 | CID005486818 | |
| Drug | Ald1.1-H_000455; Up 200; 10uM; PC3; HT_HG-U133A | 2.79e-05 | 191 | 232 | 10 | 7547_UP | |
| Drug | geldanamycin; Down 200; 1uM; MCF7; HT_HG-U133A_EA | CEP104 ARHGEF17 PER3 ZC3H7B COL5A1 BICRA ZNF783 ARNT SUGP2 SDC3 | 3.05e-05 | 193 | 232 | 10 | 864_DN |
| Drug | Propidium iodide [25535-16-4]; Up 200; 6uM; HL60; HT_HG-U133A | MON2 CEP104 ATXN2L ING1 ACAN COL10A1 BICRA ZNF783 RAB11FIP5 FYB1 | 3.64e-05 | 197 | 232 | 10 | 2541_UP |
| Drug | Cetirizine dihydrochloride [83881-52-1]; Up 200; 8.6uM; HL60; HT_HG-U133A | MYO1E ADRA2C CAMKV ACAN PXN COL9A3 ABI3BP KIF26B PKD2L1 SYDE1 | 3.64e-05 | 197 | 232 | 10 | 2468_UP |
| Drug | Epirizole [18694-40-1]; Up 200; 17uM; PC3; HT_HG-U133A | ATXN2L ING1 ADARB1 ZC3H7B RAB3D LRRK1 SYDE1 ZNF783 MAPK7 ARHGEF26 | 3.64e-05 | 197 | 232 | 10 | 7292_UP |
| Drug | Harmine hydrochloride [343-27-1]; Up 200; 16uM; HL60; HG-U133A | 3.64e-05 | 197 | 232 | 10 | 1758_UP | |
| Drug | Articaine hydrochloride [23964-57-0]; Up 200; 12.4uM; HL60; HT_HG-U133A | RTEL1 ARHGEF11 CAMKV ZC3H7B MBD2 PRUNE2 COL4A3 COL7A1 ELN MYO15A | 3.64e-05 | 197 | 232 | 10 | 3138_UP |
| Drug | Sparteine (-) [90-39-1]; Down 200; 17uM; PC3; HT_HG-U133A | FOXJ2 KMT2B RTEL1 GON4L ADARB1 COL21A1 DYNC2H1 MLLT10 ARNT FYB1 | 3.79e-05 | 198 | 232 | 10 | 4568_DN |
| Drug | Probenecid [57-66-9]; Down 200; 14uM; PC3; HT_HG-U133A | 3.79e-05 | 198 | 232 | 10 | 4185_DN | |
| Drug | Naringin hydrate [11032-30-7]; Up 200; 6.6uM; MCF7; HT_HG-U133A | ATXN2L ZSWIM8 ARHGEF17 ADARB1 AHNAK ARNT SDC3 ELN MAPK7 CEP170B | 3.79e-05 | 198 | 232 | 10 | 3286_UP |
| Drug | Metronidazole [443-48-1]; Up 200; 23.4uM; PC3; HG-U133A | 3.79e-05 | 198 | 232 | 10 | 1921_UP | |
| Drug | Melatonin [73-31-4]; Down 200; 17.2uM; MCF7; HT_HG-U133A | ATXN2L ING1 RTEL1 ARHGEF11 ARHGEF17 PTPRCAP PXN COL5A1 APLP1 ZNF783 | 3.79e-05 | 198 | 232 | 10 | 5393_DN |
| Drug | Bromopride [4093-35-0]; Down 200; 11.6uM; MCF7; HT_HG-U133A | RTEL1 GON4L ADARB1 HOXB2 NYNRIN C1orf159 CACNA1H TNS2 APLP1 LPP | 3.79e-05 | 198 | 232 | 10 | 3617_DN |
| Drug | Pempidine tartrate [546-48-5]; Down 200; 13uM; MCF7; HT_HG-U133A | ING1 RTEL1 RPS14 ARHGEF11 PER3 PXN C1orf159 HSPG2 DUSP10 CTNND2 | 3.79e-05 | 198 | 232 | 10 | 6027_DN |
| Drug | Tolfenamic acid [13710-19-5]; Up 200; 15.2uM; PC3; HT_HG-U133A | ARHGEF17 ADRA2C MAST4 ACAN COL10A1 LRRK1 MLLT10 CD33 LPP CTNND2 | 3.96e-05 | 199 | 232 | 10 | 2120_UP |
| Drug | Rauwolscine hydrochloride [6211-32-1]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 3.96e-05 | 199 | 232 | 10 | 2778_DN | |
| Drug | Eburnamonine (-) [4880-88-0]; Up 200; 13.6uM; MCF7; HT_HG-U133A | ZSWIM8 HDAC4 RTEL1 MAST4 CAMKV ZC3H7B ZNF446 MST1R GPR68 FYB1 | 3.96e-05 | 199 | 232 | 10 | 6802_UP |
| Drug | Etanidazole [22668-01-5]; Up 200; 18.6uM; PC3; HT_HG-U133A | HOXB2 PTPRCAP ACAN AHNAK COL2A1 COL4A6 COL9A3 COL16A1 SYDE1 CD33 | 4.13e-05 | 200 | 232 | 10 | 5730_UP |
| Drug | AC1L1EOY | 5.63e-05 | 8 | 232 | 3 | CID000028135 | |
| Drug | 4-aminoazobenzene | 5.72e-05 | 66 | 232 | 6 | CID000006051 | |
| Drug | methoxycarbonyl chloride | 6.65e-05 | 22 | 232 | 4 | CID000006586 | |
| Drug | aspirin | MARK3 COL24A1 COL21A1 VASP COL2A1 COL4A1 COL4A3 COL4A6 COL5A1 COL7A1 COL9A3 COL10A1 COL11A1 COL16A1 COL27A1 ACIN1 MAPK7 | 7.11e-05 | 563 | 232 | 17 | CID000002244 |
| Drug | PD123177 | 7.39e-05 | 43 | 232 | 5 | CID000114899 | |
| Drug | iodomethylate | 7.99e-05 | 23 | 232 | 4 | CID000123359 | |
| Drug | erbium oxide | 1.03e-04 | 2 | 232 | 2 | CID000159426 | |
| Drug | holmium oxide (Ho2O3 | 1.03e-04 | 2 | 232 | 2 | CID000159423 | |
| Drug | CentA | 1.03e-04 | 2 | 232 | 2 | CID000133358 | |
| Drug | AC1L97KT | 1.03e-04 | 2 | 232 | 2 | CID000439552 | |
| Drug | 3,7-decadiene | 1.03e-04 | 2 | 232 | 2 | CID006429632 | |
| Drug | arsenobetaine | 1.03e-04 | 2 | 232 | 2 | CID000047364 | |
| Drug | mitraphylline | 1.03e-04 | 2 | 232 | 2 | CID000094160 | |
| Drug | NSC-364372 | HDAC4 TRIP6 NUMBL HCN2 PER3 ACAN RECQL4 TAF4 JPT2 CRAMP1 ARNT LPP CHFR MAPK7 EP300 | 1.43e-04 | 484 | 232 | 15 | CID000435143 |
| Drug | Mepenzolate bromide [76-90-4]; Up 200; 9.6uM; PC3; HT_HG-U133A | 1.45e-04 | 189 | 232 | 9 | 4304_UP | |
| Drug | Fenoprofen calcium salt dihydrate [53746-45-5]; Up 200; 7.2uM; PC3; HT_HG-U133A | 1.51e-04 | 190 | 232 | 9 | 4274_UP | |
| Drug | 2-propylpentanoic acid; Up 200; 500uM; HL60; HT_HG-U133A | 1.51e-04 | 190 | 232 | 9 | 6199_UP | |
| Drug | Chlorprothixene hydrochloride [6469-93-8]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 1.57e-04 | 191 | 232 | 9 | 2627_UP | |
| Drug | 15d-PGJ2; Down 200; 10uM; PC3; HG-U133A | 1.63e-04 | 192 | 232 | 9 | 446_DN | |
| Drug | Lasalocid sodium salt [25999-20-6]; Up 200; 6.6uM; HL60; HT_HG-U133A | 1.70e-04 | 193 | 232 | 9 | 3021_UP | |
| Drug | 6-Furfurylaminopurine [525-79-1]; Up 200; 18.6uM; PC3; HT_HG-U133A | 1.70e-04 | 193 | 232 | 9 | 4477_UP | |
| Drug | Zalcitabine [7481-89-2]; Up 200; 19uM; MCF7; HT_HG-U133A | 1.77e-04 | 194 | 232 | 9 | 7352_UP | |
| Drug | CGX 0596987; Down 200; 20uM; PC3; HT_HG-U133A | 1.77e-04 | 194 | 232 | 9 | 6417_DN | |
| Disease | Disproportionate short stature | 1.71e-07 | 77 | 232 | 8 | C0878659 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 3.06e-07 | 19 | 232 | 5 | DOID:2256 (is_implicated_in) | |
| Disease | Osteochondrodysplasias | 3.06e-07 | 19 | 232 | 5 | C0029422 | |
| Disease | Multiple Epiphyseal Dysplasia | 4.05e-07 | 20 | 232 | 5 | C0026760 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 3.73e-06 | 53 | 232 | 6 | C4707243 | |
| Disease | Stickler syndrome, type 1 | 4.74e-06 | 5 | 232 | 3 | C2020284 | |
| Disease | Spondyloepiphyseal Dysplasia | 6.29e-06 | 16 | 232 | 4 | C0038015 | |
| Disease | Schwartz-Jampel Syndrome | 6.29e-06 | 16 | 232 | 4 | C0036391 | |
| Disease | Spondyloepiphyseal Dysplasia Tarda, X-Linked | 6.29e-06 | 16 | 232 | 4 | C3541456 | |
| Disease | Schwartz-Jampel Syndrome, Type 1 | 6.29e-06 | 16 | 232 | 4 | C4551479 | |
| Disease | Melnick-Needles Syndrome | 6.29e-06 | 16 | 232 | 4 | C0025237 | |
| Disease | Van Buchem disease | 8.18e-06 | 17 | 232 | 4 | C0432272 | |
| Disease | Dyschondroplasias | 1.32e-05 | 19 | 232 | 4 | C0013366 | |
| Disease | urate measurement, bone density | COL6A5 HCN2 MAST4 DNAH8 DNAH9 COL5A1 ATG9B ZNF618 SYNE1 DNAH1 LATS2 LPP ELAVL2 PRKAR2B PEAK1 CTNND2 | 3.54e-05 | 619 | 232 | 16 | EFO_0003923, EFO_0004531 |
| Disease | congestive heart failure (is_implicated_in) | 5.67e-05 | 27 | 232 | 4 | DOID:6000 (is_implicated_in) | |
| Disease | PORENCEPHALY, FAMILIAL | 6.16e-05 | 2 | 232 | 2 | C1867983 | |
| Disease | Phelan-McDermid syndrome (implicated_via_orthology) | 6.16e-05 | 2 | 232 | 2 | DOID:0080354 (implicated_via_orthology) | |
| Disease | HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO | 6.16e-05 | 2 | 232 | 2 | C3281105 | |
| Disease | Ehlers-Danlos syndrome type 1 | 6.16e-05 | 2 | 232 | 2 | C0268335 | |
| Disease | Ehlers-Danlos syndrome type 2 | 6.16e-05 | 2 | 232 | 2 | C0268336 | |
| Disease | Developmental Porencephaly | 6.16e-05 | 2 | 232 | 2 | C4082301 | |
| Disease | Congenital porencephaly | 6.16e-05 | 2 | 232 | 2 | C0302892 | |
| Disease | choline deficiency disease (implicated_via_orthology) | 6.16e-05 | 2 | 232 | 2 | DOID:8456 (implicated_via_orthology) | |
| Disease | Ehlers-Danlos syndrome classic type | 6.16e-05 | 2 | 232 | 2 | C4225429 | |
| Disease | Porencephaly, Type 1, Autosomal Dominant | 6.16e-05 | 2 | 232 | 2 | C4551998 | |
| Disease | Post-traumatic Porencephaly | 6.16e-05 | 2 | 232 | 2 | C3698507 | |
| Disease | Porencephaly | 6.16e-05 | 2 | 232 | 2 | C4082173 | |
| Disease | Ehlers-Danlos syndrome, classic type | 6.16e-05 | 2 | 232 | 2 | cv:C4225429 | |
| Disease | degenerative disc disease (biomarker_via_orthology) | 7.56e-05 | 11 | 232 | 3 | DOID:90 (biomarker_via_orthology) | |
| Disease | collagen disease (implicated_via_orthology) | 1.00e-04 | 12 | 232 | 3 | DOID:854 (implicated_via_orthology) | |
| Disease | Breast Carcinoma | ABL1 RXRB PER3 HERC2 HSPA1B DNMT1 FLNA COL7A1 DYNC2H1 PPM1D SYNE1 KMT2D NISCH EP300 | 1.02e-04 | 538 | 232 | 14 | C0678222 |
| Disease | pulse pressure measurement | RAMP2 MYO1E ING1 MARK3 WBP1L TTC8 COL21A1 DNMT1 COL2A1 COL4A1 COL11A1 DYNC2H1 ZNF618 WWP2 COL27A1 RNF213 KCNH4 VAC14 LATS2 SLC12A2 LPP ABCB11 ZFHX3 ELN CTNND2 | 1.10e-04 | 1392 | 232 | 25 | EFO_0005763 |
| Disease | Malignant neoplasm of breast | ABL1 HDAC4 RXRB PER3 LRRC7 HERC2 HSPA1B DNAH9 DNMT1 FLNA COL7A1 COL11A1 DYNC2H1 PPM1D SYNE1 NUP98 TACC2 KMT2D NISCH PUS1 EP300 | 1.27e-04 | 1074 | 232 | 21 | C0006142 |
| Disease | Muscular Dystrophy, Facioscapulohumeral | 1.29e-04 | 13 | 232 | 3 | C0238288 | |
| Disease | EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 1 | 1.84e-04 | 3 | 232 | 2 | C4552122 | |
| Disease | Ehlers-Danlos Syndrome, Autosomal Dominant, Type Unspecified | 1.84e-04 | 3 | 232 | 2 | C0220679 | |
| Disease | Ehlers-Danlos syndrome classic type 1 (implicated_via_orthology) | 1.84e-04 | 3 | 232 | 2 | DOID:14720 (implicated_via_orthology) | |
| Disease | choline deficiency disease (biomarker_via_orthology) | 1.84e-04 | 3 | 232 | 2 | DOID:8456 (biomarker_via_orthology) | |
| Disease | Hemorrhage, intracerebral, susceptibility to | 1.84e-04 | 3 | 232 | 2 | cv:C3281105 | |
| Disease | HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO | 1.84e-04 | 3 | 232 | 2 | 614519 | |
| Disease | Dupuytren Contracture | 2.17e-04 | 108 | 232 | 6 | EFO_0004229 | |
| Disease | atherosclerosis (is_implicated_in) | 2.49e-04 | 16 | 232 | 3 | DOID:1936 (is_implicated_in) | |
| Disease | Mammary Carcinoma, Human | ABL1 RXRB PER3 HSPA1B DNMT1 FLNA COL7A1 DYNC2H1 PPM1D SYNE1 KMT2D NISCH EP300 | 2.91e-04 | 525 | 232 | 13 | C4704874 |
| Disease | Mammary Neoplasms, Human | ABL1 RXRB PER3 HSPA1B DNMT1 FLNA COL7A1 DYNC2H1 PPM1D SYNE1 KMT2D NISCH EP300 | 2.91e-04 | 525 | 232 | 13 | C1257931 |
| Disease | Mammary Neoplasms | ABL1 RXRB PER3 HSPA1B DNMT1 FLNA COL7A1 DYNC2H1 PPM1D SYNE1 KMT2D NISCH EP300 | 3.01e-04 | 527 | 232 | 13 | C1458155 |
| Disease | Stickler syndrome (is_implicated_in) | 3.66e-04 | 4 | 232 | 2 | DOID:0080046 (is_implicated_in) | |
| Disease | Primary Ciliary Dyskinesia | 5.09e-04 | 47 | 232 | 4 | C4551720 | |
| Disease | myopathy (implicated_via_orthology) | 5.52e-04 | 48 | 232 | 4 | DOID:423 (implicated_via_orthology) | |
| Disease | Malignant Cystosarcoma Phyllodes | 6.06e-04 | 5 | 232 | 2 | C0600066 | |
| Disease | Endometrial Stromal Sarcoma | 6.06e-04 | 5 | 232 | 2 | C0206630 | |
| Disease | migraine disorder, type 1 diabetes mellitus | 6.06e-04 | 5 | 232 | 2 | MONDO_0005147, MONDO_0005277 | |
| Disease | Phyllodes Tumor | 6.06e-04 | 5 | 232 | 2 | C0010701 | |
| Disease | graft-versus-host disease (biomarker_via_orthology) | 6.06e-04 | 5 | 232 | 2 | DOID:0081267 (biomarker_via_orthology) | |
| Disease | Intervertebral disc disorder | 6.06e-04 | 5 | 232 | 2 | cv:C0158252 | |
| Disease | Stickler syndrome | 6.06e-04 | 5 | 232 | 2 | cv:C0265253 | |
| Disease | Lumbar disc disease | 6.06e-04 | 5 | 232 | 2 | C0221775 | |
| Disease | INTERVERTEBRAL DISC DISEASE | 6.06e-04 | 5 | 232 | 2 | 603932 | |
| Disease | mean arterial pressure | HDAC4 PCNX3 WBP1L DNMT1 COL5A1 COL9A3 TCF20 PKD2L1 RNF213 TNS2 RAB11FIP5 ZFHX3 | 6.40e-04 | 499 | 232 | 12 | EFO_0006340 |
| Disease | otitis media (implicated_via_orthology) | 6.62e-04 | 22 | 232 | 3 | DOID:10754 (implicated_via_orthology) | |
| Disease | S-6-hydroxywarfarin to S-warfarin ratio measurement | 6.63e-04 | 88 | 232 | 5 | EFO_0803332 | |
| Disease | nevus count, cutaneous melanoma | 7.73e-04 | 91 | 232 | 5 | EFO_0000389, EFO_0004632 | |
| Disease | osteoarthritis, hip | 8.12e-04 | 92 | 232 | 5 | EFO_1000786 | |
| Disease | Carcinoma, Pancreatic Ductal | 8.60e-04 | 24 | 232 | 3 | C0887833 | |
| Disease | Intervertebral disc disorder | 9.04e-04 | 6 | 232 | 2 | C0158252 | |
| Disease | Clear cell sarcoma of kidney | 9.04e-04 | 6 | 232 | 2 | C0334488 | |
| Disease | Nephrotic Syndrome | 1.22e-03 | 27 | 232 | 3 | C0027726 | |
| Disease | Obesity | 1.24e-03 | 205 | 232 | 7 | C0028754 | |
| Disease | hair colour measurement | IL16 HDAC4 MARK3 ADGRV1 ZNF469 AHNAK HERC2 ZNF618 KMT2D LORICRIN SP6 SLC45A1 ARHGEF26 | 1.25e-03 | 615 | 232 | 13 | EFO_0007822 |
| Disease | Autoimmune Lymphoproliferative Syndrome Type 2B | 1.26e-03 | 7 | 232 | 2 | C1846545 | |
| Disease | Bleeding tendency | 1.26e-03 | 7 | 232 | 2 | C1458140 | |
| Disease | degenerative disc disease (implicated_via_orthology) | 1.26e-03 | 7 | 232 | 2 | DOID:90 (implicated_via_orthology) | |
| Disease | C-reactive protein measurement | ATXN2L ZSWIM8 ING1 HLX GBX1 ADARB1 ZNF469 CAMKV NYNRIN AHNAK PXN TAF4 ZNF316 ZBTB9 MLLT10 MST1R CD33 ABCB11 SSBP4 FYB1 | 1.44e-03 | 1206 | 232 | 20 | EFO_0004458 |
| Disease | cutaneous melanoma, hair color | 1.45e-03 | 62 | 232 | 4 | EFO_0000389, EFO_0003924 | |
| Disease | serum alanine aminotransferase measurement | ATXN2L DLGAP1 MARK3 NYNRIN AHNAK RECQL4 DNMT1 COL4A2 WWP2 COL27A1 PKD2L1 TRMT44 LINC02902 FAM222B SP6 ABCB11 | 1.52e-03 | 869 | 232 | 16 | EFO_0004735 |
| Disease | carcinoma (implicated_via_orthology) | 1.64e-03 | 64 | 232 | 4 | DOID:305 (implicated_via_orthology) | |
| Disease | arterial stiffness measurement | 1.64e-03 | 64 | 232 | 4 | EFO_0004517 | |
| Disease | osteoarthritis, spine, body mass index | 1.67e-03 | 8 | 232 | 2 | EFO_0004340, EFO_1000787 | |
| Disease | Ehlers-Danlos syndrome | 1.67e-03 | 8 | 232 | 2 | cv:C0013720 | |
| Disease | corneal topography | 1.73e-03 | 109 | 232 | 5 | EFO_0004345 | |
| Disease | Early Pregnancy Loss | 1.73e-03 | 109 | 232 | 5 | C3830362 | |
| Disease | Spontaneous abortion | 1.73e-03 | 109 | 232 | 5 | C0000786 | |
| Disease | Miscarriage | 1.73e-03 | 109 | 232 | 5 | C4552766 | |
| Disease | Abortion, Tubal | 1.73e-03 | 109 | 232 | 5 | C0000822 | |
| Disease | Schizophrenia | DLGAP1 HDAC4 NUMBL CSMD2 ARHGEF11 ADARB1 MBD2 HSPA1A HSPA1B DNMT1 CACNA1F LASP1 SHANK3 SLC12A2 ELAVL2 CTNND2 | 1.78e-03 | 883 | 232 | 16 | C0036341 |
| Disease | Ciliopathies | 1.80e-03 | 110 | 232 | 5 | C4277690 | |
| Disease | myocardial infarction | 1.91e-03 | 350 | 232 | 9 | EFO_0000612 | |
| Disease | Ehlers-Danlos syndrome (is_implicated_in) | 2.14e-03 | 9 | 232 | 2 | DOID:13359 (is_implicated_in) | |
| Disease | Major depression, single episode | 2.14e-03 | 9 | 232 | 2 | C0024517 | |
| Disease | hand, foot and mouth disease, illness severity status | 2.14e-03 | 9 | 232 | 2 | EFO_0007294, EFO_0007863 | |
| Disease | Leukemia, Myelocytic, Acute | 2.54e-03 | 173 | 232 | 6 | C0023467 | |
| Disease | Kartagener Syndrome | 2.61e-03 | 35 | 232 | 3 | C0022521 | |
| Disease | coronary aneurysm | 2.61e-03 | 35 | 232 | 3 | EFO_1000881 | |
| Disease | Ciliary Dyskinesia, Primary, 1, With Or Without Situs Inversus | 2.61e-03 | 35 | 232 | 3 | C4551906 | |
| Disease | Polynesian Bronchiectasis | 2.61e-03 | 35 | 232 | 3 | C4317124 | |
| Disease | diastolic blood pressure, systolic blood pressure | HDAC4 ADD1 COL21A1 ACAN COL4A1 COL4A2 DYNC2H1 COL5A3 SYDE1 VAC14 FAM222B ZFHX3 ELN | 2.65e-03 | 670 | 232 | 13 | EFO_0006335, EFO_0006336 |
| Disease | osteoporosis | 2.65e-03 | 73 | 232 | 4 | EFO_0003882 | |
| Disease | tauopathy (implicated_via_orthology) | 2.66e-03 | 10 | 232 | 2 | DOID:680 (implicated_via_orthology) | |
| Disease | Primary ciliary dyskinesia | 2.83e-03 | 36 | 232 | 3 | cv:C0008780 | |
| Disease | hoarding disorder | 2.83e-03 | 36 | 232 | 3 | EFO_0803361 | |
| Disease | Acute Myeloid Leukemia, M1 | 3.14e-03 | 125 | 232 | 5 | C0026998 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QGVTKGEGGTPAPAS | 171 | Q96PM9 | |
| KGVPAGNSDTEGGQP | 831 | Q9UKV3 | |
| TRSTKAGGPGAAAGP | 261 | Q8N350 | |
| SLGPAIASGNSGPGI | 16 | P27540 | |
| TGAPVGLGNPSSLGV | 431 | Q09472 | |
| VGGPPEDSGASAAKG | 376 | Q9Y2D5 | |
| NGQTVEISGSPGPKG | 1071 | Q14031 | |
| EISGSPGPKGQPGES | 1076 | Q14031 | |
| LNGLPGTKGTHGTPG | 1176 | Q14031 | |
| LGPSGLVGPKGESGS | 456 | Q14050 | |
| QGPQGVPGTSKDGQD | 621 | Q14050 | |
| VPGTSKDGQDGAPGE | 626 | Q14050 | |
| GGDLTGPSGVILSPN | 1446 | Q7Z408 | |
| SGSKGEQGFPGLPGT | 126 | Q01955 | |
| PGRQGAAGLKGSPGS | 501 | Q01955 | |
| DPSLEGGVNGKNLGP | 446 | P26358 | |
| LGPSGLPGSTGEKGQ | 386 | Q07092 | |
| GAQGSPGVKGATGPV | 821 | Q07092 | |
| QPGPAGISAVGLKGD | 1301 | Q07092 | |
| VGPDGASPTTENGLG | 251 | P18825 | |
| KLVNISGGSPGPGGQ | 1206 | Q8WXG9 | |
| GPPEVEGGTKATGNC | 1346 | O15085 | |
| GGSSEDKGGLQPPDS | 501 | P51693 | |
| TGVTGVQGPPGLKGQ | 1136 | P08572 | |
| PGSAALPGSKGDTGN | 1301 | P08572 | |
| PEITPGNQSDGGGTL | 296 | Q69YQ0 | |
| KPGEMTALVGPSGAG | 446 | O95342 | |
| KGPQITGPSLEGDLG | 371 | Q09666 | |
| EGPSKGSVNGGKASP | 156 | O14490 | |
| PGGSPKSPANGAVTL | 121 | Q96DR7 | |
| KPLAAPGDGEGLGQT | 811 | Q9Y4F5 | |
| KNEGEAAASGGGPPS | 326 | Q13319 | |
| APQGGSPTKLQRGGS | 271 | Q9UQB3 | |
| KGGVPGTPSTQSLGS | 51 | Q96CP6 | |
| IGSARGQSTGKGPPQ | 96 | Q8WWM7 | |
| GVKGESGSPGENGSP | 306 | P02458 | |
| ASGNPGTDGIPGAKG | 406 | P02458 | |
| GPTGVTGPKGARGAQ | 876 | P02458 | |
| LAGSPGIPGSKGEQG | 1196 | P02462 | |
| GPGEAAASGSGLEKP | 56 | Q2M1V0 | |
| PGEKGEAGTPVAAGT | 271 | Q9Y6R0 | |
| PTTGTPGSEGGTVKN | 46 | O60895 | |
| IPSTDANLPSGGKGF | 166 | Q9UL26 | |
| APDGVLLFSGGKSGP | 3961 | P98160 | |
| SSLPGFQPVGSKDGA | 86 | Q8IVA1 | |
| SSGSNGKGPAVGDAP | 196 | O95716 | |
| SSLGEKGGPILGASP | 481 | Q9BXF6 | |
| PGAGGGAPLQEELKS | 686 | Q9Y4B5 | |
| ITKPGGSAKDAAPGG | 291 | Q08AF8 | |
| DKGLGTGQGAVSGPP | 506 | O00255 | |
| SAEGVGGAPTPKGQA | 216 | Q9P2A4 | |
| KVPPSGSGGSELSNG | 711 | Q96PE2 | |
| GPPAVEGESSGASGL | 31 | O60840 | |
| KERGAGASGGPSTDP | 541 | Q13164 | |
| AGAKLEPSIGVNGGP | 21 | Q0GE19 | |
| GNSIFGSKPAPGTLG | 416 | P52948 | |
| PVGKGGAGASSSLSP | 161 | Q16849 | |
| GSGVGGKPEEESPST | 266 | A8MTJ6 | |
| GQAVIGPPGSGKTTY | 11 | Q9H9Y4 | |
| LGLPATGPSAGTAGQ | 356 | P56524 | |
| PGAVGGTSGKPALED | 101 | Q8NHW3 | |
| GNGKTVPGETGLPGS | 321 | Q6P0N0 | |
| GGGGASELLPATQPT | 456 | Q14774 | |
| GDKPGVSPSIGLSVG | 191 | Q9UGP4 | |
| PETGGYASLPTKGQG | 281 | Q9NRM7 | |
| ISGGISGQGNPFKPS | 1461 | Q96NW7 | |
| DTGGKPSTRGGDPAA | 36 | Q38SD2 | |
| GTEGPAASRGGPKVV | 2306 | Q9UKN7 | |
| AVGADGKAAGTPGPT | 181 | Q5T442 | |
| TGDVHGTPATKGPGS | 266 | O95714 | |
| QNPTTGIFPGDGSGK | 236 | P20138 | |
| AVGQGSSSPPGGKHT | 1766 | Q2KJY2 | |
| TNPPGGKGSGIFDES | 61 | Q9H910 | |
| APVSIQRSAPGGGGK | 191 | Q14847 | |
| TAPGGGPGSGVDAKA | 1121 | Q96Q04 | |
| TPLVGKAGSSCQGPG | 1861 | Q9P219 | |
| SGVGSPVSGTPKQLA | 131 | Q9Y6W6 | |
| KGVLSGAEAPTQSPG | 296 | Q5VYM1 | |
| GSTGPAGQKGDSGLP | 1516 | P12107 | |
| GPKGGSGSGPTIEEV | 626 | P0DMV9 | |
| FKPVTGTRTEPNGGG | 486 | P56645 | |
| SGGGGLTSLSNNPPV | 1841 | Q9H6A9 | |
| SGVPGSKTGTAGVPS | 7451 | Q7Z5P9 | |
| TAAPGKQAGTSGVAP | 7676 | Q7Z5P9 | |
| NGGLSPGNPGDSKDM | 366 | Q9H792 | |
| SGTPAPGLTGKHAAG | 381 | Q8WU58 | |
| GGAPAGPAGTGKTET | 1841 | Q96JB1 | |
| PAASRGGPGLSKNGE | 266 | O15117 | |
| PGSPGAAAVVKGLAG | 236 | P58012 | |
| PGPGIGPQTKSSTEG | 661 | Q14005 | |
| NLGGAPEGPAGTGKT | 1246 | Q6ZR08 | |
| PLGPSRGKGVGSTFE | 761 | Q9P1Y6 | |
| KDITQSGSPGLGPQG | 131 | Q9UQ05 | |
| KGGHSGQLGPSSVAP | 371 | Q93052 | |
| KTPGNGDGGSTSEAP | 81 | Q15014 | |
| QPPVDCVKTSGGGGG | 11 | P23490 | |
| VGLSGPPGAGKSTFI | 146 | Q8IVH4 | |
| ASEDTPQVPGLGSGG | 2306 | Q9UMN6 | |
| AALPGGEVSGKGPAV | 56 | O15297 | |
| TDGCTPPGGKQAGAE | 341 | Q9P0K8 | |
| QVPGAGQDGSPGLSK | 226 | Q14749 | |
| PSSGGALKPGRAVEG | 716 | Q7Z3U7 | |
| PGTGLGTSPALAGDE | 496 | P35568 | |
| SPKDGSTPGPGEGSQ | 26 | P78563 | |
| GRGAGKPATGPTNSS | 6 | Q9BT25 | |
| LVAPSPDQKGSGTGG | 206 | C9JSJ3 | |
| GQAKTPLGVPMSGTG | 156 | Q969R2 | |
| SAGAGGIDGKPRTSP | 6 | Q02978 | |
| LGKLPSGTLGSGQAP | 1606 | P16112 | |
| AGDISGATPVLPGSG | 2076 | P16112 | |
| AGGSTPSVAGPLGVN | 451 | Q86XN7 | |
| VPASGVGSPADGLGL | 121 | P14652 | |
| YGVPETNSPLGGKAG | 181 | P49023 | |
| PKGLQGVGPGSNDET | 306 | Q9UBB5 | |
| ETGSILPGAIGGSKP | 156 | P15863 | |
| GGAPAGPAGTGKTET | 1576 | Q9P2D7 | |
| IPGDASGPLSGKNLS | 466 | Q8NCM8 | |
| PKSLAGSLGPGASSG | 56 | Q658K8 | |
| GGISPKGSGPSVASD | 211 | Q96EP1 | |
| QPGKSSAVAASGPLG | 886 | O60308 | |
| EGAPVTAGVTAPGGK | 246 | Q14549 | |
| ITKPGGSAKDAAPGG | 291 | Q0D2H9 | |
| TGQAPPSSKGEEAAG | 476 | Q8NCB2 | |
| SEGPTGPQGLQGLSI | 416 | Q2UY09 | |
| PAGQGLPGSKGEVGQ | 471 | Q2UY09 | |
| ASKVTAQGPGLEPSG | 381 | P21333 | |
| ARLGAGGGSPEKSPS | 11 | Q9UNE7 | |
| EKGDPGSQGSPGSRG | 1486 | A8TX70 | |
| KDPPSAVGSGNAGGS | 96 | Q96RY5 | |
| SVGTPVGPETGGEKN | 1441 | Q3T8J9 | |
| PGPREGGSGKETTSE | 16 | Q6ZTY9 | |
| TPGSKGSKGEPGIQG | 651 | Q96P44 | |
| PQVLGLTASPGTGGA | 161 | Q96C10 | |
| VTPTSKAGSGAPGGT | 851 | P00519 | |
| AIGTDGTPGAKGPTG | 421 | P05997 | |
| SSGPKGEQGITGPSG | 1511 | P20908 | |
| SVNSTPGDKGPGIKG | 296 | Q494V2 | |
| GRTGLPGNQGEPGSK | 1511 | Q8IZC6 | |
| DPSSVSPGGTGGQKL | 806 | Q674R7 | |
| SPGGTGGQKLAQLPE | 811 | Q674R7 | |
| TSLAGINIPGHPGTG | 261 | Q12926 | |
| QGATGTPGPQGEKGS | 216 | Q9UEW3 | |
| SGVPGPAGVKGEQGS | 366 | Q9UEW3 | |
| SGSAVGGKGIAPASP | 456 | P27448 | |
| PATPGSQNKASDGIG | 2251 | O15021 | |
| GLKGGIPLEFGSQTP | 71 | P59910 | |
| QGQKPPSGDELLGGA | 271 | Q12952 | |
| GGGTPSKGVNFAEEP | 66 | P31323 | |
| QGPPGSATAKGERGF | 1286 | Q02388 | |
| QGSPGLPGQVGETGK | 2241 | Q02388 | |
| SKTDTGRGNGPLPLG | 426 | Q8N8S7 | |
| RGGFAVPSGETPKGV | 356 | A6NMB9 | |
| GAPAGPAGTGKTETT | 1866 | Q9NYC9 | |
| GPKGGSGSGPTIEEV | 626 | P0DMV8 | |
| LIPGSSGKNGPVSSG | 321 | Q7Z2K8 | |
| KGAGLGPQAPDSQAS | 741 | Q9NZM4 | |
| ILPSGVGSGKGSTSP | 616 | O95180 | |
| RFSGAGSGGPKSQPV | 336 | Q96HA4 | |
| PGIGPGGVAAAAKSA | 546 | P15502 | |
| VGGAAAKASSPPGTL | 336 | O75056 | |
| SGTNPKDLTGGSLPG | 491 | Q9UJQ4 | |
| KDLTGGSLPGDLQPG | 496 | Q9UJQ4 | |
| LAIPDAAGGGGPETS | 491 | Q9Y2W3 | |
| TAKEGAPGGTPQAGG | 1351 | P21817 | |
| GTPGAASTAKGSPNG | 86 | Q9UL51 | |
| TPGGIQIAGKTPNDG | 591 | Q86YS7 | |
| VASNKIGGGEPSLPS | 676 | Q9P232 | |
| QSGSEGPVGPAGKKG | 1026 | P25940 | |
| IVNPEPGAASGKSAG | 1291 | Q96JN8 | |
| DEGSQGSPGKRGTPG | 1486 | A6NMZ7 | |
| SGEVGNPLGGSPVKN | 241 | Q9Y5R6 | |
| APGAPGGGQAKAISD | 241 | Q0P6D2 | |
| GAPAGPAGTGKTETT | 1976 | Q8TE73 | |
| LPTGQGKPVAQGGLT | 516 | Q9P2P1 | |
| KAGTAPGQTLAPRGG | 446 | A6NNC1 | |
| TSGGGKVAPAQPSEE | 506 | P23588 | |
| PLGAPEASGKSGAQG | 321 | Q15743 | |
| PGVGTKDALDLPGGS | 726 | Q8IVF1 | |
| PGVGTKDALDLPGGS | 726 | A6NNL0 | |
| PGVGTKDALDLPGGS | 726 | B1AL46 | |
| EGSPGSPAGLGALQS | 406 | Q9NZ71 | |
| GGAKPAEDTSLGPGV | 86 | Q6ZW31 | |
| TPTGLPKGAAGAVTQ | 396 | O00268 | |
| STGGDGGTPKPTVAV | 56 | Q15542 | |
| GSASGPAAPGKVGSV | 176 | Q15542 | |
| GKGELGSEPPSGLQL | 186 | Q3SY00 | |
| ALPKQEGTASGGPDG | 356 | Q08AM6 | |
| TSAGSEQKERGPGPG | 61 | Q8IYL2 | |
| PAGISGSDLQSSGGP | 576 | Q3ZLR7 | |
| AGGDIGPPNGASKEI | 2496 | Q8WUY3 | |
| GLLKTGSSGALGPPE | 421 | Q9BZL4 | |
| KGGSDSSLSEPGPGR | 8721 | Q8NF91 | |
| GLKPPATGGLSSLGS | 71 | P78426 | |
| SAGILEQGPSPGDGS | 561 | Q68EM7 | |
| AGGTGAKVPSPLEGS | 406 | Q9Y606 | |
| IPGESAVLGPGAGSQ | 221 | O94761 | |
| PSKSAIPIGGGSRGA | 91 | Q9UK53 | |
| PPALGKIANGGGTGA | 196 | P57071 | |
| EGDLVLGSPGPASAG | 156 | Q14761 | |
| PAGVSPKGDIGGTQS | 31 | Q5VWT5 | |
| QGKPESSGQQGKPGS | 201 | A0A1B0GUY1 | |
| GGNRTKTPGPGAQSA | 101 | P62263 | |
| GTPGCAATAKGPGAQ | 76 | Q8IVW8 | |
| DEAAAPGGSVGAGKP | 56 | O00287 | |
| AASGEGKAGGAVEPP | 346 | Q3SY56 | |
| PRGAGGPASAQGSVK | 1021 | Q9UHV7 | |
| QINSTVSLPGGGSGP | 161 | P28702 | |
| GAPAPAGISGSGLQS | 601 | P0C7V6 | |
| KPGGGRNPGTTVSAA | 331 | P55197 | |
| AKSRSPGSPVGEGTG | 351 | P35611 | |
| GPAGIATKGLNGPTG | 476 | Q03692 | |
| RGKSGPSGQTGDPGL | 746 | Q17RW2 | |
| QGKPGLQGLPGSTGD | 971 | Q17RW2 | |
| GVKGSSGLPGSPGIQ | 1336 | Q17RW2 | |
| LSQEGTGPPTSAGEG | 216 | Q63HN8 | |
| EATNVTGPGGVPVKG | 156 | Q9Y2T7 | |
| VAEIPSAGTGPGSKG | 196 | Q9Y2T7 | |
| PNKSAGSGPGKGVSV | 991 | Q5T6F2 | |
| PGAKEEAAGVSGPAG | 221 | Q15654 | |
| RPGFESGTKQGSPGA | 476 | O00308 | |
| VPGLDPSKSGLVGGQ | 331 | Q9H7S9 | |
| LAGAAGLPSTQGTPG | 636 | P0CJ78 | |
| GTSLKLPGTNQTGGP | 91 | Q8TAM2 | |
| LEGPGAPTQGGSKEA | 426 | Q9UPR6 | |
| TLDGKAPEGSPHGGS | 111 | Q5T7W0 | |
| GSSGLSPGPSGQELV | 56 | O95210 | |
| AGRAGQSKISPSGPG | 426 | Q9BYB0 | |
| NSGQLEGSGGAKPPR | 236 | Q8TDD2 | |
| EGSGGAKPPRGASTG | 241 | Q8TDD2 | |
| DGLPKSSPGAVAGLS | 336 | Q9BWG4 | |
| TAPSSGAPGLAGVGE | 6 | P55011 | |
| GAPGLAGVGETPSAA | 11 | P55011 | |
| GAGKSEGSTPADGLP | 911 | Q8IX01 | |
| VAQPAKEGGSGGSGP | 1071 | Q6ZT07 | |
| VVIAKTPGTGGSPQG | 1011 | Q9Y2I1 | |
| PQPGADCKTVVGGGS | 186 | Q5GH76 | |
| SGELKAQVPGSSPGL | 286 | Q86W42 | |
| GLGLGPGQASASSPD | 221 | Q6ZSY5 | |
| GGEIPAVQASSGSPK | 1301 | O95359 | |
| KPGSNQGRPDGSLGG | 1471 | Q9UGU0 | |
| SPQGKSGPEAARAGG | 686 | Q9P0L9 | |
| LAPQKASGGGSSSPG | 841 | Q2VWA4 | |
| PGSSREKVPGGLQGS | 1086 | P49750 | |
| SGPGVQSPGLATGES | 356 | Q9NWS9 | |
| GSQGALGTAGKTPGP | 516 | Q96JG9 | |
| EPKEEISGSGTQPGG | 291 | Q96C00 | |
| GAGPGPTEGFTEKNV | 1071 | A7E2V4 | |
| KGPSSAGPGERGSAL | 961 | A6NFI3 | |
| GAQAAGVTKEGPVGP | 106 | Q8N1G0 | |
| GKPGSAGIISSGPIT | 721 | Q7Z7G0 | |
| KSVQSLATGPAGDPG | 86 | Q04912 | |
| VTGKDGGPGVGPNSV | 351 | Q04912 | |
| LTPEGNKGVTGSGFP | 276 | Q9UPU7 | |
| PSGSVAGLGELDPGA | 196 | Q9NX94 | |
| QGAGPISGPSTGAEE | 116 | Q3YBR2 | |
| QAGTGKAPELPSGSG | 951 | Q63HR2 | |
| SAGVPGPGGSQSADK | 421 | Q8NBT3 | |
| GQGDTRGDGSLPKPS | 16 | B6A8C7 | |
| APAGPEAGGGVAIKT | 261 | Q6ZMS7 | |
| LNSLPGAGGKQGDPS | 171 | Q15911 | |
| AEGGEGNTGPKETLP | 1896 | Q15911 | |
| GGPTAPKAESGRSGG | 246 | P50552 | |
| QGGLSGSGVPSELPQ | 276 | Q9UGR2 | |
| TGTLQKPPNDGGITG | 721 | Q9C0D4 | |
| AVPESPGVGGGKASE | 2256 | O14686 | |
| IQFSPGGEPDGGKIS | 176 | Q12965 |